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Abstract 
 
Neural differentiation from human embryonic stem cells (hESCs) provides a promising source for cell 
replacement therapies. However, the mechanisms underlying the control of neural specification 
remains unclear, which largely hinders their use. Sox2, one of the core transcription factors, has been 
well documented to be vital in the maintenance of pluripotency. However, recent studies on mESCs 
reveal that overexpression of Sox2 promotes neural differentiation, indicating a dual role of Sox2 in 
mESCs, which is still unknown in hESCs. Thus, the function of Sox2 in neural specification was 
investigated. Downregulation of Sox2 in hESCs dramatically leads to non-neural differentiation, 
while in NPCs, the depletion results in the loss of NPC identity, supporting its important role in both 
cells. Interestingly, overexpression of Sox2 regulates hESCs depending on their culture conditions. 
When culture condition is optimized for hESC self-renewal, Sox2 functions to suppress differentiation 
and enhance pluripotency. However, when culture condition does not support hESCs, upon exit of 
pluripotency, Sox2 appears to promote neural differentiation and inhibit the differentiation to other 
lineages. Furthermore, Pax6 is identified to be a binding partner of Sox2 during neural induction and 
Sox2 binds to Oct4 and Pax6 via a same interface. Sox2 and Pax6 co-bind to several regulatory 
elements within Sox2, Pax6 and Oct4 genes during neural differentiation, implying that Sox2 and 
Pax6 function as a complex to regulate these genes. Functionally, an overexpression of Pax6 inhibits 
the transcription activity of Oct4 PE and DE enhancers, possibly with Sox2. Collectively, these results 
demonstrate dual roles of Sox2 in hESCs: maintaining pluripotency and specifying neural 
differentiation upon losing pluripotency, which is likely to be implemented by switching its binding 
partner from Oct4 to Pax6. This study provides a better understanding in the neural differentiation of 
hESCs. In the long term, it will be beneficial for stem cell therapies.  
2 
 
Statement of Originality 
 
All the experiments in this thesis were performed by me unless otherwise stated in the text. 
3 
 
Copyright Declaration 
 
The copyright of this thesis rests with the author and is made available under a Creative 
Commons Attribution Non-Commercial No Derivatives licence. Researchers are free to copy, 
distribute or transmit the thesis on the condition that they attribute it, that they do not use it 
for commercial purposes and that they do not alter, transform or build upon it. For any reuse 
or redistribution, researchers must make clear to others the licence terms of this work 
  
4 
 
Acknowledgement 
 
First and foremost, I would like to thank my supervisor, Dr. Wei Cui, for her encouragement, 
guidance and support to me throughout my PhD projector. Her dedication and enthusiasm for 
research was contagious and motivational for me. The past and present members of SCD lab 
have contributed immensely into my personal and professional life in the I.R.D.B. Especially, 
I want to acknowledge Dr. Fiona Sewell who was the first person to teach me how to do 
experiments, even how to use pipettes.  I would like to thank Dr. Jason Shu Lim Yu for his 
detailed and constructive suggestions. Whenever I encountered any troubles in experiments, 
he was always delightful to help and discuss it. I very appreciated his time and effort. I thank 
Dr. Patrick Ovando-Roche and Dr. Rafal Czapiewski for encouraging me to keep positive 
during tough time in my Ph.D. pursuit. Also my sincere thank goes to the present members, 
Siti Aminah Muhammad Imran and Yueh-Ho Chiu for their invaluable support, 
companionship and encouragement all the time. I thank the following people for providing 
helpful discussions time to time to my project:  Dr. Nick Dibb, Dr. Veronique Azuara and Dr. 
Robert Kypta. I would like to thank Sara Brown, Yunnan Gao and Jonwon Kim for being the 
best students who I had great pleasure from supervising, as well as for their contributions and 
great enthusiasm for this project. The I.R.D.B is a great source of friendships, helpful advice 
and collaboration. I am especially grateful for the intelligent people I meet here: Dr. Camilla 
West, Dr. Shoma Nakagawa, Dr. David Barneda, Dr. Roberta Migale, Silvia Sposini, Sandra 
Riad, Catherine Long and Diana Alexieva. Dr. Rute Tomaz, thank you for sharing me with 
your expertise in Chip-qPCR and being a lovely friend. Miss Emma Bell, thank you for your 
invaluable contributions, enthusiasm in this project and being a lovely friend. I am grateful to 
our department laboratory manager, Mr. Nicholas Wood and technicians, Mrs Pushpa 
Fernando and Mr. Joel Eustaquio who keep the lab organized and always ready to help. For 
this thesis and viva, I sincerely thank Dr. Tristan Rodriguez and Dr. Sally Lowell for their 
time and insightful questions and helpful comments. I greatly acknowledge the Genesis 
Research Trust for supporting my experiment financially. Lastly, I would like to thank my 
family for all their love and encouragement and my parents, Mr. Gaochao Zhang and Dr. 
Yongping Tan for their unconditional love and support. Most of all, great thank goes to my 
husband, Dr Weiqi Li for being the most solid back up for me all the time.   
5 
 
Table of Contents 
 
Abstract ...................................................................................................................................... 1 
Statement of Originality ............................................................................................................. 2 
Copyright Declaration ................................................................................................................ 3 
Acknowledgement ..................................................................................................................... 4 
Table of Contents ....................................................................................................................... 5 
Table of Figures ......................................................................................................................... 9 
Abbreviations ........................................................................................................................... 11 
Chapter One ............................................................................................................................. 13 
1.1 Neural induction ........................................................................................................ 14 
1.1.1 Emergence of neuroectoderm during embryogenesis ........................................ 14 
1.1.2 Regulation of neural induction........................................................................... 15 
1.1.2.1 Intercellular signals ..................................................................................... 15 
1.1.2.2 Transcription factors ................................................................................... 26 
1.2 Modelling neural specification using hESCs ............................................................ 31 
1.2.1 Derivation of hESC lines ................................................................................... 31 
1.2.2 Maintenance of pluripotency ............................................................................. 33 
1.2.2.1 Intrinsic factors ........................................................................................... 33 
1.2.2.2 Extrinsic factors .......................................................................................... 36 
1.2.3 Differentiation of hESCs to neural lineages ...................................................... 38 
1.3 Sox2, a key factor in the regulation of pluripotency and neural differentiation ....... 41 
1.3.1 Sox2 is indispensable in embryonic development ............................................. 41 
1.3.2 Critical role of Sox2 in maintaining pluripotency of ESCs and generation of 
iPSCs 42 
1.3.3 Sox2 in neural differentiation and maintenance of NPCs .................................. 45 
1.3.4 Molecular mechanisms underlying the role of Sox2 in pluripotency and neural 
differentiation ................................................................................................................... 46 
1.3.5 A potential binding partner for Sox2 in neural initiation: Pax6......................... 50 
1.4 Aim and objectives .................................................................................................... 56 
Chapter Two............................................................................................................................. 57 
2.1 Cell culture ................................................................................................................ 58 
2.1.1 Materials ............................................................................................................ 58 
2.1.1.1 Cell Lines .................................................................................................... 58 
2.1.1.2 Growth Factors and Inhibitors .................................................................... 58 
2.1.1.3 Media Components ..................................................................................... 59 
6 
 
2.1.1.4 Media Recipes ............................................................................................ 60 
2.1.1.5 Disassociation Enzymes ............................................................................. 60 
2.1.1.6 Reagents, Chemicals and Kits .................................................................... 61 
2.1.2 Methods.............................................................................................................. 61 
2.1.2.1 Culture and propagation of hESCs ............................................................. 61 
2.1.2.2 Neural differentiation from hESCs ............................................................. 64 
2.1.2.3 Culture and propagation of HEK293T, HT1080 and PC-3 cells ................ 65 
2.1.2.4 Genetic manipulation of cell lines .............................................................. 65 
2.2 Molecular Biology - DNA/RNA techniques ............................................................. 69 
2.2.1 Materials ............................................................................................................ 69 
2.2.1.1 Reagents, Chemicals and Kits .................................................................... 69 
2.2.1.2 Buffers and Solutions ................................................................................. 70 
2.2.1.3 DNA Modifying Enzymes .......................................................................... 72 
2.2.1.4 Plasmids ...................................................................................................... 73 
2.2.1.5 Primers qRT-PCR and ChIP-qPCR ............................................................ 74 
2.2.2 Methods.............................................................................................................. 75 
2.2.2.1 DNA manipulation and cloning .................................................................. 75 
2.2.2.2 Gene expression analysis ............................................................................ 81 
2.3 Molecular Biology – Protein techniques ................................................................... 85 
2.3.1 Materials ............................................................................................................ 85 
2.3.1.1 Reagents, Chemicals and Kits .................................................................... 85 
2.3.1.2 Buffers and Solutions ................................................................................. 87 
2.3.1.3 Antibodies ................................................................................................... 89 
2.3.2 Methods.............................................................................................................. 91 
2.3.2.1 Immunoblotting .......................................................................................... 91 
2.3.2.2 Co-immunoprecipitation (Co-IP) ............................................................... 92 
2.3.2.3 Immunostaining of hESCs .......................................................................... 92 
2.3.2.4 Fluorescence activated cell sorting ............................................................. 93 
2.4 Software and Online Tools ........................................................................................ 94 
Chapter Three........................................................................................................................... 95 
3.1 Introduction ............................................................................................................... 96 
3.2 Results ....................................................................................................................... 97 
3.2.1 Dynamic expression of Sox2, Oct4, Pax6 and Brn2 during early neural 
differentiation of hESCs ................................................................................................... 97 
3.2.2 Sox2 is essential for maintenance of pluripotency in hESCs .......................... 104 
3.2.3 Deficiency of Sox2 in hESCs results in differentiation into non-neural lineages.
 106 
7 
 
3.2.4 Sox2 is required to maintain NPC identity ...................................................... 107 
3.3 Discussion ............................................................................................................... 110 
3.3.1 Pax6 is an early marker of human neural differentiation ................................. 111 
3.3.2 Sox2 is indispensable for the pluripotency of hESCs ...................................... 112 
3.3.3 Sox2 is required to maintain NPC identity ...................................................... 113 
Chapter Four .......................................................................................................................... 114 
4.1 Introduction ............................................................................................................. 115 
4.2 Results ..................................................................................................................... 116 
4.2.1 Generation of Sox2 overexpressing hESC lines .............................................. 116 
4.2.2 Sox2 overexpression enhances hESC self-renewal under the hESC culture 
conditions........................................................................................................................ 119 
4.2.3 Versatile effects of Sox2 overexpression on hESCs in suboptimal cultures ... 121 
4.2.4 Sox2 Overexpression enhances neural differentiation in serum-free medium 124 
4.3 Discussion ............................................................................................................... 127 
4.3.1 Manipulation of Sox2 level in hESCs .............................................................. 127 
4.3.2 Sox2 enhances self-renewal of hESCs under optimal and suboptimal hESC 
culture conditions ........................................................................................................... 129 
4.3.3 Sox2 promotes neural differentiation upon losing pluripotency ...................... 132 
4.3.4 Effect of Sox2 in hESCs is influenced by extrinsic factors ............................. 134 
Chapter Five ........................................................................................................................... 136 
5.1 Introduction ............................................................................................................. 137 
5.2 Results ..................................................................................................................... 138 
5.2.1 Identification of Pax6 as a binding partner of Sox2 in early neural 
differentiation ................................................................................................................. 138 
5.2.2 Sox2 interacts with Oct4 and Pax6 via the same interface .............................. 140 
5.2.3 Binding of Sox2, Oct4 and Pax6 in Sox2 locus ............................................... 144 
5.2.4 Binding of Sox2, Oct4 and Pax6 Oct4 locus ................................................... 147 
5.2.5 Binding of Sox2, Oct4 and Pax6 on Pax6 locus .............................................. 149 
5.2.6 OCT4 and SOX2 are unable to induce Oct4-luciferase activity in HT1080 cells
 152 
5.2.7 Regulation of Oct4 transcriptional activity in hESCs is through PE and DE 
enhancers ........................................................................................................................ 155 
5.2.8 Pax6 negatively regulates Oct4 transcriptional activity................................... 157 
5.3 Discussion ............................................................................................................... 159 
5.3.1 Partnership of SOX2 and Pax6 in neural differentiation ................................. 159 
5.3.2 Cooperation of Sox2 and Pax6 in neural induction ......................................... 160 
5.3.3 Regulatory elements of Oct4 in hESCs ........................................................... 162 
8 
 
5.3.4 Requirement for Oct4 and Sox2 to activate Oct4 expression is more 
complicated ..................................................................................................................... 163 
Chapter Six............................................................................................................................. 165 
6.1 Dual role of Sox2 in hESCs .................................................................................... 166 
6.2 Effect of Sox2 in hESCs is influenced by extrinsic factors .................................... 169 
6.3 Identification of Pax6 as a binding partner of Sox2 in NPCs ................................. 170 
6.4 Future work ............................................................................................................. 173 
6.4.1 Does Pax6 compete with Oct4 to bind to Sox2 during neural differentiation?173 
6.4.2 Characterize the effect of Sox2/Oct4 and Sox2/Pax6 complexes on their target 
genes 173 
6.4.3 Identify Sox2-centered interaction network during neural differentiation ...... 174 
Reference ............................................................................................................................... 176 
 
  
9 
 
Table of Figures 
 
Figure 1.1 Discovery of the organizer within amphibian blastopore that can induce the 
formation of neural tissue ........................................................................................................ 16 
Figure 1.2 The default model in Xenopus ............................................................................... 19 
Figure 1.3 Transcriptional regulation of the mouse Oct4 gene ............................................... 35 
Figure 1.4 Sox2 regulates gene expression in pluripotent stem cells and neural progenitor 
cells .......................................................................................................................................... 43 
Figure 1.5 Transcriptional expression of Sox2 is regulated by multiple enhancers located in 
the Sox2 locus .......................................................................................................................... 48 
Figure 1.6 Sox2 binding partners and their functions .............................................................. 50 
Figure 1.7 Pax6 binding sites in NECs revealed by genome-wide ChIP-Seq ......................... 53 
Figure 1.8 Expression of Oct4, Sox2 and Pax6 during mouse/human embryonic development
.................................................................................................................................................. 54 
Figure 1.9 Sox2 and its partners regulate pluripotency and neural differentiation in hESCs .. 56 
Figure 3.1 Neural differentiation from hESCs ......................................................................... 99 
Figure 3.2 Dynamic changes in expression of Oct4, Sox2, Pax6 and Brn2 during hESC neural 
differentiation ......................................................................................................................... 101 
Figure 3.3 Dynamic nuclear expressions of Oct4, Sox2 and Pax6 during neural differentiation
................................................................................................................................................ 103 
Figure 3.4 Deficiency of Sox2 in hESCs by shRNA-knockdown leads to lose of pluripotency
................................................................................................................................................ 105 
Figure 3.5 Sox2 knockdown upregulates non neural lineage markers .................................. 106 
Figure 3.6 Sox2 knockdown in neural progenitors leads to the downregulation of Pax6 and 
Brn2........................................................................................................................................ 108 
Figure 3.7 Effect of Sox2 knockdown in early neural progenitors ........................................ 109 
Figure 4.1 Generation of Sox2-overexpressing hESC lines .................................................. 118 
Figure 4.2 Sox2 overexpression enhances pluripotency of hESCs under the hESC culture 
conditions ............................................................................................................................... 120 
Figure 4.3 Sox2 Overexpression impedes spontaneous differentiation of hESCs ................. 123 
Figure 4.4 Sox2 promotes neural differentiation under the N2B27 culture condition .......... 126 
Figure 5.1 Sox2 interacts with Oct4 and Pax6 in hESCs and NPCs, respectively ................ 139 
10 
 
Figure 5.2 Sox2 mutations affect its interaction with both Oct4 and Pax6 ........................... 143 
Figure 5.3 Binding of Sox2, Oct4 and Pax6 on the Sox2 locus in hESCs or neural 
differentiating cells ................................................................................................................ 146 
Figure 5.4 Binding of Sox2, Oct4 and Pax6 on the Oct4 locus in hESCs or neural 
differentiating cells ................................................................................................................ 148 
Figure 5.5 Binding of Sox2, Oct4 and Pax6 on the Pax6 locus in hESCs or neural 
differentiating cells ................................................................................................................ 151 
Figure 5.6 Sox2 and Oct4 fail to activate Oct4 enhancers in HT1080 cells .......................... 154 
Figure 5.7 Oct4 expressions is regulated by both PE and DE enhancers in hESCs .............. 156 
Figure 5.8 Ectopic expression of Pax6 inhibits Oct4 expression in hESCs. ......................... 158 
  
11 
 
Abbreviations 
 
bFGF Basic fibroblast growth factor 
BMP Bone morphogenetic protein 
ChIP Chromatin immunoprecipitation 
Co-IP Co-immunoprecipitation 
CRs Conservative regions 
DE Distal enhancer 
EBs Embryo bodies 
EpiSCs Epiblast stem cells 
ERK Extracellular signal-regulated kinases 
ESCs Embryonic stem cells 
HMG High-mobility group 
HRE Hormone responsive element 
ICM Inner cell mass 
iPSCs Induced pluripotent stem cells 
IRES Internal ribosomal entry site 
KSR Knockout serum replacement 
LIF Leukaemia inhibitory factor 
MAPK Mitogen-activated protein kinase 
MEFs Mouse embryonic fibroblasts 
NECs Neuroepithelial cells 
NLK Nemo-like kinase 
NPCs Neural progenitor cells 
12 
 
Pax6 Paired-box protein 6 
PE Proximal enhancer 
PI3K Phosphatidylinositol-3 kinase 
POU Pit-oct-unc 
Smad3 Mothers against decapentaplegic homolog 3 
Sox SRY (sex determining region Y)-box 
Sox2-OE Sox2-overexpressing (Sox2-OE) 
SRR Sox2 regulatory regions 
TGF-β Transforming growth factor 
Chapter one 
___________________________________________________________________________  
13 
 
Chapter One 
 
Introduction  
Chapter one 
___________________________________________________________________________  
14 
 
1.1 Neural induction 
1.1.1 Emergence of neuroectoderm during embryogenesis 
In mammals, fertilisation occurs when a sperm successfully enters into an egg cell and then 
the genetic material from sperm and egg fuses together to form a single cell, called zygote. 
The zygote goes through a process called cleavage to produce a cluster of cells which form 
the blastocyst. Cells within this blastocyst turn into two layers: an out layer of cells called 
trophectoderm (TE) and inner cell mass (ICM). Further the ICM differentiates into an upper 
layer, the epiblast and a lower layer the hypoblast (primitive endoderm), which make up the 
main layers of the bilaminar germ disc. After implantation, the epiblast undergoes 
gastrulation to form three germ layers: ectoderm, mesoderm and endoderm, which will give 
rise to all the cell types within the body.  
 
Following gastrulation, the next event occurs in the ectoderm is called neurulation that finally 
contributes to the formation of neural tube, neural crest cells and epidermis. Cells from 
ectoderm respond to the signal from the notochord to form the neural plate (O'Rahilly and 
Muller, 1994). The neural plate then becomes thicker and continues to elongate until its ends 
fold upward as neural fold. Ends of the fold migrate towards the middle line and fuse together 
to form the neural tube which will develop to centre nervous system. 
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1.1.2 Regulation of neural induction 
1.1.2.1 Intercellular signals  
The concept of neural induction was first defined by Spemann and Mangold around 1920s 
(Spemann, 1921, Spemann and Mangold, 1924). Studying on amphibian embryos, these 
scientists found that transplantation of a dorsal lip of the blastopore to a host embryo in a 
different location induces a formation of a second body axis which subsequently becomes a 
second neural tube and finally a second mature nervous system (Figure 1.1). An interesting 
finding from this experiment is that the second nervous system was derived from the cells of 
the recipient embryo but not from the donor tissue itself. Therefore, the dorsal lip of the 
blastopore in amphibian embryos is defined as the organizer which can organize an 
appropriate formation of the second axis from a host tissue. Following this, many studies also 
identified the organizer in mammals, birds and reptiles, is in the Hensen’s node (Waddington, 
1936, Waddington, 1932, Waddington, 1933, Waddington, 1937). The discovery of the 
organizer provided the first evidence that a certain tissue induces neighbouring tissue to adopt 
a particular fate. Spemann also showed that cells from the surface ectoderm, which 
eventually become skin, can be induced to become neural tissue by the organizer transplanted 
into their midst. Therefore, these cells must still possess the ability to adopt other fates. Thus, 
the process of neural induction includes: 1) Signals emitting from cells of the organizer; 2) 
competent cells responding to these signals.  
Chapter one 
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(Adapted from Price et al., 2011.) 
Figure 1.1 Discovery of the organizer within amphibian blastopore that can induce the 
formation of neural tissue 
(A) The dorsal lip of the blastopore (red) from the embryo 1 (the donor) was transplanted 
into the embryo 2 (the host) at a different location, so that the embryo 2 has two lips. (B) An 
additional neural plate was generated in embryo 2. Some of the cells within this additional 
plate are derived from the donor (red), while most of cells come from the host embryo. 
Therefore, the donor tissue can induce the host cells to generate an additional neural plate, 
as termed organizer. (C) The additional neural plate subsequently generated a second 
nervous system. (D) Base on the generation of the second nervosa system, an entire second 
body axis was formed.  
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The default model: BMPs inhibition 
After the discovery of the organizer, during the 1990s a hypothesis, known as the default 
model, was made to explain neural induction. As we know, currently many studies have 
indicated that the default mode is too simple to explain the complex neural induction, but it 
still helps us to understand the neural induction in many species. Majority of the studies led 
to this hypothesis were performed on tissue called the animal cap in the blastula of amphibian 
embryos (Born et al., 1989, Godsave and Slack, 1989, Grunz and Tacke, 1989, Sato and 
Sargent, 1989, Saint-Jeannet et al., 1990). When the animal caps were dissected and cultured 
at a high density, they developed into epidermis. However, when cells from this tissue were 
dissociated into single cells, they differentiate into neural cells. One suggestion to explain this 
phenomenon was that the dissociation of cells enables molecules that prevent neural 
differentiation diffuse into surrounding fluid. Consequently, the concentration of the 
molecules is decreased, which allows the cells differentiate into neural lineage by default.  
 
If that is the case, what are the molecules preventing neural induction? Bone morphogenetic 
protein (BMP) family consists of about 20 secreted intercellular signalling molecules, was 
originally identified by their function on inducing the formation of bone and cartilage in the 
mid-1960s (Urist, 1965). Now they have been found to medicate signalling between cells in 
many organs and at many stages of embryogenesis and development (Munoz-Sanjuan and 
Brivanlou, 2002, Christiansen et al., 2000, Niswander and Martin, 1993, Wall and Hogan, 
1994). Among these family of proteins, BMP2, BMP4 and BMP7 were found in the animal 
cap of the blastula. When added into the in vitro culture, BMP4 blocked neural differentiation 
from the dissociated cells isolated from the animal cap (Hawley et al., 1995, Wilson and 
Hemmati-Brivanlou, 1995). More evidence was found to support the critical role of BMP in 
Chapter one 
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preventing neural differentiation: By blocking the BMP signalling in culture, the intact 
animal cap cells (not dissociated) adopted neural fates (Sasal et al., 1995, Xu et al., 1995, 
Hawley et al., 1995). These experiments indicated that the organizer induces neural 
differentiation by producing active molecules that inhibit BMP signalling into the animal cap, 
thereby avoiding acquisition of an epidermal fate and promoting neural differentiation. If this 
is the case, what are the molecules generating by the organizer? 
 
During the 1990s, Richard Harland’s group at the University of California at Berkeley were 
working on the frog egg with neural defect caused by exposing to ultraviolet light. They were 
taking these eggs as a model system to examine which molecules producing by the organizer 
can reverse this defect. Finally, they found that an active protein, called noggin can rescue the 
defect (Smith and Harland, 1992). The name, noggin, which is slang for “head”, came from 
its ability to produce embryo with abnormally large heads when exposed at a high 
concentration. At the same time, other proteins potentially important for neural induction 
were found in the organizer, such as chordin (named because it is expressed in both the 
organizer and later in notochord) (Sasal et al., 1995, Sasai et al., 1994), follistatin (Hemmati-
Brivanlou and Melton, 1994) as it was first identified in ovarian fluid and Cerberus (named 
after the multi-headed dog in Greek mythology). Experiments on these molecules showed 
that they all function to inhibit the activity of BMPs and deficiency of these proteins in 
Xenopus embryos resulted in severe loss of neural plate tissue. According to the above 
experiments, a default model was proposed (Figure 1.2). 
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(Adapted from Stern, 2005.) 
Figure 1.2 The default model in Xenopus 
 (A) A rough fate map of a blastula-stage embryo. In it, the organizer (red), ventral 
mesoderm (pink), neural tissue (blue), epidermis (yellow) and yolky endoderm (green) were 
marked. The red lines represent BMP antagonists emitting from the organizer. (B) A 
schematic diagram of neural induction proposed by the model. Cells from the ectoderm have 
an autonomous tendency to give rise to neural cells, but its differentiation is directed by 
BMP4 into epidermis. Blocking the BMP4 by its antagonists allows surrounding ectoderm 
cells to differentiate according to their default neural fate. 
 
Fibroblast growth factors (FGFs) 
Increasing evidence has indicated that neural induction is a more complex process, not simply 
being regulated by a default pathway and that FGF signalling has been shown to participate 
in the regulation of neuroectoderm formation (Stern, 2005, Stern, 2006). However, 
conflicting results have been obtained from different model systems and experimental 
conditions, thereby the role of FGF signalling in neural induction is still not fully understood. 
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FGFs are a family of secretory growth factors, consisting of at least 22 members in human. 
They exert their function via specifically binding to 4 highly conserved FGF receptors 
(Ornitz and Itoh, 2001, Ornitz et al., 1996) and this ligand–receptor interaction leads to the 
activation of multiple downstream signal transduction pathways, such as the Ras/ERK 
pathway associated with proliferation and differentiation, the Akt pathway involved in cell 
survival and the protein kinase C (PKC) pathways related with morphology and migration 
(Dailey et al., 2005, Mohammadi et al., 2005, Schlessinger, 2000). 
 
The requirement of FGFs in neural induction was initially proposed by the experiments 
which showed that a dominant negative FGF receptor (XFD) in amphibians prevented 
organizer-induced neural induction and blocked the animal cap neutralization in response to 
BMP inhibition (Launay et al., 1996, Sasai et al., 1996). However, subsequent experiments 
suggested that the BMP antagonists-initiated neural induction was independent of FGFs, 
while FGFs may play a role in posterior neural patterning (McGrew et al., 1997, Barnett et al., 
1998). This notion was further reinforced by the experiments using a dominant negative Ras 
mutant (N17Ras) to show that FGF signalling or MAP kinase activation is dispensable for 
neural induction, but required for the formation of posterior neural tissues (Ribisi et al., 2000). 
Later experiments with application of specific FGF receptor inhibitor SU5402 at different 
time point of embryonic development in Xenopus suggested that FGF signalling may be 
temporally required at pre-gastrulation stage, but weak FGF signals in combination of BMP 
inhibition elicit neural specification, where the function of FGFs at each stage of 
development still needs to be investigated (Delaune et al., 2005). 
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Pluripotent stem cells provide a valuable in vitro system to study the regulation of 
extracellular signals on lineage differentiation. Researches within these cells have indicated 
that neural induction includes multiple steps where FGFs exert their function differently at 
each stage, leading to a complicated role of FGF signalling involved in neural induction. In 
mESCs, inactivation of FGF/ERK signalling resulted in a failure of neural formation (Ying et 
al., 2003, Kunath et al., 2007, Stavridis et al., 2007), however, this could due to the failure of 
mESCs to enter an epiblast-like stage at which cells are primed for multi-lineage 
differentiation (Lanner and Rossant, 2010, Nichols et al., 2009). Although mESCs and hESCs 
are both derived from the ICM of blastocyst, the molecular basis of their self-renewal and 
differentiation is quite different, whereby mESCs represent an ICM-like ground state and 
hESCs appear to be in a primed state (Nichols and Smith, 2009), similar to mouse epiblast-
derived stem cells (EpiSCs) (Brons et al., 2007, Tesar et al., 2007). Recent findings suggest 
that FGF/ERK signalling plays an important role in the transition of mESCs from ground 
state pluripotency to an epiblast-like pluripotent state (Greber et al., 2010, Nichols and Smith, 
2009, Sterneckert et al., 2010). Therefore, interference of FGF/ERK activity at the ground 
state of mESCs does not hamper their self-renewal. Instead, this inactivation disables their 
differentiation to either neural or non-neural lineages (Kunath et al., 2007). Subsequent 
studies with EpiSCs or hESCs have better addressed the function of FGF signalling in neural 
induction. In hESCs, Actin/Nodal in combination of FGF signalling maintains their 
pluripotency and resists differentiation (Greber et al., 2010, Yu et al., 2011). Upon the 
inhibition of BMP signalling, hESCs gradually lose the expression of pluripotent markers and 
exhibit an upregulation of early neural markers, Otx and Pax6, and inhibition of FGF shortens 
this BMP-inhibition-induced neural conversion (Greber et al., 2011). However, prolonged 
inhibition of FGF impedes neuroectoderm formation (Cohen et al., 2010, Yoo et al., 2011) 
and diverts the differentiation of early neural progenitor cells into neural crest cells and 
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peripheral neurons, similar to the cells derived from the neuroectoderm/epidermis border in 
vivo (Greber et al., 2011). Therefore, these data suggest that FGF signalling may hinder 
initial neural induction but positively regulating neural progenitor maintenance.  
 
Notably, different FGFs may activate distinct signalling pathways (Goetz and Mohammadi, 
2013), which might exert different functions during neural differentiation (Sterneckert et al., 
2010). Thus, further experiments are still required to clarify the specific role of FGF 
signalling at each stage of neural development. 
 
Wnts 
In addition to FGFs, Wnt signalling pathways are also implicated in the regulation of neural 
induction. So far, there are 19 mammalian Wnt proteins identified and these protein ligands 
activate different intracellular effectors after binding to membrane-bound receptors (Logan 
and Nusse, 2004). Based on the downstream effectors, Wnt signalling pathways have been 
classically divided into two groups: canonical (β-catenin dependent) pathway and non-
canonical (β-catenin independent) pathway. However, recent findings suggest that Wnt 
signalling may integrate into other signalling pathways to form an interconnected network, 
rather than functions in a linear way (Kestler and Kuhl, 2008, van Amerongen and Nusse, 
2009).  
 
During early neural development, the function of Wnt signalling remains obscure. In chick 
epiblast explants, activation of Wnt signalling impedes neuroectoderm formation but 
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promotes an epidermal cell fate (Wilson et al., 2001, Heeg-Truesdell and LaBonne, 2006). In 
contrast, the study in Xenopus suggested that Wnt signalling activation is required for neural 
induction (Baker et al., 1999). The possible reason for this discrepancy could be that the 
functions of Wnt signalling change dynamically during different stage of differentiation. At 
very early stage of development when the embryo is acquiring dorsoverntral polarity, Wnt 
signalling is required for the establishment of the organiser, thus having a positive role in 
neural induction. However, at the post-implantation/gastrulation stage, Wnt signalling 
inhibits neural induction by modulating BMP activities (Stern, 2005, Gaulden and Reiter, 
2008). Therefore, Wnt signalling has temporally dynamic role in regulating neural induction 
during the embryonic development. 
 
Thus, studies using ESCs differentiation as an in vitro model have better clarified its role at 
specific stage of differentiation. It has been known that the cell fate decision in ESCs is 
controlled by extracellular signals. Activation of Activin/Nodal, BMP and Wnt/β-catenin 
signaling promotes mESCs to give rise to primitive streak-like cells (Gadue et al., 2005), 
while cultured in N2B27 and retinoic acid, mESCs highly converted to neural progenitor cells, 
as shown by an upregulation of Sox1/GFP reporter (Abranches et al., 2009, Ying et al., 2003). 
Within this commitment, a transient rise of Wnt/β-catenin signaling pathway was captured 
(Faunes et al., 2013) and it is shown to promote both cell fates in a context-dependent manner. 
With high levels of Activin/Nodal and BMP, it promotes mesodermal differentiation, 
whereas with low levels of them, it facilities neural induction (Turner et al., 2014b). 
Therefore, it suggests that the activation of Wnt/β-catenin pathway at the initial stage of 
differentiation is generally required for mESCs differentiation and how exactly Wnt signaling 
functions in this early stage is yet to be known.  
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Apart from its temporal role in neural induction, Wnt signalling also has a spatial role in 
regulation of embryonic neural induction, being involved in the establishment of posterior 
identities during neural development. In hESCs, activation of Wnt/β-catenin signalling 
combined with TGFβ inhibition is sufficient to specify midbrain or hindbrain/spinal cord 
fates in a dose-dependent way (Kirkeby et al., 2012). Conversely, abolition of endogenous 
Wnt/β-catenin enhances forebrain specification in ESCs (Hendrickx et al., 2009). Also this 
posteriorization effect of Wnt/β-catenin could exert within cells already adopted an anterior 
fate or in progenitor cells pre-induced towards anterior neuroectoderm (Pankratz et al., 2007, 
Chambers et al., 2009, Bouhon et al., 2006). Therefore, Wnt signalling plays multiple roles in 
promoting and patterning neural tissue at different stage of embryonic development. Further 
researches are required to find out their contributions in the dynamic neural differentiation. 
 
Mechanisms for the anterior and posterior neural induction 
An important event during neural development is the anteroposterior (AP) regionalization of 
the neuroectoderm, which eventually gives rise to forebrain, midbrain, hindbrain and spinal 
cord (Stern et al., 2006). According to the classical ‘activation/transformation’ hypothesis 
(Nieuwkoop et al., 1952, Nieuwkoop and Nigtevecht, 1954), this process is divided into two 
steps: neural induction and subsequent AP patterning. In this model, the neural plate is 
initially induced to possess anterior identity and then some of these neural cells are exposed 
to proper caudalising signals to become posterior fate. In support with this hypothesis, many 
signalling pathways have been identified in specifying anterior or posterior fate.  
For example, BMP inhibition has been reported to convert the cells already with caudal 
forebrain and/or midbrain identities into rostral forebrain fates, which only occurred after the 
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initial neutralization of mESCs. Thus it suggests that this novel function of BMP inhibition is 
distinct from its role in neural induction. Furthermore, activation of Wnt/β̻catenin, FGF, and 
RA signalling have been well characterised in the posterization of neuroectoderm (Chambers 
et al., 2009, Kirkeby et al., 2012, Wichterle et al., 2002, Lupo et al., 2013). 
 
However, recent findings on the identification of bipotent neuromesodermal progenitors 
(NMps) challenge this traditional activation/transformation hypothesis. The NMps were 
identified within the growing caudal end of mouse embryo, co-expressing both primitive 
streak marker (Brachyury) and neuroectoderm marker (Sox2) (Tzouanacou et al., 2009, 
Nowotschin et al., 2012). These cells are able to generate both the spinal cord neural cells and 
paraxial mesodermal cells in mouse embryo. Single epiblast cell labelling experiments 
showed that these bipotent posterior cells are not derived from those anterior neural cells but 
a separate cell population, raising the possibility that some posterior neural cells are 
generated through a mechanism(s) different from that induces the anterior neural plate 
(Henrique et al., 2015). These dual-fated cells can also be generated from mESCs, EpiSCs 
and hESCs by activation of Wnt and FGF signalling pathways in primed pluripotent stem 
cells (Gouti et al., 2014, Turner et al., 2014a, Denham et al., 2015), which is different from 
those anterior neural induction signals.  
 
These data suggest that neural induction is probably a more complicated process that is 
regulated by both temporal and spatial signals. More studies are required to further elucidate 
the mechanisms. 
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1.1.2.2 Transcription factors 
Having discussed intercellular signalling involved in neural induction, eventually they go 
through transduction pathways to affect the expression of specific transcription factors (TF). 
TFs are potent factors and bind to many regulatory elements, called enhancers and promoters 
in genome, thus regulating the transcription from DNA to mRNA. They function as a switch, 
determining which genes are expressed and which are not in cells at different places and 
times during development. In this section, intrinsic regulation of neural induction by TFs is 
discussed. The success of maintaining and differentiating embryonic stem cells (ESCs) in 
vitro allows scientists study the early transition of ESCs from an undifferentiated state to 
lineage differentiation. Therefore, many recent works are obtained from ESCs. Detailed 
description of the derivation of hESCs and their in vitro neural differentiation is in section 1.2. 
 
Sox family  
SRY (sex determining region Y)-box (Sox) genes encode a family of transcription factors 
that are similar to the testis determination factor Sry and share a conserved high-mobility 
group (HMG) domain (Gubbay et al., 1990, Sinclair et al., 1990, Wegner, 1999). The HMG 
domain endows Sox proteins with the ability to bind to the minor groove of DNA, regulating 
DNA transcription (Guth and Wegner, 2008). There are about 20 Sox genes found in human 
and mice. According to their homology within the HMG domain, structure motif and 
functional assays, these proteins are divided into 10 subgroups. Among them, mainly SoxD 
(Sox5,6,13), SoxB (Sox1, 2, 3, 14, 21) and SoxC (Sox4 and 11) groups are associated with 
neural induction and development (Guth and Wegner, 2008). 
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SoxB1 group proteins (Sox1, Sox2 and Sox3) are well documented as early neural 
transcription activators (Penzel et al., 1997, Uchikawa et al., 1999, Uwanogho et al., 1995, 
Collignon et al., 1996, Rex et al., 1997, Mizuseki et al., 1998, Graham et al., 2003, Linker 
and Stern, 2004, Takemoto et al., 2006, Rogers et al., 2008). They have similar but not 
identical expression pattern throughout CNS. In fish, chick and frog, Sox3 expression is 
detectable in ectoderm prior to neural induction and then limited to the neuroectoderm 
(Koyano et al., 1997, Okuda et al., 2006, Penzel et al., 1997, Rex et al., 1997, Rogers et al., 
2008, Wood and Episkopou, 1999). Sox1 is not detected until the end of gastrulation in the 
anterior neuroectoderm (Nitta et al., 2006, Rex et al., 1997, Rogers et al., 2008, Wood and 
Episkopou, 1999). The expression pattern and function of Sox2 will be discussed in detail in 
the section 1.3. This similar expression pattern of Sox B members indicates that they have 
overlapping function during neural development. The increase of Sox3 expression 
compensates the loss of Sox2 in the mouse CNS (Miyagi et al., 2008). Also a high level of 
Sox1 can rescue the loss of Sox2 in chick (Graham et al., 2003). They are all required for 
maintaining neural progenitor cells (NPCs) in an undifferentiated state by counteracting 
neuronal differentiation (Graham et al., 2003, Ellis et al., 2004, Pevny and Placzek, 2005, 
Rogers et al., 2009, Bylund et al., 2003). Consistently, overexpression of both Sox2 and Sox3 
causes an impaired neurogenesis in the cranial placodes (Dee et al., 2008, Schlosser et al., 
2008), but leads to expanded neural plate at the expense of epidermal development in the frog 
and chick (Kishi et al., 2000, Graham et al., 2003, Rogers et al., 2009). Although SoxB1 
proteins have common features in neural development, loss of each still results in different 
phenotypes, indicating that each of them may exert distinct regulatory function in some tissue. 
Sox3 deletion in mice causes defects of pituitary development, specific CNS midline 
structure and craniofacial development (Rizzoti et al., 2004, Rizzoti and Lovell-Badge, 2007). 
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Sox1-deficient mice suffer from epilepsy due to the largely loss of neurons in the ventral 
striatum (Malas et al., 2003, Ekonomou et al., 2005). 
 
Sox 11, a member of Sox C group, is detected in the developing CNS of chick (Uwanogho et 
al., 1995), mouse (Hargrave et al., 1997), zebrafish (de Martino et al., 2000), and frog 
(Hyodo-Miura et al., 2002, Brugmann et al., 2004). Sox11 expression is induced by the 
inhibition of BMP signalling by Chordin (Hyodo-Miura et al., 2002) and also is upregulated 
directly by forkhead box protein D5 (FoxD5) (Yan et al., 2009). Also, Sox11 cooperates with 
the mitogen-activated protein (MAP) kinase, Nemo-like kinase (NLK) to induce neural 
development (Hyodo-Miura et al., 2002). Expression of Sox11 is found to be overlapped with 
that of other SoxC members, Sox4 and Sox12, suggesting that they are functionally 
redundant with each other. Depletion of each of them does not show clear phenotypic 
abnormalities in mouse (Dy et al., 2008, Hoser et al., 2008). Although expression of Sox11 is 
found in the neural epithelium (Uwanogho et al., 1995), it continues to regulate the neuronal 
differentiation and its expression is directly regulated by the proneural proneural basic helix-
loop-helix (bHLH) protein (Bergsland et al., 2006). 
 
 
POU3F1 and POU3F2  
Pit-oct-unc (POU) family transcription factors, POU domain, class 3, transcription factor1 
(POU3F1, also known as Oct6, Tst1, or SCIP) and POU3F2 (also known as BRN2, Oct7, and 
N-Oct3) are grouped into POU III subfamily according to their extensive similarity in 
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sequence, expression pattern (Alvarez-Bolado et al., 1995, He et al., 1989), DNA binding and 
transactivation characterization (Baranek et al., 2005, Schreiber et al., 1997, Sock et al., 
1996). They both are important for early neural development (Suzuki et al., 1990, Wolf et al., 
2009).  
 
POU3F1 expression is detectable in epiblast in mouse embryos at E5.5 and then is restricted 
in neuroectoderm at E7.5 and later at forebrain and midbrain (Zwart et al., 1996, Iwafuchi-
Doi et al., 2012, He et al., 1989). Similar to its expression in embryo, POU3F1 expression is 
detected in undifferentiated ESCs (Scholer et al., 1989, Meijer et al., 1990) and significantly 
enhanced upon neural differentiation (Meijer et al., 1990, Zhu et al., 2014). This expression 
pattern indicates that POU3F1 is involved in the regulation of neural fate commitment. A 
recent study characterised its function in early neural development (Zhu et al., 2014). They 
found that in vitro deficiency of POU3F1 compromises the neural fate commitment of ESCs, 
whereas overexpression of POU3F1 directs their differentiation to neural lineage. In vivo by 
injecting manipulated-ESCs into blastocyst, they shown that POU3F1-knockdown cells fail 
to develop into neuroectoderm, while POU3F1-overexpression ESCs preferentially integrate 
into neural lineage. According to these findings, Pou3F1 is dispensable and sufficient for 
neural fate specification of ESCs. The potential downstream targets of POU3F1, such as 
Sox2, zinc finger protein (Zfp) 521, zinc finger protein of the cerebellum 1 (Zic1), zinc finger 
protein of the cerebellum 1 (Zic2) was identified by Genome-wide ChIP-seq and RNA-seq 
assays (Zhu et al., 2014). In particular, an enriched signal of PU3F1 was found on the N2 
enhancer area of Sox2 gene, indicating its regulation on Sox2. Also, serials of neural genes, 
including Sox1, Smad interacting protein 1 (Sip1), orthodenticle homeobox 1 (Otx1), 
homeobox expressed in ES cells 1(Hesx1), paired box protein 6 (Pax6) and gastrulation brain 
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homeobox 2 (Gbx2) was significantly upregulated when POU3F1 was overexpressed in 
epiblast stem cells (EpiSCs) (Iwafuchi-Doi et al., 2012). Interestingly, overexpression of 
POU3F1 fails to induce neural differentiation from Zfp521- depleted ESCs, indicating that 
POU3F1 relies on Zfp521 to specify neural cell fate (Kamiya et al., 2011). Apart from its 
regulation on neural genes, POU3F1 has been found to inhibit the activity of BMP and WNT 
signalling pathways by repressing their downstream effectors, such as Inhibitor Of DNA 
Binding 1 (Id1), inhibitor Of DNA binding 2 (Id2), msh homeobox 1 (Msx1), msh homeobox 
2 (Msx2) of BMP pathway and Wnt3, axis inhibition protein 2 (Axin2), Dickkopf-related 
protein 1 (Dkk1), myelocytomatosis viral oncogene (Myc) of WNT pathway (Zhu et al., 
2014). Therefore, POU3F1 specifies neural differentiation by inducing the expression of 
neural specific genes and meanwhile, inhibiting extrinsic signals which block neural 
differentiation.    
 
Unlike POU3F1, POU3F2 was not detectable until E8.0 in the neural plate in mouse embryo 
(Bouchard et al., 2005) and strongly expressed in neuronal cells (Hagino-Yamagishi et al., 
1997). POU3F2-knockout causes lethality in mice due to the serious loss of specific types of 
neurons in the hypothalamus (Nakai et al., 1995) and the subsequent defect in posterior 
pituitary gland (Schonemann et al., 1995). Also, ectopic expression of POU3F2 and few other 
factors are enable to efficiently convert non-neural cells into neural cells (Ambasudhan et al., 
2011, Lujan et al., 2012, Pang et al., 2011), indicating that POU3F2 is involved in neural fate 
commitment. Recent data found that POU3F2 cooperates with Sox2 to regulate large group 
of neural-specific genes in neural progenitor cells (Lodato et al., 2013), reminiscent of the 
interaction between POU5F1 (also known as Oct4) further suggesting its indispensable role 
in neural development.  
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1.2 Modelling neural specification using hESCs 
1.2.1 Derivation of hESC lines  
Following fertilization, a diploid zygote goes through cell cleavage and differentiation to 
form a structure referred to as blastocyst, which consists of an outer layer cells, called 
trophoblast and the ICM. The first attempt to isolate cells from trophoblast and ICM was by 
Sherman et al in 1975 (Sherman, 1975). Four cell lines were maintained in long-term culture 
and their proliferation and differentiation were examined. However, they failed to 
differentiate into all the three germ layers in vivo and developed chromosomal abnormalities. 
Subsequently, embryonic carcinoma cells were used as model to develop an appropriate 
culture conditions and determine the stage of isolation of pluripotent embryonic stem cells, 
contributing to the successfully derivation of first mouse embryonic stem cell lines in 1981 
(Evans and Kaufman, 1981, Martin, 1980, Martin, 1981). These cells possess two striking 
features: the ability to self-renew infinitely in vitro and being able to give rise to all the cell 
types within an adult, so called pluripotency, much like the cells of the ICM. This powerful 
property of pluripotency is highlighted in the study showing that when injected into a host 
blastocyst, mESCs can produce chimeras that contribute to the formation of all fetal cell 
linages (Robertson et al. 1986 Nature 323: 445-448). More strikingly, when injected into 
developmentally compromised tetraploid blastocysts, just one or two of these founder ESCs 
can generate the entire embryo (Nagy et al., 1990, Nagy et al., 1993, Eggan et al., 2001).  
Apart from mESCs, another type of pluripotent cells were derived from the post-implantation 
murine epiblast, termed epiblast stem cells (EpiSCs) (Brons et al., 2007, Tesar et al., 2007). 
Similar to mESCs, these EpiSCs are able to self-renew in culture and differentiate into all the 
three germ layers. Despite this, they have shown notable differences from molecular and 
epigenetical aspects, such as morphology, propagation manner, and growth factors 
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requirements and may represent a more primed pluripotent population as compared to the 
naive mESCs (Brons et al., 2007, Tesar et al., 2007, Guo et al., 2009). The most remarkable 
difference between mESCs and mEpiSCs is their ability to generate chimeras after injected 
into blastocysts. Unlike mESCs, mEpiSCs can barely integrate into host ICM after injected 
into preimplantation blastocysts (Brons et al., 2007, Tesar et al., 2007;), unless a rare 
subpopulation of cells, similar to very early preimplantation epiblast were selected out (Han 
et al., 2010) or E-cadherin which enhances their attachment to the ICM after blastocyst 
injection, was overexpressed in those cells (Ohtsuka et al., 2012). However, mEpiSCs can 
incorporate into host embryo and develop to chimeras when injected into post-implantation 
mouse embryo (Huang et al., 2012), indicating that the failure of chimera formation with 
preimplantation embryo could due to its incompatibility with EpiSC survival and integration. 
 
The seminal work on mESCs and the later advances in culturing techniques contribute to the 
first successful isolation of primate and human embryonic stem cell (hESC) lines (Thomson 
et al., 1995, Thomson et al., 1998, Thomson et al., 1996). These cells were derived from ICM 
of a human embryo and fulfilled the criteria of ESCs, including being able to self-renew and 
contributing to tissues of three germ layers in teratomas when grafted to 
immunocompromised mice (Bosma et al., 1983). Given the ethical issues, it is not feasible to 
carry out chimera experiment in human embryos to further examine their developmental 
potency. However, several studies have carried out human-mouse chimera experiments to 
engraft hESCs into mouse embryos and the results are conflicting. In one report, hESCs were 
shown to integrate into the host ICM after injected into mouse blastocyst, which were able to 
further differentiate into cells of three germ layers in the in vitro culture or to develop into 
embryonic chimera after implantation (James et al., 2006). However, in other studies, human 
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PSCs were found incapable of integration into mouse blastocyst but could form embryonic 
chimeras when transplanted into post-implantation gastrula-stage-mouse embryo, (Masaki et 
al., 2015; Mascetti and Pedersen et al, 2016). It remains unclear about this discrepancy and 
further studies are required for a better understanding of human pluripotent stem cells. 
 
1.2.2 Maintenance of pluripotency  
The pluripotency, a main feature of hESCs, is tightly regulated by both intrinsic and extrinsic 
factors. Among them, the intrinsic factor, mainly referred to TFs, plays a central role in the 
control of pluripotency and its expression is influenced by extrinsic signals. During the last 
decades, Oct4, Sox2 and Nanog (OSN) are defined as master regulators together to form a 
regulatory circus to maintain expression of pluripotent genes and to repress expression of 
lineage-specific genes (Boyer et al., 2005, Chew et al., 2005, Rodda et al., 2005). The 
function of Sox2 will be discussed in the section 1.3. 
 
1.2.2.1 Intrinsic factors 
Oct4 
Oct4, encoded by the Pou5f1 allele, belongs to the POU family of DNA binding proteins. It 
regulates the expression of downstream targets by binding to the octamer motif ATGCAAAT 
within many promoters or enhancer areas (Scholer et al., 1989, Yeom et al., 1991). In human, 
two isoforms of Oct4, Oct4-1A and Oct4-1B are generated by alternative splicing of Pou5f1 
mRNA (Takeda et al., 1992, Cauffman et al., 2006). Only Oct4 1A is required to maintain 
hESC stemness. Expression of Oct4 is initially detectable in all blastomeres of the morula 
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and then was highly expressed in the ICM (Hansis et al., 2000, Palmieri et al., 1994, Pesce et 
al., 1998). By day8 when ingression via the primitive streak is almost complete, Oct4 
expression is detected in the primitive streak, neuroepithelium, portions of mesoderm as well 
as definitive endoderm (DeVeale et al., 2013). Finally, Oct4 expression becomes restricted to 
primordial germ cells (PGCs) (reviewed in Wu et al., 2014). Oct4 expression during 
embryonic development is summarised in Figure 1.8. The presence of Oct4 is also found in 
hESCs (Reubinoff et al., 2000), human embryonic carcinoma cells (Pera and Herszfeld, 1998) 
and human embryonic germ cells (Goto et al., 1999). Its essential role in the maintenance of 
pluripotency in hESCs has been well documented and recently, more evidence points out that 
it also functions as a lineage specifier. Down-regulation of Oct4 in hESCs leads to a 
dramatically increase of gene expression associated with trophoblast and endoderm (Hay et 
al., 2004, Zafarana et al., 2009), while overexpression of Oct4 results in the differentiation of 
mESCs into primitive endodermal and mesodermal lineages (Stefanovic and Puceat, 2007, 
Niwa et al., 2000, Hay et al., 2004). These results indicate that Oct4 may have multifaceted 
roles during embryogenesis according to its expression level, maintaining pluripotency by 
repressing differentiation and specifying later endoderm and mesoderm differentiation. Thus, 
the Oct4 expression must be tightly regulated at different stage of development.  
 
There are two elements, the proximal enhancer (PE) and the distal enhancer (DE), have been 
identified in the regulation of Oct4 expression in a cell-type specific manner (Yeom et al., 
1996). By comparatively analysing the sequence of these Oct4 upstream regulatory elements 
in human, bovine and murine, four highly conservative regions (CRs) are identified: CR1 
(within promoter), CR2 and CR3 (PE), as well as CR4 (DE) (Nordhoff et al., 2001). Among 
these regions, several sites, named 1A and 1B (within PE), 2A (within DE) contain nearly 
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identical sequence homologous to the GC box and are important for the activity of PE and 
DE (Yeom et al., 1996) (Figure 1.3). In human embryonic carcinoma cells, each of these CRs 
takes part in controlling the expression of human Oct4 gene (Yang et al., 2005). However, 
this regulation mechanism differs from their mouse counterparts which exhibit only the DE 
activity in mESCs (Tesar et al., 2007), while the PE activates Oct4 expression in EpiSCs 
(Tesar et al., 2007). Several positive factors, such as nuclear receptor subfamily 5, group A, 
member 2 (Nr5a2) (Gu et al., 2005), steroidogenic factor-1 (SF1) (Barnea and Bergman, 
2000) and retinoid X receptor-β (RXR-β) (Pikarsky et al., 1994) and negative factors, such as 
germ cell nuclear factor (GCNF) (Gu et al., 2005) and chicken ovalbumin upstream 
promoter-transcription factors- I/II (COUF-TFI/II) (Ben-Shushan et al., 1995, Schoorlemmer 
et al., 1994), have been found to regulate Oct4 expression (Figure 1.3).  
 
(Adapted from Wu and Scholer, 2014.) 
Figure 1.3 Transcriptional regulation of the mouse Oct4 gene 
The diagram represents factors’ binding sites in the vicinity of Oct4 gene which has five 
exons, depicted as blue boxes. Upstream regulatory regions, including the promoter, PE, and 
DE are depicted as unfilled boxes. The transcription factors binding to these regions are 
shown above within coloured boxes. They functions either as activator (green box) or 
repressor (red box) in the transcriptional regulation of Oct4. HRE, hormone responsive 
element. Sp1, GC-rich site recognized by the Sp1/Sp3 family of transcription factors. CR1, 
CR2, CR3, and CR4 are conserved regions (CRs) at the 5’ upstream region of the Oct4 gene.  
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Nanog 
The another core transcription factor is Nanog, which was originally identified as a molecule 
that enables mESCs to self-renew in the absence of leukaemia inhibitory factor (LIF) as well 
as represses neuroectoderm differentiation (Chambers et al., 2003, Mitsui et al., 2003). Like 
Oct4 and Sox2, Nanog expression is detectable in the ICM, epiblast and germ cells (Mitsui et 
al., 2003). Loss of Nanog in embryo resulted in a cessation of development at blastocyst stage 
due to the absent of epiblasts (Mitsui et al., 2003). The Nanog-null ESCs still can be derived 
from the Nanog-null blastocyst, but they gradually differentiate into extraembryonic 
endoderm in vitro (Mitsui et al., 2003).  Similar to mESCs, high level of Nanog in hESCs 
enable their propagation even in the absence of conditioned media (Darr et al., 2006). 
Although an acute downregulation of Nanog by shRNA causes ESCs to differentiate into 
extraembryonic lineages (Ivanova et al., 2006, Hough et al., 2006, Hyslop et al., 2005), 
targeted Nanog-null ESCs still can be propagated in vitro and differentiate into all somatic 
lineages, but not germ cells, indicating that Nanog is dispensable for ESC pluripotency 
(Chambers et al., 2007). It has been proposed that Nanog is necessary for the establishment of 
pluripotency in ICM, but once the pluripotency is achieved, Nanog is dispensable for the 
maintenance of pluripotency. However, Nanog cooperates with Oct4 and Sox2 to regulate the 
expression of pluripotency related genes ((Loh et al., 2006, Chen et al., 2008), still important 
for the maintenance of pluripotency.   
 
1.2.2.2 Extrinsic factors 
Sustaining self-renewal and undifferentiated state of ESCs is also required external signalling 
to regulate the expression of TFs. It is believed that this regulation is through a complicated 
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signalling pathway network. Unlike the transcriptional regulatory circuitry which is similar 
between mESCs and hESCs, they require different signalling ligands to maintain their self-
renewal. When co-cultured with mitotically inactivated embryonic fibroblasts in the presence 
of serum, mESCs still require LIF (Smith et al., 1988, Williams et al., 1988) to maintain their 
pluripotent state. LIF activates the janus kinase (Jak)-signal transducer and activator of 
transcription 3 (Stat3) and phosphatidylinositol-3 kinase (PI3K) pathways, ultimately 
promoting the expression of the OSN triad (Niwa et al., 2009). Another important component 
identified in the serum culture is BMP4 which signals through TGF-β and results in a 
powerful repression on neuroectodermal differentiation (Ying et al., 2003)). As such, mESCs 
can be propagated in a both feeder and serum-free medium supplemented with LIF and 
BMP4. Interestingly, adding PD0325901, an inhibitor of MAPK/extracellular signal-
regulated kinases (ERK) signalling and CHIR99021, a glycogen synthase kinase 3 beta 
(GSK3β) inhibitor into a serum-free medium supplemented with LIF (termed 2i/LIF) can 
replace the LIF and BMP4 to maintain their self-renewal (Ying et al., 2008). Cells in this 
2i/LIF condition can further differentiate into extraembryonic tissue (Morgani et al., 2013), 
while cells cultured on feeder layer are unable to do so. In this case, the mESCs in 2i/LIF are 
considered in a more naive sate, termed the ground state. Unlike mESCs, hESCs do not 
require LIF, instead needs FGF2 (Daheron et al., 2004, Dvorak et al., 2005). Exogenous 
FGF-2 has been found to stimulate the expression of stem cell genes, suppress the genes 
associated with cell death and apoptosis, reduce differentiation and promote proliferation 
(Greber et al., 2007, Li et al., 2007, Eiselleova et al., 2009). FGF2 also activates MEK/ERK 
signaling to inhibit extraembryonic linage differentiation (Li et al., 2007). However, FGF2 
alone is not sufficient to maintain hESCs in a feeder-free, chemical define medium. 
Activin/Nodal has been identified to couple with FGF2 to maintain the expression of 
pluripotency-related genes (Vallier et al., 2005, Vallier et al., 2009). The effect of 
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Activin/Nodal on pluripotency is supported by the study showing that its downstream 
effectors Smad2/3 bind to the promoter region of Nanog, directly enhancing Nanog promoter 
activity (Xu et al., 2008) Apart from this major signalling pathways, more components 
identified in the feeder-free medium (Xu et al., 2001, Amit et al., 2000) are found to be 
critical for the maintenance of hESCs, such as IGF and Insulin that stimulate the canonical 
phosphatidylinositol-3 kinase (PI3K) signaling pathwaysPI3K/AKT signaling ((McLean et al., 
2007, Bendall et al., 2007). It appears that multiple signalling pathways synergistically 
regulate pluripotency and repress differentiation. 
  
1.2.3 Differentiation of hESCs to neural lineages  
SCs are a valuable source of material for producing specific cells types, including functional 
neurons, glial cells that can be used to cell-based therapies. Therefore, how to direct the 
differentiation of ESCs to a certain cell type becomes a major challenge prior to their use in 
therapies.  
 
By withdrawing the growth factor essential for sustaining self-renewal and pluripotency in 
culture, ESCs start to spontaneously differentiation, resulting in heterogeneous morphologies. 
In this way, the yield of a certain type of cells is really poor. Therefore, it is necessary to 
apply certain factors to control the direction of differentiation specifically to neural lineage. 
In terms of culture system that facilitates the differentiation of hESCs and the proliferation of 
neural cells, two systems are normally employed: adherent and suspension culture.  With a 
long duration of differentiation, hESCs in suspension are able to form embryo bodies (EBs) 
which contain a mixed population of cells, including neural cells. In order to improve the 
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yield of neural cells within EBs, some growth factor and morphogens have been added into 
the suspension culture. However, this method still comes with some disadvantages: (1) 
variability of the EB size due to the different number of initial cells to form EBs or different 
duration of differentiation; (2) multiple-layer structure that makes the morphogens difficult to 
reach the innermost layers of EBs, leading to a heterogeneous differentiation; (3) difficulties 
in monitoring the differentiation state of these EBs under microscope. These issues can be 
overcome when ESCs are cultured in monolayer, since these cells are exposed uniformly to 
morphogens (Shin et al., 2006).  
 
As the loss of BMP signaling promotes neural induction from ectoderm at or before 
gastrulation (Harland, 2000), several BMPs inhibitors, including noggin (Smith and Harland, 
1992), chordin (Sasai et al., 1994) and follistatin (Hemmati-Brivanlou et al., 1994) were 
applied to promote neural differentiation. Many studies have reported a high efficient neural 
conversion from hESCs by using noggin which targets BMP-2,4, 7 and prevents 
extraembryonic endoderm differentiation (Pera et al., 2004, Gerrard et al., 2005, Baharvand 
et al., 2007), providing a promising method for neural differentiation. However, this method 
requires a long duration (around 30 days) of differentiation. Recently, a dual Smad inhibition 
protocol was developed to differentiate hESCs in a more rapid way (Chambers et al., 2009). 
In this protocol, a small molecule, SB431542 which inhibits the Lefty/Activin/TGF-β 
pathways by blocking phosphorylation of the activin receptor type-1B (ACVR1B), activin 
receptor-like kinase 5 (ALK5) and activin receptor-like kinase 7 (ALK7) receptors, was 
combined with noggin to achieve full neural conversion by suppressing differentiation into 
trophectoderm, mesoderm, and endoderm (D'Amour et al., 2005, Amita et al., 2013). 
Subsequently, a modified dual-SMADs-inhibition protocol was applied to shorten the 
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duration to 8 days while still produced high efficient neural conversion (Bhinge et al., 2014). 
In this protocol, noggin was replaced by dorsomorphin which targets SMAD5 
phosphorylation and inhibits BMP signalling (Zhou et al., 2010). These exogenous TGFβ 
inhibitors within chemical defined N2B27 medium has been shown to efficiently generate 
neuroectoderm with anterior positional identity (Surmacz et al., 2012, Lupo et al., 2013, 
Ozair et al., 2013). Together, these highly efficient neural differentiations from hESCs not 
only provide a promising source for cell-based therapies, but also can be used as a model 
system to study the mechanisms of neural development.  
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1.3 Sox2, a key factor in the regulation of pluripotency and 
neural differentiation 
1.3.1 Sox2 is indispensable in embryonic development 
Sox2 is a member of the Sox family of transcription factors and is classified as a member of 
SoxB1 group, which also includes Sox1 and Sox3. Although Sox1, Sox2 and Sox3 share 
more than 80% sequence similarity and are functionally redundant, Sox2 can exert distinct 
functions in a biologically context-dependent manner and is indispensable for embryonic 
development. Many factors have been shown to influence binding of Sox proteins to their 
target genes, leading to diverse functional effects. One such factor is the interaction between 
Sox proteins and various cofactors. Interaction with various cofactors confers upon Sox2 
greater functional versatility during developmental processes (Wegner, 2010). 
 
During mouse embryogenesis, Sox2 expression is initially detected in cells at the morula 
stage, becoming more specifically located in the ICM of blastocyst and epiblast (Avilion et 
al., 2003), summerised in Figure 1.8. This implies that Sox2 may have important roles in the 
formation of early pluripotent embryonic cells. Indeed, zygotic deletion of Sox2 is 
embryonically lethal due to the failure to form pluripotent epiblast whilst the absence of Sox2 
has little effect on the formation of trophectoderm (Avilion et al., 2003). Therefore, Sox2 is 
an essential factor in the formation of pluripotent cells in early embryos and ultimately a 
critical factor for embryonic development. 
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1.3.2 Critical role of Sox2 in maintaining pluripotency of ESCs and generation of 
iPSCs 
ESCs, derived from the ICM of preimplantation embryos, share many characteristics with the 
ICM cells. One major similarity is their pluripotent capability, being able to give rise to all 
cell types of the adult body. However, ESCs are not identical to the cells in the ICM as ESCs 
are able to amplify themselves during extended culture without compromising their 
pluripotency. Consistent with the data in pre-implantation embryos, Sox2 is highly expressed 
in ESCs. Depletion of Sox2 by either gene-knockout or RNA interference considerably 
compromises the pluripotent state of both mouse and human ESCs as shown by the changes 
in cell morphology, loss of pluripotent marker expression and their differentiation primarily 
into trophectoderm (Fong et al., 2008, Masui et al., 2007). However, forced expression of 
Oct4 in Sox2-null mouse ESCs (mESCs) can rescue the pluripotency of these cells, indicating 
that the role of Sox2 in maintaining the pluripotent state of ESCs is primarily to sustain a 
sufficient level of Oct4 expression (Fong et al., 2008, Masui et al., 2007). Collectively, these 
results demonstrate that Sox2 is crucial in the maintenance of pluripotent ESCs, possibly 
through promoting and maintaining Oct4 expression. 
 
Interestingly, to maintain pluripotency of stem cells, levels of Sox2 expression need to be 
stringently regulated, with either higher or lower Sox2 expression leading to the loss of 
pluripotency in ESCs. This could be attributed to the fact that both low and high levels of 
Sox2 reduce the promoter/enhancer activity of Sox2-Oct4 target genes (Boer et al., 2007, 
Kopp et al., 2008). The expression level of Sox2 needs to be retained in a dynamic 
equilibrium with other synergistic factors in order to maintain pluripotency. This concept is 
also supported by the finding that Sox2 cooperates with other highly dose-dependent 
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transcription factors, such as Oct4 and Nanog, in the regulation of pluripotency (Boyer et al., 
2005). In human and mouse ESCs, Oct4, Sox2 and Nanog form a core transcriptional 
regulatory circuitry in pluripotent stem cells to maintain their self-renewal. Oct4 and Sox2 
co-occupy a large number of enhancers/promoters and regulate the expression levels of their 
target genes (Figure 1.4). They activate the expression of pluripotent genes, including Nanog 
and themselves, whilst repressing the expression of key genes that are responsible for the in 
vitro differentiation and in vivo developmental processes, such as paired-box protein 6 (Pax6) 
and gastrulation brain homeobox 2 (Gbx2) (Boyer et al., 2005, Chen et al., 2008). These 
transcriptional regulatory activities of Sox2 and Oct4 have been shown to require their direct 
interaction (Ambrosetti et al., 2000). The cooperative interaction between HMG of Sox2 and 
POU homeodomain of Oct4 is thought to be critical in regulation of ESC pluripotency 
(Dailey and Basilico, 2001). 
 
(Adapted from Zhang and Cui, 2014) 
Figure 1.4 Sox2 regulates gene expression in pluripotent stem cells and neural 
progenitor cells 
Sox2 interacts with Oct4 and other nuclear factors to activate pluripotentency gene 
expression and repress differentiation gene expression in pluripotent stem cells. In neural 
progenitor cells, Sox2 interacts with neural transcription factors, such as Brn2 and Pax6, to 
activate neural progenitor gene expression.  
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Induced pluripotent stem cells (IPSCs) are generated from various somatic cell types by 
ectopically expressing transcription factors that are important for ESC pluripotency. The most 
commonly used factors are Oct4, Sox2, Kruppel-like factor 4 (Klf4) and c-Myc (Takahashi et 
al., 2007). These factors are able to reprogram the somatic cells back to their embryonic state, 
making them share the dual properties of pluripotency and long-term self-renewal much like 
their ESC counterparts. Given that Sox2 is essential in the maintenance of pluripotency in 
ESCs, it is conceivable that Sox2 is one of the key factors for the generation of iPSCs 
(Takahashi et al., 2007). In fact, by analysing gene expression profile on a single cell level 
during reprogramming, it has been found that the activation of endogenous Sox2 is a relative 
early event, which initiates a cascade of transcriptional changes, leading to the formation of 
iPSCs (Buganim et al., 2012). Interestingly, based on the shared biological properties 
between SoxB1 genes, Sox2 can be replaced by closely related Sox family members, Sox1 
and Sox3, in the generation of iPSCs, but not by more distant members, like Sox7 and Sox15 
(Nakagawa et al., 2008). However, it has been reported that Sox17 is able to replace Sox2 in 
the successful generation of iPSCs after it is genetically modified in which two amino acids 
in the Sox17 HMG domain are converted to those of Sox2. This conversion does not alter 
Sox17 HMG DNA binding motif but confers its ability to interact with Oct4. The modified 
Sox17 is able to interact with Oct4 and the resulting Sox17-Oct4 complex can cooperatively 
bind to the canonical subset of Sox-Oct motifs and successfully reprogram somatic cells 
(Jauch et al., 2011). Taken together, Sox2 is therefore important for the successful 
reprogramming of somatic cells to iPSCs. As such, the physical interaction between Sox2 and 
Oct4 is likely to be critical in induction and maintenance of pluripotency. 
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1.3.3 Sox2 in neural differentiation and maintenance of NPCs 
During embryonic development, Sox2 is persistently expressed, initially in the epiblast of 
preimplantation embryos, then more predominantly in the central nervous system after 
gastrulation (Figure 1.8), hinting at a possible function for Sox2 in neural commitment 
(Wegner and Stolt, 2005). Recently, it has been suggested that the three core pluripotent 
transcription factors Sox2, Oct4 and Nanog not only play an important role in the induction 
and maintenance of pluripotency, but also in functioning as lineage specifiers, regulating the 
differentiation of ESCs to specific lineages (Loh and Lim, 2011, Wang et al., 2012). Sox2 
governs ESC specification to neuroectoderm while Oct4 and Nanog promote their 
differentiation to mesendoderm, a common precursor of mesoderm and definitive endoderm 
(Thomson et al., 2011). Sox2 induces neural induction and enhances neural differentiation by 
repressing key regulators of other lineage fates, for example brachyury (Thomson et al., 2011, 
Wang et al., 2012, Zhao et al., 2004). Therefore, Sox2 appears to be an important regulator in 
controlling PSC neural initiation and differentiation. 
 
In addition to its role in regulating neural induction, Sox2 also functions to maintain the self-
renewal of neural progenitor stem cells in vitro as well as in vivo. Sox2 is highly expressed in 
proliferating NPCs and is downregulated upon differentiation to post-mitotic neuronal and 
glial cells. Reduction of Sox2 in neural progenitor stem cells hinders their self-renewal and 
proliferation, promoting their earlier exit from cell cycle and terminal differentiation; whereas 
ectopic expression of Sox2 inhibits the differentiation of NPCs into neurons and glia (Bylund 
et al., 2003, Graham et al., 2003). The fact that ectopic expression of Sox2 alone or in 
combination with other neural transcription factors can directly reprogram fibroblasts to 
multipotent neural progenitor stem cells further highlights the essential role Sox2 plays in 
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these cells (Yang, 2011, Ring et al., 2012). Taken together, Sox2 is therefore a key factor in 
both the establishment and maintenance of neural progenitor properties. 
 
1.3.4 Molecular mechanisms underlying the role of Sox2 in pluripotency and 
neural differentiation 
In the last decade, intensive studies have been carried out in order to elucidate the molecular 
mechanisms that control pluripotency and lineage specification. Although considerable 
progress has been made, the mechanisms are still not fully understood. Given that Sox2 
functions in both PSCs and NPCs, it is thought that stringently regulated Sox2 expression is 
necessary to govern both pluripotency and initiation of neural differentiation in PSCs. 
Furthermore, differentially orchestrated mechanisms are required to control distinct functions 
of Sox2 in self-renewal of PSCs and during their neural differentiation. 
 
Like other transcription factors, the expression of Sox2 is regulated by both intrinsic factors 
and extrinsic signalling pathways. It has been identified that several regulatory regions in the 
Sox2 locus are responsible for controlling Sox2 expression, which include Sox2 core 
promoter (Lengler et al., 2005) and a number of enhancers located both upstream and 
downstream of the Sox2 gene (Figure 1.5) (Uchikawa et al., 2003, Miyagi et al., 2006, 
Miyagi et al., 2004, Catena et al., 2004). All of these regulatory regions are highly conserved 
across species, responding to different factors and signalling pathways (Uchikawa et al., 
2003). In ESCs, several laboratories have clearly demonstrated that Sox2 interacts with Oct4 
to form a regulatory complex, which binds to Sox2 regulatory region 2 to activate Sox2 
transcription (Loh et al., 2006, Tomioka et al., 2002, Boyer et al., 2005, Chen et al., 2008), 
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indicating that Sox2 is positively auto-regulated by the Sox2-Oct4 complex in ESCs. In 
addition to Oct4, several other transcriptional factors, including Nanog, mothers against 
decapentaplegic homolog 1 (Smad1) and Stat3, are also identified to be involved in the 
formation of the autoregulatory complex in mESCs, which activate Sox2 as well as other 
pluripotent genes (Chen et al., 2008). In this complex, State3 and Smad1, which are the key 
components of the bone morphogenetic protein and leukemia inhibitory factor signalling 
pathways of mESCs, allow the core transcriptional network integrated into external signalling 
pathways of mESCs. In hESCs, Sox2-Oct4 complex co-occupies their target genes with 
mothers against decapentaplegic homolog 3 (Smad3) protein, a downstream effector of the 
transforming growth factor beta signalling pathway which is required for hESC maintenance 
(Mullen et al., 2011). In NPCs, Sox2 expression is promoted by transcriptional factors that 
are highly expressed during neural development and differentiation, such as activating protein 
2(AP-2), prospero homeobox protein 1 (PROX1) and Pax6 (Lengler et al., 2005). Signalling 
pathways, such as phosphatidylinositol-4,5-bisphosphate 3-kinase /Akt and Stat3, also 
function to regulate Sox2 expression (Foshay and Gallicano, 2008, Peltier et al., 2011). 
Recently, cell cycle regulators E2f3a and E2f3b have been reported to regulate Sox2 
expression and control neural progenitor cell proliferation in adult brain (Julian et al., 2013, 
Marques-Torrejon et al., 2013). E2f3a and E2f3b are shown to differentially regulate Sox2 
expression in neural progenitor cells, thus affecting adult neurogenesis (Julian et al., 2013). 
E2f3a cooperates with the pRb family member p107 to repress Sox2 expression, reducing 
neural progenitor self-renewal and promoting terminal differentiation, whereas E2f3b 
activates Sox2 expression by recruiting RNA polymerase II to its promoter, leading to 
increased self-renewal and neural progenitor/stem cell expansion. Cyclin-dependent kinase 
inhibitor P21 has also been found to directly bind to a Sox2 enhancer and repress Sox2 
expression in NPCs (Marques-Torrejon et al., 2013). The various enhancers/regulatory 
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regions of Sox2 work together to stringently regulate the expression of Sox2 from early 
preimplantation embryos to various neural progenitor cells (Tomioka et al., 2002, Uchikawa 
et al., 2003, Kamachi et al., 2001). 
 
(Adapted from Zhang and Cui, 2014) 
Figure 1.5 Transcriptional expression of Sox2 is regulated by multiple enhancers 
located in the Sox2 locus 
The Sox2 gene locus is illustrated in yellow box, in which Sox2 exon and location of the N1 to 
N5 enhancers are indicated. TSS, transcription starting site; TTS, transcription termination 
site; SRR1 and 2 are Sox2 regulatory regions 1 and 2. 
 
Other than transcriptional regulation, Sox2 expression and activity are also regulated by post-
transcriptional and translational mechanisms. MicroRNA-145 has been demonstrated to 
negatively affect the expression of pluripotent transcription factors, including Oct4, Sox2 and 
Klf4 (Xu et al., 2009). Sox2 protein can be modulated by methylation, acetylation, 
sumoylation and phosphorylation, which subsequently affect its activities as a transcriptional 
regulator. Three phosphorylation sites, S249, S250 and S251, have been identified in Sox2, 
the phosphorylation of which promotes sumoylation of Sox2, subsequently inhibiting the 
binding of Sox2 to DNA motifs (Tsuruzoe et al., 2006, Van Hoof et al., 2009). Acetylation of 
Sox2 by a histone acetyltransferase, p300, induces its nuclear export in ESCs, leading to 
increased ubiquitination and proteasomal degradation of Sox2 protein (Baltus et al., 2009). 
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Sox2 regulates distinct target genes in pluripotent ESCs and during neural differentiation. 
Although the exact mechanisms that govern its selection on target genes are not fully 
elucidated, transcription factors that function as Sox2 interacting partners may play an 
important role in this selection. Sox2 is similar to all Sox family members, in that achieving 
their regulatory functions requires pairing and coordination with other transcription factors to 
form complexes (Kondoh and Kamachi, 2010). The Sox transcription factor and its 
interacting partner bind to adjacent DNA sequences in promoter/enhancer of target genes to 
regulate their expression. Several Sox2 partners have been identified in various cell types 
(Figure 1.6) (Aota et al., 2003, Tanaka et al., 2004, Donner et al., 2007, Engelen et al., 2011, 
Kamachi et al., 2001, Loh et al., 2006, Tomioka et al., 2002, Boyer et al., 2005). The most 
studied Sox2 partner is Oct4 in PSCs. As discussed earlier, Sox2 has been shown to interact 
directly with Oct4 in PSCs and the Sox2-Oct4 complex binds to adjacent DNA motifs located 
in the enhancer/promoter regions of thousands of genes genome-wide to either activate or 
repress the expression of these genes. They cooperatively activate pluripotent genes whilst 
repressing lineage-specific ones, hence maintaining pluripotency in these cells (Figure 1.4) 
(Boyer et al., 2005, Loh et al., 2006, Tomioka et al., 2002). However, it is less clear which 
transcription factors serve as the Sox2 binding partners during the neural differentiation of 
PSCs. In early murine neural progenitors, Sox2 is shown to interact with the brain-specific 
POU domain-containing transcription factor Brn2 to activate the NPC-associated Nestin gene 
expression (Tanaka et al., 2004). During lens development, Sox2 and Pax6 form a complex 
which binds to lens-specific enhancer elements to initiate lens development (Kamachi et al., 
2001). Recently, it is also reported that Sox2 is able to interact with long non-coding RNA 
rhabdomyosarcoma 2 associated transcript (lnRMST) to activate the expression of their 
neural target genes and to promote neural differentiation (Favaro et al., 2009). It is possible 
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that Sox2 requires different partners in different neural progenitor cells, which regulate 
expression of different gene sets, leading to the formation of different neural cell types. 
 
(Adapted from Zhang and Cui, 2014) 
Figure 1.6 Sox2 binding partners and their functions 
 
1.3.5 A potential binding partner for Sox2 in neural initiation: Pax6 
Pax6 locus encodes at least three isoforms: the canonical Pax6a, Pax6b, and Pax6 (PD). Pax6 
protein consists of two conserved DNA binding domains, the paired domain (PD) and the 
paired-type homeodomain (HD) and a proline/serine/threonine-rich (PST) domain possessing 
a transactivation function (Epstein et al., 1994, Czerny and Busslinger, 1995, Jun and 
Desplan, 1996); (Tang et al., 1998). There are four transcription starting sites identified 
within mouse Pax6, associated with P0, P1, Pα and P4 promoters (Kammandel et al., 1999, 
Xu et al., 1999); (Kleinjan et al., 2004, Morgan, 2004). Both Pax6a and Pax6b mRNAs are 
produced by transcription from both P0 and P1 promoters, while the transcript from Pα 
promoter encodes Pax6(PD) (Kim and Lauderdale, 2006, Kammandel et al., 1999). 
 
During mouse CNS development, Pax6 expression was initially detectable at E8.5 embryo in 
which the neural plate entirely consists of Sox1-expressing neuroepithelial cells (NECs) and 
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latter its expression is restricted in forebrain and spinal cord (Bylund et al., 2003, Pevny et al., 
1998, Walther and Gruss, 1991, Inoue et al., 2000, Zhang et al., 2010) (Figure 1.8). Unlike 
mouse, Study in human foetus tissues reveals that Pax6 expression emerges at the single-
layer neural plate at which the cells do not express Sox1, but express Sox2. This overlapping 
expression of Sox2 and Pax6 latter is restricted in the forebrain and spinal cord, but not 
midbrain (Zhang et al., 2010). This expression pattern of Pax6 is also reflected in the neural 
differentiation of ESCs. In hESCs, Pax6 expression appears earlier than the Sox1 expression, 
whereas in mESCs, Sox1 expression emerges much earlier than Pax6 (Zhang et al., 2010). 
These results raise an intriguing possibility that Pax6 might play an important role in the 
human neural specification. 
 
By employing hESCs neural differentiation as an in vitro model system of neural 
specification, Pax6 was uncovered to play a decisive role in neural induction. Pax6-
knockdown severely affects the neural differentiation from hESCs, while Pax6a, but not 
pax6b, along is sufficient to induce efficient neural differentiation in hESCs even in the 
optimal hESCs culture condition (Zhang et al., 2010). A recent study analysing the genome-
wide binding sites of Pax6 in early neural differentiation (Bhinge et al., 2014) reveals that 
Pax6 binds to the genes associated with nervous system development, neural tube patterning, 
and spinal cord, forebrain and eye development (Figure 1.7 A). A significant proportion of 
these genes are TFs, such as Sox2, lim Homeobox 2(Lhx2), lim domain Only 3 (Lmo3), 
myeloid ecotropic viral integration site 1 homolog (Meis2), dachshund family transcription 
factor (Dach1) and lim like homeobox1 (Lix1), which are mainly responsible for neural 
development including forebrain development, neural tube development, and spinal cord 
patterning (Figure 1.7 B). Interestingly, Pax6 binding sites are also found near the Pax6 TSS 
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as well as within Pax6 gene body, overlapping with H3K27Ac peaks, indicating that PAX6 
activates its own transcription (Figure 1.7C). 
 
In addition to its function in neural specification, Pax6 plays multiple function during CNS 
development, such as regulating NPC proliferation (Arai et al., 2005), neurogenesis (Estivill-
Torrus et al., 2002, Hevner et al., 2006, Scardigli et al., 2003). It appears that Pax6 needs to 
cooperate with other co-factors to specifically regulate target genes in a cell-context 
dependent manner. For example, Pax6 interacts with mDia to act on Pax6 in cerebellar 
granule cells (Tominaga et al., 2002) with Brg1/Brm associated factors complex (BAF) in 
regulating adult neurogenesis ((Ninkovic et al., 2013) and with Meis2 neurogenesis and 
dopaminergic periglomerular fate specification (Agoston et al., 2014). So far, what is the 
binding partner of Pax6 during neural initiation is still unknown. Considering that Pax6 
expression is overlapped with Sox2 in NECs, it would be interestingly to explore whether 
they bind to each other and what functions they exert. 
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Figure 1.7 Pax6 binding sites in NECs revealed by genome-wide ChIP-Seq 
 (A) Enriched functional categories derived by GREAT analysis for all PAX6 targets. (B) 
Enriched functional categories derived by GREAT analysis for PAX6 transcriptional targets. 
(C) Genome browser snapshot of Pax6 binding sites overlapping with H3K27Ac and 
H3K27Me3 signal proximal to Pax6. (Adapted from Bhingel et al., 2014.) 
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Figure 1.8 Expression of Oct4, Sox2 and Pax6 during mouse/human embryonic 
development 
The expression of Oct4, Sox2 and Pax6 are listed according to the stage of embryonic 
development. CS, Carnegie Stage; “N/A”, No published data available; ICM, inner cell mass; 
TE, trophectoderm; PS, primitive streak; NE, neuroepithelium; PGCs, primordial germ cells; 
CNS, central nervous system. 
 
In summary, Sox2 is one of the key transcription factors that play an essential role in 
maintaining pluripotency of stem cells. Sox2 interacts with Oct4 to form a binary complex, 
which then recruits other nuclear factors to activate pluripotent gene expression and repress 
genes involved in differentiation. Furthermore, Sox2 is also a critical factor for initiating the 
neural induction and maintaining neural progenitor stem cell properties throughout neural 
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differentiation. Recently, it has been reported that Sox2 is expressed in adult stem cells of 
several epithelial tissues and regulates trophoblast stem cell differentiation (Aota et al., 2003, 
Adachi et al., 2013). However, how Sox2 achieves these pleiotropic functions remains to be 
elucidated. Sox2, like other Sox family members, performs its regulatory functions more 
efficiently when paired with an interacting partner. Although Oct4 has been well 
demonstrated as being such a partner in pluripotent stem cells, the identities of Sox2 partners 
in other tissues are largely unknown. Understanding the molecular mechanisms governing 
Sox2 functions will facilitate the use of pluripotent stem cells for clinical and biomedical 
applications, with particular relevance to the modelling and treatment of various neurological 
disorders. 
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1.4 Aim and objectives 
Following the above review, I hypothesize that Sox2 plays important roles in both 
pluripotency maintenance and neural differentiation. These distinct functions of Sox2 are 
achieved via interaction with different factors and binding to different DNAs in the genome. 
In pluripotent stem cells, Sox2 interacts with Oct4 to activate Oct4, Nanog and other 
pluripotent genes’ expression. During neural differentiation, Sox2 may interact with neural 
transcription factors to repress the expression of Oct4 and Nanog but activate expression of 
neural genes, which subsequently promote neural differentiation (Figure 1.9). 
 
Figure 1.9 Sox2 and its partners regulate pluripotency and neural differentiation in 
hESCs  
Dash and solid lines represent the functions in hESCs and neural differentiation, respectively; 
NTF, neural transcription factors; NG, neural genes; Smads Inh, Smads inhibitors. 
 
To verify this hypothesis, I will carry out experiments following the objectives below. 
(1) Examine the role of Sox2 in hESCs and NPCs. 
(2) Investigate the effect of Sox2 overexpression in hESC differentiation. 
(3) Determine the binding partners of Sox2 during neural initiation and elucidate the 
molecular mechanism by which neural transcription factors and Sox2 initiate neural 
differentiation from hESCs. 
Chapter two 
___________________________________________________________________________  
 
57 
 
Chapter Two 
 
Materials and Methods 
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2.1 Cell culture 
2.1.1 Materials 
2.1.1.1 Cell Lines 
Cells Source 
H1 hESC (WA-01) Male human ES cell line isolated by Thomson et al., 1998, distributed by WiCell. 
H7 hESC (WA-07) Female human ES cell line isolated by Thomson et al., 1998, distributed by WiCell. 
HT1080 Fibrosarcoma cell line, obtained from ATCC. 
HEK293T Kidney cell line immortalised by T-antigen delivered by adenovirus, obtained from the ECACC. 
Mouse Embryonic Fibroblasts 
(MEFs) Wild-type MEFs isolated from E13.5 CD-1 mouse embryos. 
PC-3 Prostate adenocarcinoma cell line derived from a metastatic site in the bone, kind gift from Dr. Robert Krypta. 
 
2.1.1.2 Growth Factors and Inhibitors 
Reagent Supplier Working Concentration 
Basic Fibroblast Growth Factor(bFGF) R&D 10 ng/ml 
Epidermal growth factor (EGF)  Peprotech 20ng/ml 
Noggin R&D 100ng/ml 
SB431542 R&D /Tocris 10μM 
Dorsomorphin R&D /Tocris 1μM 
Neomycin(G418) Sigma-Aldrich 400~1000 μg/ml 
Puromycin Sigma-Aldrich 1~2μg/ml 
 Rho Kinase Inhibitor (ROCKi) Sigma-Aldrich 10 μM 
 
Chapter two 
___________________________________________________________________________  
 
59 
 
2.1.1.3 Media Components 
Component Supplier 
200 mM L-Glutamine  Sigma-Aldrich 
100X Penicillin-Streptomycin  Sigma-Aldrich 
20% Bovine Serum Albumin (BSA)  Sigma-Aldrich 
50X B27 Supplement  Life Technologies 
100X N2 Supplement Life Technologies 
Dulbecco's Modified Eagle AQ Media (DMEM-AQ)  Sigma-Aldrich 
Heat-inactivated Foetal Bovine Serum (FBS)  Sigma-Aldrich 
Knockout DMEM  Life Technologies 
Knockout Serum Replacement (KSR)  Sigma-Aldrich 
Non-essential Amino Acids (NEAA) Life Technologies 
Opti-MEM® Reduced Serum Medium  Life Technologies 
50 mM β-mercaptoethanol  Life Technologies 
DMEM:F12 (1:1) Life Technologies 
Neurobasal Life Technologies 
100X Penicillin/Streptomycin (P/S) Life Technologies 
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2.1.1.4 Media Recipes 
Knockout Serum Replacement Medium  
(KSR-M) 
KO-DMEM supplemented with:  
20% KSR 
1 mM L-glutamine 
1x NEAA 
0.1 M β-mercaptoethanol for TC 
1x Penicillin-Streptomycin 
MEF/HEK293T/HT1080 (D10) DMEM-AQ supplemented with: 
10% FBS 
1x NEAA 
1x Penicillin-Streptomycin 
MEF-conditioned medium for hESCs 
(MEF-CM) 
MEF conditioned KSR-M supplemented with:  
1 mM L-glutamine 
10 ng/ml bFGF 
PC-3 medium (R10) RPMI-AQ supplemented with: 
10% FBS 
1x NEAA 
1x Penicillin-Streptomycin 
N2/B27 medium DMEM/F12 /Neurobasal medium (1:1) 
supplemented with: 
0.5 x B27 
0.5 x N2 
1 mM L-glutamine 
 
 
2.1.1.5 Disassociation Enzymes 
Enzyme  Supplier 
Accutase  Sigma-Aldrich 
Collagenase IV  Life Technologies 
Trypsin-EDTA  Sigma-Aldrich 
TryLE Express Sigma-Aldrich 
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2.1.1.6 Reagents, Chemicals and Kits 
Reagent Supplier 
2% Gelatine in PBS  Sigma-Aldrich 
Calcium Phosphate Transfection Kit  Sigma-Aldrich 
Laminin Sigma-Aldrich 
Chondroitin Sulphate  Sigma-Aldrich 
Dimethyl sulphoxide (DMSO)  Sigma-Aldrich 
Dual-Glo® Luciferase Assay Kit  Promega 
Dulbecco's Phosphate Buffered Saline (DPBS)  Sigma-Aldrich 
Hexadimethrine bromide (Polybrene)  Sigma-Aldrich 
LipofectamineTM LTX with PLUS Reagent  Life Technologies 
Matrigel® Matrix Growth Factor Reduced  BD Bioscience 
Water Tissue Culture Grade (TC-H2O)  Sigma-Aldrich 
 
2.1.2 Methods 
2.1.2.1 Culture and propagation of hESCs 
i. Preparation of mouse embryonic fibroblast conditioned medium  
Mouse embryonic fibroblasts (MEFs) were originally isolated from the embryo of E13.5 
pregnant CD-1 mice. After carefully removing the liver and heart tissue, the left MEFs were 
minced and dissociated into single cells by trypsinization.  After the neutralization with D10 
medium, cells were spinned down and washed by DPBS for several times before seeding on 
to T75 flasks for 2-3 days. Once the MEFs become confluent on the T75 flasks, they were 
collected and frozen down at 1 x 107 cells per cryovial in D10 medium supplemented with 10% 
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DMSO and defined as passage 0. Once needed, these MEFs were defrosted and expanded up 
to 3 or 4 passages in D10 medium. Cells were then trypsinised and irradiated at 40 grays (IBL 
637 cell irradiator) to eliminate their replication potential. After irradiation, cells were seeded 
back to T225 flasks pre-coated with 0.5% gelatine at a density of 2 x 10E7 cells per flask and 
cultured for 24 hours in D10 medium. After 24 hours, D10 medium was replaced with 150ml 
per flask of KSR-M, supplemented with 0.4ng/ml bFGF. The following day, this MEF 
conditioned medium (MEF-CM) was collected and stored at -80ć. Another 150ml of KSR-
M was added back onto the MEFs and the entire CM collection procedure was repeated over 
the next 6 days. When in use, MEF-CM was defrosted and filtered to remove cell debris and 
supplemented with additional 2 mM L-glutamine to replenish uptake by MEFs during the 
conditioning process. Defrosted MEF-CM was routinely stored at 4 and freshly added 8-
10ng/ml bFGF before feeding hESCs and consumed within one week. 
 
 
 
ii. Preparation of Matrigel coated plates 
Growth factor-reduced matrigel was slowly thawed on ice at 4ć overnight and the next day, 
matrigel solution was diluted 1in 2 with chilled KO-DMEM on ice and aliquoted into 1ml per 
15ml centrifuge tube. These matrigel aliquots were kept at -20ć for long term storage. Upon 
use, 1 tube of the aliquots was again slowly thawed on ice and diluted with 15ml of chilled 
KD-DMEM. 6 well plates were routinely used for hESC culture. Each well of 6-well plate 
was coated with 1 ml of this new dilution and the coated plate need to be set overnight at 4ć. 
The next day, before cell culture, these coated plates were taken out and warmed to room 
temperature.  Excess matrigel was aspired off just before plating cells down to the plates. In 
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emergency situation, fresh coated matrigel plates can be only after setting at room 
temperature for at least 4 hours. 
 
iii. Routine culture and maintenance of hESCs 
In this work, both H1 and H7 hESC lines were routinely cultured and passaged in pre-coated 
matrigel 6-well plates in MEF-CM supplemented with freshly added 10ng/ml of bFGF. Cells 
were changed medium daily and routinely passaged when they reached 80~90% confluency 
every 5~7 days by using 200U/ml collagenase IV to remove spontaneously differentiated 
cells followed by mechanical disassociation. Cell were normally split out in 1into 2~3 ratio 
depending on their confluency. For long-term storage, 80~90% confluent hESCs were treated 
with 200U/ml collagenase IV followed by mechanical dissociation within cold KSR. The 
resulting clumps were collected within KSR plus 10% v/v DMSO and transferred into 
cryovial, stored overnight at -80ć before transfer into liquid nitrogen tank. 
 
 
iv. Accutase/ROCKi passaging of hESCs 
Due to their properties, hESCs need to grow in colonies to prevent differentiation as once 
dissociated into single cells, they rapidly go through apoptosis and differentiation. This 
growing manner hinders their use in genetic manipulation as a really low efficiency of 
transfection was obtained. An accutase/ROCKi split was developed to solve this problem. 
Accutase is a milder enzyme than trypsin and can be used to dissociate them into single cells.  
ROCKi need to be added into medium at the day of passage and was left in medium for 24 
hours to inhibit apoptosis. The following day, ROCKi was removed from the culture to 
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minimise the chronic effects of Rho kinase inhibition. After another one day of culture, these 
monolayer cells were ready for transfection. 
 
2.1.2.2 Neural differentiation from hESCs 
i. Noggin 
Neural differentiation was performed based on our established protocol (Gerrard et al., 2005). 
When the confluency of hESCs reached to around 90%, these cells were subjected to 
200U/ml collagenase IV treatment followed by mechanical dissociation into small clumps 
and split out in a ratio of 1:3 or 1:4 on PLL/Laminin coated 6-well plates in N2B27 
supplemented with 100ng/ml Noggin, defined as passage 1. Medium was changed every 
other day with freshly added Noggin. Once reaching ~100% confluent, cells were 
mechanically dissociated using collagenase IV and split out in a ratio of 1:3 on PLL/Laminin 
plates. In the first week, cell colonies became more and more compact. After another 1~2 
passage, cells exhibited typical neural rosettes morphology mimicking the formation of 
neural tube in vivo development and latter around 30days, cells exhibited a typical bipolar 
appearance, representing the emergence of neural progenitor cells. Form that on, Noggin was 
remove and replaced by 10ng/ml bFGF and 20ng/ml EGF to maintain the self-renewal of 
these cells in N2B27 medium (detail of this protocol was presented in section 3.2.1). To 
further differentiate them into neurons and glial, the growth factors were withdrawn for 1~2 
weeks. 
 
ii. SB431542, Dorsomorphin 
A modified dual SMAD inhibition protocol, using SB43542 and Dorsomorphin was recently 
established (Bhinge et al., 2014). As the same in Noggin protocol, 90% confluent hESCs 
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were initially treated with 200U/ml collagenase IV followed by a mechanically dissociation 
into small clumps and split out in a ratio of 1:3 on Matrigel-coated plates. Cells were 
continuously cultured in MEF-CM as same as hESCs for another 2~3 days. Until they 
became 30~40% confluent, MEF-CM was replaced with 10μm SB431542 and 1μM 
Dorsomorphin. Cells were allowed to differentiate for 8 days with medium changes every 
other day, defined as passage 1. By 8 days, 40~50% cells already exhibit typical neural 
rosette morphology. For the first 1~2 passage, cells were passaged as colonies by using 
collagenase IV. From passage 3, these rosettes were dissociated into single cells by using 
TryLE Express and the SB431542 and Dorsomorphin were replaced by 100ng/ml bFGF and 
20ng/ml EGF to maintain their neural progenitor identity.  
 
2.1.2.3 Culture and propagation of HEK293T, HT1080 and PC-3 cells 
HEK293T and HT1080 cells were routinely cultured in D10 medium and the PC-3 cells were 
cultured in R10 medium on T75 flasks. Once reaching ~100% confluency, they were split out 
in a ratio from 1:5 to 1:10 using trypsin-EDTA. For long-term storage, every 1X10E6 cells 
were frozen in to 1 cryovial in fresh medium supplemented with 10% v/v DMSO. 
 
2.1.2.4 Genetic manipulation of cell lines 
i. Transfection mediated by lipofectamine 
A modified lipofectamine mediated transfection was used in this study (Ma et al., 2012). For 
1X10E6 cells, 1.6 μg of plasmid DNA was diluted in 50 μl of OptiMEM supplemented with 
1.6 μl PLUS reagent in a sterile Eppendorf tube. In another tube, 4μl of LipofectamineTM 
LTX reagent was diluted in 50 μl of OptiMEM. Both tubes were allowed to incubate for 5 
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minutes at room temperature before mixing them together for another 30 minutes’ incubation. 
During this incubation time, hESCs or tumour cells were dissociated into single cells by 
using Accutase/ROCKi split in hESCs or trypsin-EDTA split in tumour cells. After 
dissociation, cells were washed and pelleted down in a 15ml centrifuge tube before 
incubating with the lipofectamine/DNA mixture for no longer than 15 minutes. This small 
volume transfection mixture allows cells fully contact with the mixture in suspension, thus 
enhancing transfection efficiency. After incubation, the culture medium was added into the 
reaction mixture and cells were seeded back to 6 well plates for overnight. On the following 
day, medium was changed and 48 hours post transfection, cells could be collected for 
analysis. 
 
ii. Lentiviral Transduction 
Viral particles were first generated from 293T cells. 1.5 x 10E7 of low passage 293T cells 
were seeded on T225 flask in D10 medium and allowed to reach 40~50% confluency before 
transfection.  In order to keep the PH to be around 7.5, the medium was changed 2~3 hours 
before transfection using the calcium phosphate method. A DNA mixture containing 60 μg 
lentivector: 40 μg pCMVΔ8.91 helper: 40 μg VSV-G envelope diluted in 2ml of HEPE’s 
buffer was made according to the manufacturer’s instructions.  Cells were transfected 
overnight in D10 medium supplemented with 25μM chloroquine in order to inhibit 
endosomal DNA degradation during endocytosis of the DNA.  Medium was changed 18 
hours post transfection. Supernatant was collected at 48 hours and 72 hours, as it contains 
viral particles. These supernatant were first stored at -80ć before the particle purification. 
When all the supernatant were collected, they were mixed and filtered through a 0.45μm 
syringe filter system into Ultra-ClearTM Beckman centrifuge tubes. Then 120 μg/ml of 
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polybrene and chondroitin sulphate was added to aid in precipitating the particles. All 
collected supernatant were then centrifuged at 10000 xg for 1.5 hours in a Beckman Coulter 
Avanti J-20 centrifuge at 4ć  in order to pellet down the virus-chondroitin-polybrene 
complexes. The pellet containing virus was further diluted in 200μ DPBS and allowed them 
to slowly dissolve in DPBS in 4ć overnight. On the following day, the DPBS mixture was 
aliquoted into 50μl/tube and stored at -80ć for up to one month. These virus aliquots can be 
directly added into cell culture medium to infect hESCs or tumor cells. 
 
iii. hESC Luciferase Assay 
As to improve the transfection efficiency, the modified transfection protocol mentioned 
above was applied. In this case, 1μg of DNA containing both firefly (pGL3-luc) and Renilla 
(pRL-T7-renilla) plasmids as an internal control at a ratio of 100:1was diluted in 30μl 
OptiMEM and then mixed with another 30μl OptiMEM containing 2.4μl of lipofectamine 
LTX reagent. These mixtures were allowed to incubate at room temperature for 30 minutes to 
form DNA/lipofectamine complex. After incubation, hESCs were dissociated into single cells 
by using Accutase/ROCKi protocol and 1X10E6 cells were subjected to incubate with the 
lipofectamine/DNA mixture for 15minutes. After this, cells were seeded onto 12-well plate 
and allowed them in culture for 18 hours before changing medium. 48 hours post transfection 
hESCs were washed three times with DPBS and dissociated into single cells using accutase. 
Cell suspension was equally dispensed into 3 corresponding wells of a 96-well luminometer 
plate. According to the instruction of Dual-Glo® luciferase assay kit, cells were first treated 
with Dual-Glo luciferase assay reagent for 10 minutes and luciferase luminescence was 
measured by using a Perkin Elmer Victor II luminometer. Following this, a Dual-Glo® Stop 
& Glo reagent was added into each well and the resulting renilla luciferasemediated 
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luminescence was recorded as an internal control for each transfection. Firefly luminescence 
readings were normalised with corresponding renilla luminescence readings to give a 
luciferase expression values that are independent of transfection efficiency and cell number. 
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2.2 Molecular Biology - DNA/RNA techniques 
2.2.1 Materials 
2.2.1.1 Reagents, Chemicals and Kits 
Reagent  Supplier 
1 kb Full Scale DNA ladder  Thermo Fisher 
100 bp ladder  NEB 
6X DNA loading buffer NEB 
Agarose (molecular biology grade)  Sigma-Aldrich 
Ampicillin  Sigma-Aldrich 
Chloroform:Isoamyl alcohol 24:1  Sigma-Aldrich 
DH5α Competent E. coli  Sigma-Aldrich 
Ethanol  VWR 
Ethidium Bromide  Sigma-Aldrich 
Ethylenediaminetetraacetic acid (EDTA)  Sigma-Aldrich 
HiSpeed Maxiprep Kit  Qiagen 
HiSpeed Midiprep Kit  Qiagen 
Hydrochloric acid (37%)  Sigma-Aldrich 
Isopropanol  VWR 
Magnesium chloride (MgCl2), anhydrous  Sigma-Aldrich 
Molecular Grade Water  Sigma-Aldrich 
Murine RNAse Inhibitor  NEB 
Oligo(dT)12-18  Thermo Fisher 
Potassium chloride (KCl)  Sigma-Aldrich 
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Q5 Site Directed Mutagenesis Kit  NEB 
QIAprep Gel Extraction Kit  Qiagen 
Sodium chloride (NaCl)  Sigma-Aldrich 
Sodium hydroxide  Sigma-Aldrich 
SYBR® Green JumpstartTM Taq Ready Mix  Sigma-Aldrich 
Tri Reagent®  Sigma-Aldrich 
Tris Base  Sigma-Aldrich 
 
2.2.1.2 Buffers and Solutions 
10X Tris-Borate-EDTA Buffer (TBE)  
 
 
108 g Tris Base 
55 g Boric Acid 
9.3 g EDTA 
Autoclaved water to 1 L 
50X Tris-Acetate-EDTA Buffer (TAE)  242 g Tris Base 
57.1 ml Acetic Acid 
18.6 g EDTA 
Autoclaved water to 1 L 
Tris-EDTA Buffer (TE)  1 ml Tris-HCL pH 8.0 (10 mM) 
200 μl of 0.5M EDTA pH 8.0 (1 mM) 
Autoclaved water to 100 ml 
Lysis Buffer 1 (LB1) 50 mMHepes-KOH, pH 7.5 
140 mM NaCl 
1 mM EDTA 
10% glycerol 
0.5%NP-40 
0.25%Triton X-100 
ddH2O to 100ml 
Lysis Buffer 2 (LB2) 10 mM Tris-HCl 
200 mM NaCl 
1 mM EDTA 
0.5 mM EGTA 
ddH2O to 100ml 
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Lysis Buffer 3 (LB3) 10 mM Tris-HCl, pH 8.0 
100 mM NaCl 2 
1 mM EDTA 
0.5 mM EGTA  
0.1% Na-Deoxycholate  
0.5%N-lauroylsarcosine 
ddH2O to 100ml 
ChIP Wash Buffer A 50mM HEPES pH 7.9 
140mM NaCl 
1mM EDTA 
1% Triton X-100 
0.1% Na-deoxycholate 
0.1% SDS 
500mM NaCl 
ChIP Wash Buffer B 20mM Tris pH 8.0 
1mM EDTA 
250mM LiCl 
0.5% NP-40 
0.5% Na-deoxycholate 
ChIP Elution Buffer 50mM Tris pH 8.0 
1mM EDTA 
1% (w/v) SDS 
Lysogeny Broth (LB) Medium  10 g Bacto-tryptone 
5 g Yeast extract 
10 g NaCl 
Autoclaved water to 1 L 
LB Agar  5 g Bacto-tryptone 
2.5 g Yeast extract 
5 g NaCl 
7.5 g Agar 
Autoclaved water to 500 ml 
SOC Media  20 g Bacto-tryptone 
5 g Yeast extract 
2 ml of 5 M NaCl 
2.5 ml of 1 M KCl 
10 ml of 1 M MgCl2 
20 ml of 1 M glucose 
Autoclaved water to 1 L 
Chapter two 
___________________________________________________________________________  
 
72 
 
P1 Resuspension Buffer (Qiagen)  50 mM Tris-HCl pH 8.0 
10 mM EDTA 
100 μg/ml RNAse A 
P2 Lysis Buffer (Qiagen)  200 mM NaOH 
1% Sodium Dodecyl Sulphate (SDS) 
P3 Neutralisation Buffer (Qiagen)  3M Potassium acetate pH 5.5 
Oligos annealing buffer  
 
400 μl Tris-HCl pH 7.5 (10 mM) 
80 μl of 0.5 M EDTA pH 8.0 (1 mM) 
400 μl of 5 M NaCl (50 mM) 
Molecular grade water to 50 ml 
 
2.2.1.3 DNA Modifying Enzymes 
Enzyme Source 
Antarctic Phosphatase  NEB 
DNAse I  Sigma 
JumpstartTM Taq Polymerase  Sigma 
ProtoScript II Reverse Transcriptase  NEB 
Q5® High Fidelity Polymerase  NEB 
Restriction endonucleases  NEB 
T4 ligase  NEB 
T4 polynucleotide kinase (PNK)  NEB 
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2.2.1.4 Plasmids 
Plasmid  Source 
pCMV-Flag-Oct4 (L75) Insert PCR Flag-Oct4 into C16 backbone 
pCMV.sport-b-gal (C16) Invitrogen 10586-014 
pCS2-Sox2 (R75E) (L101) Subcloned mutant into L46 
pCS2-Sox2 (K57E-R60E) (L102) Site mutagenesis from L46 
pCS2-Sox2 (K57E-R60E-R75E) (L103) Site mutagenesis from L102 
pCS2-HA-SOX2 (L46) Insert Sox2 PCR fragment into G55 using FseI/AseI 
pCS2-HA-PIAS-V5(G55) Gift from Dr. Mark Christian 
pBlue KS (-)-Puro-2A-Sox2(L50) Insert HA-Sox2 from L46 into L27  to replace TRF2 
pBlue KS (-)-Puro-2A-TRF2 (L27) Lab owned 
pLVTHM-puro-2A-HA-Sox2 (L51) Subcloned from L50 and G42 
PLVTHM (G42) Addgene 12247 
pCMV-Pax6-v5-his Insert Pax6 from PCR into G66 plasmid using EcoRI+XbalI to replace Cidea 
pCdna3.1-V5-His-Cidea(G66) Gift from Dr. David Barneda 
pCAG-puro-2A-HA-Sox2 Insert puro-2A-HA-Sox2 into L19 using EcoRI+NotI to relapce DsRed 
pOct4 (4kb)-Luc (L115) Insert Oct4 pmt from L8 into C19 
pOct4-EGFP (L8) Lab owned 
pGL4.10   (C19) Promoga E6651 
pOct4 (mini)-Luc (L116) Digest plasmid L115 with EcoRI-EcoRV and end-filled. 
pOct4 (DE+mini)-Luc (L117) Subcloned from  L8 and C19 
pLKO.1-Puro-shGFP  Lab owned 
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pLKO.1 Sox2 3H b Addgene 26352 
pRL-TK-Renilla  Promega, GenBank® no. AF025846 
 
2.2.1.5 Primers qRT-PCR and ChIP-qPCR 
i. Primers for qRT-PCR 
Primer Forward strand Reverse strand 
Brachyury TGCTTCCCTGAGACCCAGTT  GATCACTTCTTTCCTTTGCATCAAG 
Oct4 TCGAGAACCGAGTGAGAGGC CACACTCGGACCACATCCTTC 
Eomes AGGAATTCTTGCTTTGCTAATTCTG CGAAGAAACAGCAAGAGCAGC 
Gata6 ACTTGAGCTCGCTGTTCTCG CAGCAAAAATACTTCCCCCA 
FoxA2 GGGAGCGGTGAAGATGGA TCATGTTGCTCACGGAGGAGTA 
GFAP  CACCACGATGTTCCTCTTGA GTGCAGACCTTCTCCAACCT 
Nestin  GAGGGAAGTCTTGGAGCCAC AAGATGTCCCTCAGCCTGG 
Nanog  TGATTTGTGGGCCTGAAGAAAA GAGGCATCTCAGCAGAAGACA 
Sox1  AACACTTGAAGCCCAGATGGA GCAGGCTGAATTCGGTTCTC 
Pax6  TCCGTTGGAACTGATGGAGT GTTGGTATCCGGGGACTTC 
Mash1  GGAGCTTCTCGACTTCACCA CTAAAGATGCAGGTTGTGCG 
RPL22  TCGCTCACCTCCCTTTCTAA TCACGGTGATCTTGCTCTTG 
Sox17  ACGCCGAGCTCAGCAAGAT TCCACGTACGGCCTCTTCTG 
Sox2  GCCGAGTGGAAACTTTTGTCG GCAGCGTGTACTTATCCTTCTT 
β-actin  TGTCTGGCGGCACCACCATG AGGATGGAGCCGCCGATCCA 
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ii. Primers for ChIP-qPCR 
Primer  Forward strand Reverse strand 
Sox2-N2 AGGACATTCTCCAAGACTCTGC GGTGAGAACTAGCCAAGCATCT 
Sox2 (-1.0kb) CGGCCACCACAATGGAAATC GCACTGTATGGAGGTGGCTT 
Sox2 (+4.1kb) TAAGCAAGGCATTTTCCCCC TGTGAGCAAGAACTGGCGAA 
Oct4-PE ACCAGGCCCCATAATCTACC TTCCCCCACTCTTATGTTGC 
Oct4-DE TGAGAAACACTGGTGTGGAGAT TCTCAATCCCCAGGACAGAA 
Pax6 (+3.2kb) AGGGGGAGACCTGTCTGAATA CCAGCAACTCCTTTAAAACACC 
Pax6 (-1.2) GGACACACCTCAGTACACTCC CTTCAGCCCTATTCCCCCTC 
Pax6 (-2.3kb) GAAAACTCGGCCTCATTCTG AGGAGTGAATGCCACTGACG 
Pax6 (+22kb) TGGGCCCTGCTTCATAGATT CTTTCTGTGCGGTTGTGGATG 
GAPDH 
2nd intron AATGAATGGGCAGCCGTTAG AGCTAGCCTCGCTCCACCTGAC 
 
2.2.2 Methods 
2.2.2.1 DNA manipulation and cloning 
i. Bacterial Transformation 
DH5α E.coli cells were slowly thawed on ice until it totally defrosted before adding less than 
10% of total volume of DNA plasmid into it with tapping. The DNA and bacterial mixture 
was incubated on ice for 30 minutes before being subjected to a heat shock upon immersion 
in 42ć water bath for exactly 40 seconds. Then the mixture was incubated on ice again for 2 
minutes before adding 200μl of SOC media into per reaction. This mixture was the incubated 
for 1hour at 37ć with shaking at 225-250 rpm to promote the outgrowth of transformants. 
After shaking the 250 μl of bacterial was plated onto LB agar plates supplemented with 
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100ng/ml ampicillin to select incorporated colonies. Plates were kept upside down during the 
incubation in a 37 ć oven for 24 hours.  The positive transformed colonies were inspected 
on the following day. 
 
ii. Plasmid Amplification and Purification 
For small scale DNA purification normally used for subcloning, the bacterial colonies 
bearing plasmid were picked and grow in 6ml of LB broth supplemented with 100μg/ml 
ampicillin overnight at 37ć with 230 rpm shaking. The next day, a cloudy suspension of LB 
broth, indicating a successful growing of transformed bacterial, was collected and the 
bacterial was pelleted down by centrifugation at 6000 xg for 15 minutes. The bacterial pellets 
were first resuspended in 300μl P1 resuspension buffer. After fully resuspension, an equal 
volume of P2 lysis buffer was added and the pellets were further incubated for 5 minutes at 
room temperature before the addition of 300 μl of P3 neutralisation buffer to neutralise and 
precipitate out the bacterial debris. The debris was removed from the suspension by a 
centrifugation at 14000 rpm for 5minutes and the supernatant containing soluble plasmid 
DNA was transferred into another clean Eppendorf tube. 600 μl of isopropanol was 
immediately added into the supernatant and the mixture was centrifuged for 1 minute at 
14000 rpm to pellet down plasmid DNA.  After removing supernatant, the DNA pellet was 
resuspended with molecular grade water and then subjected to concentration measurement by 
nanodrop spectrometer 1000 (Thermo Fisher) at A260. 
 
For large scale of DNA amplification which is normally used for transfection or lentiviral 
production, bacterial colonies were picked and grow in 5ml of LB broth for 5 hours before 
being used to inoculate 50 ml (Midiprep), 150 ml (Maxiprep, high copy no.) or 250 ml 
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(Maxiprep, low copy no.) LB broth supplemented with 100ng/ml ampicillin. This large 
volume of bacterial suspension wad further incubated overnight at 37ć with shaking. On the 
following day, bacterial was pelleted down via centrifugation at 6000 rpm for 15 minutes and 
subjected to the purification using HiSpeed Midiprep or Maxiprep kits.  
 
iii. Restriction digests and gel extraction 
DNA digestion is normally used for the variation of a plasmid sequence or generating 
fragment used for subcloning.  According to the NEB restriction enzyme instruction, a 
digestion reaction was normally set up in a 20~30 μl of total volume containing 1~2 μg of 
DNA, restriction enzyme less than 10% of total volume and an appropriate buffer. The 
mixture was incubated at 37ć for 1~2 hours. For the purpose of sequence verification, the 
digested samples were run in a agarose gel electrophoresis in parallel with an appropriate 
DNA ladder to determine whether the digested product gives the right size as expected. For 
the subcloning purpose, whole volume of digested samples were run in an agarose gel 
electrophoresis and the band at the correct size was cut out from the whole gel by using a 
sharp scalpel and then the DNA form the band was extracted by using a QIAprep Gel 
Extraction Kit. Purified DNA fragments are typically eluted in 30μl of TE buffer to maximise 
the concentration for ligation. 
 
iv. DNA dephosphorylation 
After purification, the linearized plasmid was subjected to DNA dephosphorylation by 
Antarctic phosphatase to rule out any chance of relegation from the single digested plasmid. 
A typical reaction contains 1~5 μg of DNA, 1/10th volume of 10X Antarctic phosphatase 
buffer and 5 U Antarctic Phosphatase and was incubated for 30 minutes or 60 minutes to 
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dephosphorylate 5’ or 3’ extensions respectively. Enzyme was inactivated at 70ć for 5 
minutes before use for following ligation. 
 
v. Oligo annealing and phosphorylation 
Equal volumes of sense and antisense strands were mixed with annealing buffer to make up 
an annealing reaction of total 100 µl at final 10μM concentration. The reaction was placed 
onto a 95ć heating block  for 5 minutes and the whole block with the reaction inside, was 
removed from the heating plate and allowed to slowly cool down to room temperature to 
enable the annealing occur within the reaction. The annealed double-stranded fragment was 
quantified by using nanodrop and 300 pM 5’ ends were phosphorylated with 10 U of T4 PNK 
in 1X T4 ligase buffer with appropriate amount of ATP according to the conversion equation: 
1 μg of 20 bp oligo = 150 pM 5’ ends. The reaction was incubated at 37ć for 5 minutes and 
heat inactivated at 65ć for 20 minutes. 
 
vi. Ligation 
Ligation was performed when an insert DNA need to be ligased with a linearized plasmid to 
generate a circular plasmid for further use in transfection. According to the NEB guideline, a 
typical reaction of total 10μl volume contains appropriate amount of a vector and an insert 
molar ratio of 1:3, 10U of T4 ligase and 1μl of 10XT4 ligase buffer supplemented with ATP 
and allowed to incubate for 1hour at 22 ć. If the digested insert or vector bearing blunt ends, 
this reaction was considered as a difficult ligation which needs to be incubated overnight at 
16ć. After ligation, 5~10 μl of the reaction was used to transform bacterial as mentioned in 
above section. 
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vii. Generation Sox2 expression construction 
Firstly, the Sox2 fragment was amplified from a polymerase chain reaction (PCR) reaction by 
using the OKSIM plasmid as a template and the primers containing restriction enzyme sites, 
FseI and AscI in the forward and reverse primers respectively. The forward primer was 5’-
TATAGGCCGGCCAGATCTTATGT-3’ and reverse primer was 5’-
AATTGGCGCGCCACTAGTTCACATGTGT-3. The FseI/AscI fragment of Sox2 PCR 
product was then inserted into the FseI/AscI sites of pCS2-HA vector (a gift from Mark 
Christian’s lab) to generate PCS2-HA –SOX2. Then the BamHI/SpeI fragment of HA-Sox2 
was cut out and inserted into pSkII-Puro-2A-TRF2 plasmid to replace TRF2. The HA-Sox2 
sequences have been confirmed in-frame with the puro-2A sequences. Then the PmeI/SpeI 
fragment of Puro-2A-HA-Sox2 was inserted into pLVTHM vector (Addgene) to replace the 
fragment of green fluorescent protein (GFP). 
 
Viii Chromatin Immunoprecipitation (ChIP) 
Fixation˖ChIP experiments were carried out with chromatin prepared from hESCs or NPCs. 
Along procedures, protease inhibitor cocktail, PMSF (1:100), NaF (1:200) and Na3VO4 
(1:50) were added to all buffers used to prevent protein degradation. 1x10E8 hESCs cultured 
in T225 flasks were washed in PBS before fixation with 1% (v/v) formaldehyde at 37°C, 10 
min. The reaction was quenched by addition of glycine to a final 1.25M concentration and 
allowed to incubate for 5 minutes at room temperature. After another three times of wash 
with cold DPBS, cells were scraped down and pooled into a 50ml Falcon tube followed by a 
centrifugation at 1,350 x g for 5 minutes at 4°C and the pelleted cells were resuspended in 
5ml of LB1 swelling buffer for 10 minutes at 4°C with rotation. Cells were pelleted down via 
centrifugation at1350 x g for 5 minutes at 4°C and resuspended in 5ml of LB2 buffer to 
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extract the nuclei protein. After washed, pellets were resuspended in LB3 buffer, ready for 
sonication. Sonication was carried out in a Bioruptor Sonicator at 4°C for 20 minutes total in 
pulses of 30 sec, generating DNA fragments of 400-800bp. Cell debris was removed from the 
sonicated DNA via centrifugation at 16000xg, 10 minutes at 4 °C. 
 
Immunoprecipitation: Prior to IPs, protein concentration form the sonicated sample was 
measured using the BCA Assay Protein Quantification Kit following manufacturer’s 
instructions, with the protein absorbance read at a wavelength of 562 nm on an Optimax 
Tuneable microplate reader (Bio-Rad). Typically 1 mg of sonicated fragment was incubated 
with protein-G conjugated Dynabeads pre-linked with a primary antibody at 4°C for 24 hours 
with rotation, to form immunecomplexes. Precipitated immunecomplexes were separated by 
magnetic stand and washed off the non-specific bound chromatin/protein once with 
sonication buffer, once with ChIP wash buffer A and buffer B, then twice with TE buffer. 
After the final wash, immunecomplexes were eluted from the beads by incubation with 250μl 
ChIP elution buffer for 15 minutes at 65°C with vigorously shaking. Both the eluates and pre-
saved 1% input were subjected to reverse crosslink via incubation at 65°C overnight with 
shaking. 
 
DNA purification:  After reverse-crosslink, the DNA was purified by addition of 0.2 µg/ml 
final concentration of RNaseA with incubation at 37°C for 2 hours and latter addition of 0.2 
µg/ml final concentration of proteinase K with incubation at 55°C for 2 hours. DNA was then 
extracted using 400ul phenol:chloroform:isoamyl alcohol (P:C:IA) and precipitated by using 
1mL 100% ethanol and 2μL 15mg/mL glycogen at -80°C for 30minutes followed by 
centrifugation at 20,000 x g for 10 minutes at 4°C to pellet DNA. Pelleted DNA was 
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resuspended within 50μl of molecular grad water and stored at -20°C. The purified DNA here 
is ready for further quantitative real-time polymerase chain reaction analysis. 
 
2.2.2.2 Gene expression analysis 
i. RNA Isolation and extraction 
For gene expression analysis, one ~90% confluent hESCs or tumour cells were lysed in 1ml 
of TRI Reagent and were collected in an eppendorf tube before processing. 200μl of 
chloroform: isoamyl alcohol was added into the tube and allowed to vigorously shake. After 
centrifugation at 12000xg for 15 minutes at 4ć, samples were formed three layers of which 
the aqueous top layer contained the RNA. After transferring the RNA into a clean tube, 500 
μl of isopropanol was added in and the tubes were allowed to stand at room temperature for 
10 minutes to precipitate RNA. After another centrifugation at 12000 xg for 10 minutes at 
4 ć, RNA was pelleted down and washed once by 1ml 75% ethanol followed by a final 
centrifugation at 12000 xg for 10 minutes.  After removing the supernatant, the washed pellet 
was allowed to air-dried for 5~10 minutes and was resuspended in 20μl of molecular grade 
water to dissolve RNA. DNase I treatment was used on the RNA sample to remove any 
possible genomic DNA residual. 2μl of 10X reaction buffer and 2Uof DNase I were added 
into each 20μl of RNA solution which was further incubated at room temperature for 15 
minutes before the addition of 2μl of 10X stop solution to heat inactivate the reaction of 
DNase I at 70ć  for 15 minutes. The final treated RNA products was measured their 
concentration by nanodrop and 1μg of total RNA was used in cDNA synthesis. 
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ii. cDNA Synthesis 
Normally 1μg of total RNA was used for cDNA synthesis. In a typical reaction, 1μg of RNA 
was first mixed with 2μl of 50μM oligo(Dt)12-18 and 1μl of 10mM dNTP and the total 
volume was made up to 12 µl by the addition of molecular grade water. This mixture was 
allowed to incubate in a thermocycler at 65 ć for 5 min to fully denature the RNA and 
anneal the Oligo(dT)12-18 primers to the template. After the initial incubation, this 12μl 
reaction was added with 4 μl of 5X ProtoScript II RT reaction buffer, 2 μl 0.1 M DTT, 40 U 
of murine RNAse inhibitor, 200 U of ProtoScript II reverse transcriptase and the final volume 
was adjusted by water to become 20μl, defined as RT+ sample. Notably, Another tube of 
reaction with everything the same as RT+ sample, but without the 200 U of ProtoScript II 
reverse transcriptase was also prepared  to go through the following thermocycler incubation 
and was considered as “RT-” sample to be used as a negative control for later cDNA analysis.  
The reactions were incubated for 1hour at 42ć and were heat inactivate the enzyme at 80ć 
for 5minutes. At this stage, cDNA was synthesised within the reaction and further diluted 
with 180μl of molecular grade water and stored at -20ć. 
 
iii. Semi-quantitative Polymerase Chain Reaction (PCR) 
Before analysing the gene expression by real-time PCR, the quality of the cDNA was 
assessed by standard PCR using housekeeping genes, such as β-actin and RPL-22 and also 
the quality of any new designed primers can be assessed by standard PCR prior to use in real-
time PCR analysis. A typical reaction contains 1~2μl of template cDNA, 1/10th of 10X 
JumpstartTM Taq reaction buffer, 200 μM dNTP, 200 nM of forward and reverse primer, and 
1.25 U of JumpstartTM Taq polymerase and molecular grade water to make up a total 25μl of 
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reaction. Assembled reactions were incubated in the thermocycler with the following cycling 
conditions:  
1: 94 ć 2 min Initial denaturation 
2: 94 ć 30 sec Cycling denaturation 
58~60 ć30 sec Primer annealing (Ta) 
72 ć 45 sec Extension 
Repeat from step 2 for 25-35 cycles depending on primer used. 
3: 72 ć 5 min Final extension 
4: 4 ć Hold 
Primers were designed with a melting temperature (Tm) within the range of 60 to 65ć
calculated by NEB Tm calculator. The Ta of the primer at annealing step was decided based 
on their originally Tm to be 3 to 5ć lower than Tm. After PCR reaction, samples were run in 
a agar gel as mentioned above. A good quality PCR product should generate a single product 
with high efficient. 
 
iv. Quantitative Real-Time PCR (qRT-PCR) 
Once the quality of the synthesised cDNA was confirmed, cDNA was ready for the qRT-PCR 
analysis. A typical reaction contained 2μl of template cDNA, 15μl of SYBR Green 
JumpstartTM Taq Ready Mix, 300 nM of forward and reverse primer and with water to make 
up a total volume of 30μl. For each cDNA, it was set up in triplicate for each primer, so that I 
can calculate an average CT value from these triplicate readings. Reactions were run on a 
Bio-Rad Opticon2TM DNA Engine Real-time fluorescence thermocycler with the following 
conditions: 
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1: 94 °C 2 min Initial denaturation 
2: 94 °C 15 sec Cycling denaturation 
60 °C 30 sec Primer annealing (Ta) 
72 °C 30 sec Extension 
75 – 84 °C +3 °C /sec Real-time fluorescence read/sec 
Repeat from step 2 for 40 cycles depending on primer used. 
3: 67 – 91 °C +0.3 °C /sec Melting curve read/sec 
Analysis was performed using accompanying software and using the 2ΔΔCt method. In brief, 
raw Ct values were normalised to either RPL22 and β-actin values for each sample to 
generate the ΔCt value and each ofCt was further normalised to that of control to generate 
a ΔΔCt values. Then the relative gene expression was calculated by taking the ΔΔCt value as 
the exponential function of 2.  
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2.3 Molecular Biology – Protein techniques 
2.3.1 Materials 
2.3.1.1 Reagents, Chemicals and Kits 
Reagent Supplier 
30% Acrylamide/Bis  Sigma 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) Sigma 
4’,6 diamidino-2-phenylindole (DAPI)  Sigma 
Adenosine triphosphate (ATP)  Sigma 
Bicinchoninic Acid Assay (BCA) Protein Quantification Kit  Thermo Fisher 
Bromophenol blue Sigma 
Bovine Serum Albumin (BSA)  Sigma 
CL-Xposure film  Scientific Labs 
Dithiothreitol (DTT)  Sigma 
Enhanced chemiluminescence substrate (ECL)  Thermo Fisher 
Ethylene glycol tetraacetic acid (EGTA)  Sigma 
Glycerol  Sigma 
Glycine  Sigma 
Goat serum Sigma 
Immobilon® polyvinylidene fluoride (PVDF) membrane  Millipore 
Luminate Forte Enhanced ECL substrate  Millipore 
Methanol  VWR 
Mowiol 4-88  Sigma 
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Nonidet P-40 (NP-40)  Anachem 
PageRuler Plus Protein Ladder  Thermo Fisher 
Paraformaldehyde  NEB 
Phenylmethanesulfonylfluoride (PMSF)  Sigma 
Phosphatase Inhibitor Cocktail 2 Sigma 
Protease Inhibitor Cocktail  Sigma 
Protein G Dynabeads®  Life Technologies 
Skim milk powder  Sigma 
Sodium azide (NaN3) Sigma 
Sodium deoxycholate  Sigma 
Sodium dodecyl sulphate (SDS)  Sigma 
Sodium orthovanadate (Na3VO4)  Sigma 
Tetramethylethylenediamine (TEMED)  Sigma 
Triton X-100 Sigma 
Tween-20 Sigma 
β-mercaptoethanol  Sigma 
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2.3.1.2 Buffers and Solutions 
Immunoblot & Immunoprecipitation  
Radio Immunoprecipitation Assay Buffer 
(RIPA) 
25 ml 1 M Tris-HCl pH 8.0 (50 mM) 
15 ml 5 M NaCl (150 mM) 
5 ml NP-40 (1% v/v) 
2.5 g Sodium deoxycholate (0.5% w/v) 
0.5 g SDS (0.1% w/v) 
Autoclaved water to 500 ml 
2X Sample buffer  2.5 ml 0.5 M Tris-HCl pH 6.8 (125 mM) 
2 ml glvcerol (20% v/v) 
4 ml 10 % SDS (4% w/v) 
160 μl 1.25% bromophenol blue (0.02 % w/v) 
500 μl β-mercaptoethanol (715 mM) 
Autoclaved water to 10 ml 
5X Sample buffer  
 
1.25 ml 0.5 M Tris-HCl pH 6.8 (50 mM) 
2.5 ml glycerol (25 % v/v) 
2 ml 10% SDS (2% w/v) 
400 μl 0.5% bromophenol blue (0.02 % w/v) 
500 μl β-mercaptoethanol (715 mM) 
Autoclaved water to 10 ml 
8% Polyacrylamide Running Gel  2.5 ml 0.5 M Tris-HCl pH 6.8 (125 mM) 
2.7 ml 30% Acrylamide/Bis (6% v/v) 
100 μl 10% SDS (0.1 % w/v) 
75 μl 12% APS (0.075 % w/v) 
18 μl TEMED (0.18 % v/v) 
Autoclaved water to 10 ml 
10X SDS Running Buffer 
 
30.3 g Tris base (250 mM) 
144.2 g Glycine (1.9 M) 
50 ml 20% SDS (1%)  
Autoclaved water to 1 L 
Transfer Buffer  5.82 g Tris base (48 mM) 
2.93 g Glycine (39 mM) 
3.75 ml 10% SDS (0.04% w/v) 
200 ml methanol (20% v/v) 
Autoclaved water to 1 L 
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Tris Buffered Saline with Tween-20 
(TBS-T) 
20 ml Tris-HCl pH 7.6 (20 mM) 
26 ml NaCl (130 mM) 
1 ml Tween-20 (0.1 % v/v) 
Autoclaved water to 1 L 
Blocking buffer 5 g BSA or Skim milk (5% w/v) 
1 L 1X TBS-T 
Stripping buffer  
 
10 ml Tris-HCl pH 7.5 (20 mM) 
286.6 g GnHCl (6 M) 
1 ml NP-40 (0.2% v/v) 
3.5 ml β-mercaptoethanol (0.1 M) 
Autoclaved water to 500 ml 
HEPES lysis buffer 476.6 mg HEPES (40 mM) 
1 ml 0.5 M EDTA pH 8.0 (10 mM) 
5 ml glycerol (10% v/v) 
Autoclaved water to 50 ml 
Adjust pH to 7.4 with 10 M NaOH 
 
Immunostaining   
Fixation buffer  
 
4 g paraformaldehyde dissolved in 
90 ml autoclaved water at 60 oC 
10 M NaOH added dropwise till solution clears 
10 ml 10X DPBS 
Adjust pH to 7.2 with 9.61 M HCl acid 
Adjust volume to 100 ml with autoclaved water 
Blocking/permeablising buffer  1 ml goat serum (10% v/v) 
0.25 g BSA (2.5% w/v) 
30 μl Triton X-100 (0.3% v/v) 
DPBS to 10 ml 
Mowiol mounting solution  
 
12 ml 200 mM Tris-HCl pH 8.5 (135 mM) 
6 g glycerol 
2.4 g Mowiol 4-88 
6 ml autoclaved water 
Heat tubes at 60 °C to dissolve Mowiol 
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2.3.1.3 Antibodies 
Antigen Supplier Application and dilution 
Brachyury  R&D: AF2085 IB: 1:500 
Sox17  R&D: MAB1924 IB: 1:500 
GATA6 Abcam: ab22600 IB: 1:400 
Flag  Sigma: F1804 IB: 1:1000, IP: 1:100 
Tuj1 (β-tubulin III) Sigma-T8660 IF:1:1000 
FoxA2  Abcam: ab60721 IB: 1:200 
Caspase 3 Cell Signalling: 9662 IF:1:200 
HA Sigma: H3663 IB:1:1000  IF :1:100 
Nestin R&D: MAB1259 IF: 1:100 
Oct4 Santa cruz: sc-5279 IB 1:400  IF 1:100 
Pax-6 Millipore: AB2237 IB˖1:1000   IF˖1:200 
Pax6 Abcam: 109233 IB: 1:1000 
Phospho Histone H3 (Ser10) Millipore: 05-806 IF 1:200 
Sox2 R&D : AF2018 IB: 1:400  IF: 1:40 
Tra-1-81 Santa Cruz: sc-21706 IF: 1:50 
β-actin  Sigma: A5316 IB: 1:5000 
α-tubulin  Cell Signaling:10376 IB: 1:200 
MC-480 (SSEA-1) DSHB: MC480 IF: 1:5 
Goat IgG-HRP  Santa Cruz: 2020 IB: 1:5000 
Mouse IgG-HRP Santa Cruz: 2005 IB: 1:5000 
Mouse IgG-HRP light chain Stratech: 211-032-174 IB: 1:10000 
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Normal mouse IgG2a  Santa Cruz: 2025 IP: μg equivalent to Flag 
Normal rabbit IgG  Santa Cruz: 2027 IP: μg equivalent to Smad 
Rabbit IgG-Alexa Fluor 488  Life Technologies: A11055 IF: 1:400 
Rabbit IgG-Alexa Fluor 568 Life Technologies: A11011 IF:1:400 
Rabbit IgG-HRP  Santa Cruz: 2004 IB: 1:2000 
Rabbit IgG-HRP light chain  Stratech: 211-032-171 IB: 1:10000 
Mouse IgG-Alexa Fluor 488 Life Technologies: A11001 IF 1:400 
Mouse IgG Alexa Fluor 568 Life Technologies: A11004 IF 1:400 
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2.3.2 Methods 
2.3.2.1 Immunoblotting 
Blots were washed 3x with 1X TBS-T the following day followed by a 1 hour incubation 
with the appropriate horse radish peroxidase (HRP)-conjugated secondary antibody diluted in 
blocking buffer. Cells from one well of 6-well plate were lysed using cold RIPA buffer 
containing phosphatase (Na3VO4, 1:100 or phosphatase inhibitor cocktail 2) and protease 
inhibitors (PMSF in ethanol or protease inhibitor cocktail, 1:100) on ice. Cell debris were 
removed from protein by centrifugation at 14000 rpm for 20 minutes at 4 ćThe protein 
within the supernatant was next quantified by using the BCA Assay Protein Quantification 
Kit following manufacturer’s instructions, with the protein absorbance read at a wavelength 
of 562 nm on an Optimax Tuneable microplate reader (Bio-Rad). Normally 10~25μg of 
whole cell lysate were diluted in 2X or 5X sample buffer resolved at 180 V for 1 hour 
through 6-8% Tris-Bis acrylamide gels in SDS running buffer before being transferred onto 
PVDF membranes via electroblotting. A semi-dry transfer method was applied at the setting 
of 20 V for 75 minutes. Blots then were blocked for 30 minutes with appropriate blocking 
buffer as suggested by the instruction of the primary antibodies and then incubated with 
primary antibody overnight. On the following day, blots were first washed with 1X TBS-T 
buffer for three times before incubating with peroxidase (HRP)-conjugated secondary 
antibody diluted in blocking buffer for 1 hour. Membranes were washed for another three 
times with 1X TBS-T buffer before the addition of ECL substrate and exposed on CL-
Xposure film. Films were developed using an Optimax Xray film processor (Thermo Fisher). 
 
Chapter two 
___________________________________________________________________________  
 
92 
 
2.3.2.2 Co-immunoprecipitation (Co-IP) 
Cells were lysed in mild HEPES lysis buffer containing protease and phosphatase inhibitors 
as mentioned in immunoblot. Due to low stringency of this buffer, cell lysate need to go 
through a 25G needle for several times to ensure a high efficient protein extraction and then 
cell debris were removed via centrifugation at 12000 rpm for 10 min. Protein from the lysate 
was quantified and typically 1 mg of protein was subjected to co-IP. Taking the HA-co IP as 
an example, 2μg of HA antibody was first incubated with 100 μl of protein-G conjugated 
Dynabeads for 40 minutes at 4 °C with rotation to form a HA-protein G complex and then 
1mg of protein was added into these reaction for another 2 hours of incubation at 4 °C with 
rotation to form HA/protein/dynabeads complex. Precipitated immunocomplexes were 
isolated from the whole cell lysate using a magnetic stand and washed 3 times with cold 
HEPES lysis buffer to remove nonspecific binding prior to immunoblot. The presence of 
precipitated protein was assessed with relevant antibodies and a light chain specific HRP-
conjugated secondary antibodies were used to minimise the effect of IgG fraction on target 
protein. 
 
2.3.2.3 Immunostaining of hESCs 
HESCs were plated down onto Matrigel pre-coated coverslips within 24-well plates. Once 
they reached the desired confluency, these cells were wash for three times with DPBS and 
fixed for15 minutes with 4% fresh paraformaldehyde solution. After fixation, cells were 
washed again to remove residual paraformaldehyde before incubation with 
blocking/permeablisation buffer for 1 hour.  After blocking, cells were washed with DPBS 
and incubated with primary antibody diluted in permeablisation buffer for 1 hour at room 
temperature followed by another three times of wash and incubation with appropriate 
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fluorophore-conjugated secondary antibody in the dark for 30 minutes. Coverslips were then 
washed for another twice with DPBS followed by an incubation of 1 μg/ml DPBS+DAPI for 
10 minutes to stain the nuclei in dark. Slides were mounted onto microscope slides with 
Mowiol 4-88 solution and are ready for being visualised using a Leica SP5 II confocal 
fluorescent microscope. For quantification, slides were normally visualised at 10X 
magnification and 5 areas within the slide were randomly chose and number of positive 
staining cells and DAPI-positive cells are counted. 
 
2.3.2.4 Fluorescence activated cell sorting 
Taking the analysis of TRA-1-81 as an example to illustrate the procedure, hESCs were 
dissociated into single cells using accutase and 1.5x106 cells were washed twice in 
fluorescence-activated cell sorting (FACS) buffer, resuspended in primary antibody (normal 
mouse IgG or mouse anti-Tra-1-81 antibody) diluted in FACS buffer and incubated for 30 
minutes on ice. Cells were then washed twice in FACS buffer and incubated with specific 
anti-mouse IgG Alexa Fluor 568 for 15 minutes. Finally, cells were washed twice to remove 
residual antibody and then resuspended in 600 μl of FACS buffer ready for analysis on a 
FACScalibur flow cytometer (BD Biosciences) with CellQuest software.   
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2.4 Software and Online Tools 
Computer Software 
A Plasmid Editor (ApE) 
Leica LAS AF Lite 
Opticon Monitor 3 
Quantity One 1D Gel Analysis Software 
Serial Cloner 2.6 
Image J 
CellQuest 
 
Online Tools Website  
Addgene Plasmid Repository  https://www.addgene.org/ 
Basic Local Alignment Search Tool (BLAST)  http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Genebank® DNA Sequence Database  http://www.ncbi.nlm.nih.gov/genbank/ 
Molarity Calculator http://www.graphpad.com/quickcalcs/Mo larityform.cfm 
UCSC Genome Bioinformatics https://genome.ucsc.edu/ 
Galaxy/Cistrome ChIP-seq databse http://cistrome.org/ap/root 
NEB Double Digest Finder https://www.neb.com/tools-andresources/ interactive-tools/double-digestfinder 
NEBaseChangerTM for Site-directed mutagenesis  http://nebasechanger.neb.com/ 
REBASE® Restriction Enzyme database https://www.neb.com/externallinks/ rebase 
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Chapter Three 
 
Sox2 is an indispensable factor for the 
maintenance of both hESCs and NPCs 
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3.1 Introduction 
Over the last decade, the essential roles of Oct4, Nanog and Sox2 in maintaining pluripotency 
of PSCs have been extensively studied (Chambers, 2004; Fong et al., 2008; Hay et al., 2004; 
Mitsui et al., 2003; Zaehres et al., 2005). However, whether these transcription factors also 
contribute to the PSCs transition from an undifferentiated state to a committed cell lineage 
remains unclear. The mechanisms that drive pluripotent stem cells to exit the pluripotent state 
and becoming a lineage-specific cell type are poorly understood. Although the three 
pluripotent core transcription factors were initially defined as part of the ‘stemness genes’, a 
growing number of evidence in recent years demonstrate that overexpression of these factors 
does not enhance PSCs pluripotency. Instead, it impedes the pluripotency of PSCs and 
promotes their differentiation (Chng et al., 2010; Kopp et al., 2008; Niwa et al., 2000; Teo et 
al., 2011; Yu et al., 2011). For example, overexpression of Oct4 results in ESCs 
differentiation to mesoderm (Niwa et al., 2000), while overexpression of Sox2 may increase 
the differentiation potency to neural lineages (Kopp et al., 2008). Therefore, it is suggested 
that these three transcription factors may also function as diverse lineage specifiers. When 
being expressed at balanced levels, they cooperatively function to maintain PSC 
pluripotency; however, upon disruption of the balances, they elicit cell differentiation to 
lineages depending on their expression levels (Loh and Lim, 2011).  
 
Given that Sox2 has been found by our and other laboratories to be highly expressed in both 
hESCs and hESC-derived neural progenitors, I hypothesised that Sox2 may have dual 
functions in hESCs: retaining pluripotency of hESCs and inducing their neural differentiation 
upon exit of pluripotency. I also anticipated that Sox2 accomplishes these dual functions in 
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hESCs by interacting with different partners and forming different transcriptional complexes, 
which lead to governing expression of different genes. On the basis of published reports 
(Kamachi et al., 2001, Tanaka et al., 2004, Boyer etal., 2005, Loh et al., 2006, Zhang et al., 2010), I 
selected Oct4 as Sox2 pluripotent partner and Pax6 and Brn2 as candidates for Sox2 neural 
partners for my studies.  
 
To verify these hypotheses, it is essential to understand the expression patterns of these genes 
and to assess whether Sox2 is necessarily required for both hESCs and NPCs. In this chapter, 
the expression patterns of Sox2 and its possible transcription partners, such as Oct4, Pax6 and 
Brn2 were characterised in hESCs and during their early neural differentiation. Following on, 
I disabled Sox2 in both hESCs and early passage NPCs by Sox2-shRNA knockdown to 
investigate the impact of Sox2 depletion on those cells. 
 
3.2 Results 
3.2.1 Dynamic expression of Sox2, Oct4, Pax6 and Brn2 during early neural 
differentiation of hESCs 
In order to capture the dynamic changes in expression of the above transcription factors, I 
applied our established neural differentiation protocol to both H1 and H7 hESC lines and 
generated efficient neural differentiation (Gerrard et al., 2005). The whole process of the 
differentiation was divided into four stages (Figure 3.1). Stage1 is hESCs culture, in which 
hESCs were cultured in MEF-conditioned medium supplemented with bFGF and maintained 
in an undifferentiated state, as previous described (Xu et al., 2001). Stage 2 represents neural 
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induction, in which confluent hESCs were dissociated with collagenase to generate small 
clumps. These clumps were then seeded at a ratio of 1:3 into poly-L-lysine/laminin pre-
coated plates and cultured for a week in N2B27 medium supplemented with 100ng/ml 
noggin, which were defined as passage 1. In this procedure, noggin acts to block the BMP 
signalling pathway and promoting neural differentiation as BMP signalling suppresses neural 
differentiation and facilitates extraembryonic endoderm differentiation (Bachiller et al., 2000, 
Pera et al., 2004). After being in this condition for one week, cell colonies became more 
compact and boundaries of individual cells were less clear than hESCs. Furthermore, the 
nuclei and nucleoli inside cells were nearly invisible, representing the sign of early neural 
induction. At stage 3, cells were split at the ratio 1:3 and continuously cultured in the same 
condition for another 10 days. By then, typical neural rosettes started to emerge. By stage 4, 
majority of the cells (~ 80%) exhibited typical bipolar appearance of neural progenitors, thus 
termed stage of neural progenitor cells (NPCs). At this stage, noggin was replaced by bFGF 
and EGF in the culture medium to maintain cells in a neural progenitor state.  
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Figure 3.1 Neural differentiation from hESCs 
An overview of neural differentiation from hESCs induced by Noggin. Full detailed 
descriptions were provided in section 3.2.1. Representative phase-contrast images depicting 
morphological changes during the differentiation of hESCs towards neural progenitors. Scale 
bar=100μm.  
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Taking the advantage of this highly efficient conversion of hESCs to neural progenitors, 
analysis on samples collected during this differentiation can well represent the dynamic 
changes in this process. A qRT-PCR analysis showed that during neural differentiation of 
hESCs, one of the key pluripotent markers, Oct4 was gradually downregulated at its mRNA 
levels. By contrast, another key pluripotent marker Sox2 exhibited an up-regulation in its 
transcripts at the early stage of neural differentiation and these high levels of Sox2 mRNA 
were maintained throughout the neural differentiation to NPCs (Figure 3.2A). These imply 
that unlike Oct4, Sox2 may play an active role during this transition, inducing hESCs to exit 
the pluripotent state and to differentiate into neural lineages and that the high levels of Sox2 
are not necessarily associated with high levels of Oct4. Regarding the expression of 
neuroectoderm markers, Pax6 and Brn2 revealed dramatically upregulation in their mRNAs. 
Particularly, the Pax6 mRNA exhibited a nearly 20-folds increase at as early as day 10 of the 
differentiation and this increase was further extended to 40 folds when cells were fully 
committed into NPCs at passage 4 (Figure 3.2 A). In comparison, the upregulation in Brn2 
mRNA occurred relatively late. However, its increase became much more pronounced when 
differentiated into NPCs.  
In consistence with the changes at the mRNA levels, western blot analysis reveals that Oct4 
and Sox2 protein levels diverged continuously during the differentiation. The Sox2 protein 
levels were increased around 2 fold upon neural differentiation while Oct4 was gradually 
downregulated to become undetectable. In contrast to Oct4, the Pax6 and Brn2 protein levels 
were considerably upregulated upon neural differentiation and the induction of Pax6 protein, 
like its mRNA, seemed appearing earlier than Brn2 (Figure 3.2 B). Expression of Oct4, Sox2, 
Pax6 and Brn2 in H7 neural differentiation (Figure 3.2 C) showed a similar pattern as in H1 
cells, indicating that this dynamic change within neural differentiation is not cell line-
dependent.  
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Figure 3.2 Dynamic changes in expression of Oct4, Sox2, Pax6 and Brn2 during hESC 
neural differentiation 
(A) MRNA expression of Sox2, Oct4, Pax6 and Brn2 was analysed by qRT-PCR during 
neural differentiation from H1 hESCs at indicated time points. Data is calculated as fold 
changes relative to undifferentiated hESCs and presented as mean ± SD from three 
independent experiments. (B & C) Proteins collected during neural differentiation at 
indicated time points from H1 (B) and H7 (C). Cell lines were analysed by immunoblotting 
with antibodies against indicated proteins.  
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Since upregulation of Pax6 upregulation appeared earlier than Brn2 at both mRNA and 
protein levels, Pax6 may play a more important role in early neural induction. Therefore, the 
expression of Pax6 during neural differentiation was further investigated in individual cells 
by immunostaining in order to disclose the relationship among the expression of Pax6, Sox2 
and Oct4 (Figure 3.3). As expected, Sox2 was consistently expressed through the neural 
differentiation, while Pax6 expression was gradually upregulated. Interestingly, co-expression 
of Oct4 and Pax6 was observed in the same nucleus of differentiating cells at an early stage 
and their expression levels appeared being negatively correlated, which is consistent with our 
previous findings (Noisa et al., 2012). This co-localisation implicates an intriguing 
relationship among these three factors.  
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Figure 3.3 Dynamic nuclear expressions of Oct4, Sox2 and Pax6 during neural 
differentiation 
Co-immunostaining with anti-Oct4 (Red), anti-Sox2 (Green) and anti-Pax6 (purple) 
antibodies on cells at different stage of neural differentiation as indicated. DAPI staining 
(blue) indicates the position of nucleus. PC3 cells which do not express those proteins were 
used as a negative control of staining. Representative images were obtained from two 
independent experiments. Scale bar=100μm. 
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3.2.2 Sox2 is essential for maintenance of pluripotency in hESCs 
I have shown in the above section that Sox2 is highly expressed in the undifferentiated 
hESCs despite its levels are increased upon neural differentiation. This is in agreement with 
the finding that Sox2 is one of the key factors for maintaining pluripotency of hESCs. To 
further interrogate the function of Sox2 in our hESCs, a shRNA-mediated Sox2 knockdown 
was performed in H1 hESCs. In order to achieve an efficient knockdown, I utilised 
previously published lentiviral vector system to introduce the shRNA expression into the 
hESCs (Figure 3.4 A) (Bass et al., 2009). To exclude non-specific effects on cells caused by 
shRNA, viral particles and the transduction procedure, a shRNA targeting GFP was cloned 
into the same lentivector to replaced Sox2-shRNA and the resulting lentivector was applied 
as a negative control. The hESCs infected with the control lentiviral particles was referred to 
as control hESCs.  
After transducing hESCs with lentiviral particles containing shRNA expression vectors for 4 
days, a striking morphological change was observed in Sox2-shRNA transduced cells, of 
which the cells became much larger and flattened (Figure 3.4 B). By contrast, GFP-shRNA 
transduced cells retained the morphology of hESCs. To confirm the successful depletion of 
Sox2 in the Sox2-shRNA transduced hESCs, cells were collected and subjected to gene 
expression analysis. Sox2 mRNA expression levels were substantially decreased to only 24% 
of the control cells (Figure 3.4 C) and correspondingly, Sox2 protein levels also exhibited 
considerable reduction by immunoblot (Figure 3.4 D). These demonstrated that a significant 
Sox2 reduction has been successfully generated by shRNA in hESCs. Furthermore, in 
consistence with the morphological changes, expression of pluripotentency markers Oct4 and 
Nanog was also shown to be significantly downregulated to 28% and 9%, respectively 
(Figure3.4 C). 
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Figure 3.4 Deficiency of Sox2 in hESCs by shRNA-knockdown leads to lose of 
pluripotency 
(A) Schematic representation of lentivector PLKO-Sox2 shRNA used for Sox2 knockdown. 
Human U6 promoter drives RNA Polymerase III transcription for generation of shRNA 
transcripts. Human phosphoglycerate kinase (hPGK) promoter drives expression of 
puromycin, which allows the transduced cells survive in puromycin selection. (B) Phase-
contrast images showing morphological changes of hESCs 4 days after shRNA transduction. 
(C) Downregulation of pluripotency markers and lineage markers in Sox2-knockdown hESCs 
4 days post transduction by qRT-PCR. Results are shown as fold change relative to the 
shGFP control. Error bars represents standard deviation (SD) from three biological 
replicates. ** indicates p<0.01 by student’s t- test. (D) Immunoblot confirms the reduction of 
Oct4 at protein levels in Sox2-knockdown hESCs. Scale bar=100um. Representative images 
were obtained from three independent experiments. 
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3.2.3 Deficiency of Sox2 in hESCs results in differentiation into non-neural 
lineages. 
In order to identify the cell types that hESCs were differentiated to as a result of Sox2-
deficiency, qRT-PCR analysis was used to examine the expression of various lineage marker 
genes (Figure 3.4 C). A significant increase in mRNA expression of mesoderm and endoderm 
marker, GATA6, GSC, Eomes and Brachyury was observed 4 days after the transduction. 
Consistently, the immunostaining for GATA6 and Foxa2 also revealed obvious increase in 
their protein expression (Figure 3.5). In contrast, neural markers Sox1 and Pax6 exhibited 
reduced expression. These data indicate that deficiency of Sox2 resulted in hESCs 
differentiation to non-neural lineages. 
 
 
Figure 3.5 Sox2 knockdown upregulates non neural lineage markers 
Representative images of immunostaining with antibodies against GATA6 and FoxA2 in Sox2 
knockdown cells as well as shGFP-transduced controls showing increased levels of these 
proteins. Nuclei are in blue (DAPI staining). Scale bar=100μm. 
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3.2.4 Sox2 is required to maintain NPC identity 
Given the failure of maintaining the Sox2-knockdown hESCs in an undifferentiated state, I 
was unable to induce neural differentiation on these cells to assess the effect of Sox2 
deficiency on neural induction of hESCs although differentiated cells by Sox2-deficiency 
exhibited non-neural identities. Therefore, I performed Sox2 knockdown in hESC-derived 
NPCs at passage 4 using similar shRNA technique (Figure 3.4 A) to address the role of Sox2 
in these cells. A significant reduction of Sox2 expression was detected in Sox2-shRNA 
transduced NPCs at both mRNA (Figure 3.6 B) and protein (Figure 3.6 C) levels, confirming 
a successful knockdown of Sox2 in NPCs. No obvious morphological change was observed 
in these knockdown cells when compared to the controls (Figure 3.6 A) and phospho-histone 
H3 staining, a proliferation index marker, also showed similar signals between knockdown 
and control cells (Figure 3.7 E & F). However, a significant increase in activated caspase-3 
staining was detected in knockdown cells, indicating that Sox2 knockdown induced stronger 
apoptosis (Figure 3.7 C & D). Furthermore, reductions in Pax6 and Brn2 expression were 
detected by qRT-PCR (Figure 3.6 B) and immunoblot (Figure 3.6 C) upon Sox2 knockdown 
and similarly, Nestin expression was shown to be significantly decreased in the Sox2 depleted 
cells by immunostaining (Figure 3.7 A & B). Corresponding to the reduction in expression of 
neural progenitor markers, Sox2-knockdown in NPCs considerably impeded their further 
differentiation to post-mitotic neurons upon withdrawal of growth factors (Figure 3.7 G & 
H). Taken together, it suggests that Sox2 is crucially important for the properties of NPCs.   
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Figure 3.6 Sox2 knockdown in neural progenitors leads to the downregulation of Pax6 
and Brn2 
(A) No obvious morphological change was observed upon sox2 knockdown in early neural 
progenitors (P4). (B) Reduced mRNA expression of Pax6, Brn2 and Sox B family members 
was detected by qRT-PCR in neural progenitors upon Sox2 knockdown. Results are shown as 
relative fold changes when normalised with the shGFP controls. Error bars indicate SD from 
three biological replicates. **P < 0.01 by student t-test. Scale bar=100μm. 
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Figure 3.7 Effect of Sox2 knockdown in early neural progenitors 
(A & B) Considerable reduction of Nestin expression upon sox2 knockdown in early neural 
progenitors (P4) as shown by Immunostaining (A) and quantification of the Nestin staining 
shown in (B). (C & D) Sox2 knockdown induces apoptosis as visualised by immunostaining 
for ASP175 (cleaved Caspase-3) (C) and their quantification (D). (E & F) Immunostaining 
for proliferation marker phosphorhistone H3 (PPH3) depicting no significant difference in 
proliferation rate between sox2 knock down and control cells. (G & H) Sox2 knockdown 
hinders neurogenesis in early neural progenitors. Tuj1 staining in sox2 knockdown and 
control cells after withdrawal of growth factor for 4 days. All images are representative ones 
from three independent experiments and quantification was performed as indicated in 
Chapter 2 with error bars as SD. *P < 0.05, **P < 0.01 by student t-test. Scale bar=100μm. 
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3.3 Discussion 
Currently, due to the lack of sufficient embryonic materials, the molecular mechanisms of cell 
lineage determination during embryogenesis are largely unknown, especially in human. 
Pluripotent hESCs, as a valuable in vitro cell model, provide a promising approach for 
investigating these very early lineage determination events. In this study, I focus my 
investigation on the neural induction of hESCs. As overexpression of Sox2 seems increasing 
the differentiation potency to neural lineages in mESCs (Kopp et al., 2008, Zhao et al., 2004), 
it is suggested that Sox2 may regulate the neural specification during differentiation. To 
elucidate the role of Sox2 in the neural differentiation of hESCs, particularly the initial neural 
induction, I firstly characterised the expression pattern of Sox2, as well as pluripotency factor 
Oct4 and two neural transcription factors, Pax6 and Brn2 during early neural differentiation 
of hESCs. Sox2 expression was shown to inversely correlate with the expression of Oct4, but 
positively correlated with that of Pax6 and Brn2. Sox2, Oct4 and Pax6 were shown to be co-
localised in differentiating hESCs at the very early stage during neural differentiating. Next, I 
carried out Sox2 knockdown experiments in both hESCs and NPCs. Knockdown of Sox2 in 
the hESCs resulted in a dramatic loss of self-renewal in these cells, which subsequently 
differentiated into non-neural lineages. Deficiency of Sox2 in the hESC-derived NPCs led to 
a significant loss in the expression of neural progenitor markers, Pax6, Brn2 and Nestin and a 
considerably impaired neurogenesis.  These results demonstrate the critical importance of 
Sox2 in maintaining identity of both hESCs and NPCs and indicate that Sox2 may play a 
crucial role in specifying neural differentiation in hESCs. 
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3.3.1 Pax6 is an early marker of human neural differentiation  
I have demonstrated that as early as 10 days after starting the neural differentiation of hESCs, 
the mRNA level of Pax6 was shown to have already been dramatically increased over 20 
folds, whereas the main increase in Brn2 mRNA occurred at a later stage. This observation 
was also confirmed by immunoblot showing that the protein expression of Pax6 appeared 
earlier than Brn2. These results support the previous finding that Pax6 is an early marker in 
initial neuroectoderm cells during hESCs neural differentiation in vitro (Zhang et al., 2010) 
as well as in vivo embryogenesis. During mouse CNS development, Pax6 expression is 
initially detected in the NECs which already express Sox1 in E8 embryo (Bylund et al., 2003, 
Inoue et al., 2000, Pevny et al., 1998, Walther and Gruss., 1991). However, study in human 
foetus tissues reveals that Pax6 expression emerges at the single-layer neural plate at which 
the cells do not express Sox1, but express Sox2 (Zhang et al., 2010). This expression pattern 
of Pax6 is also reflected in mESCs-derived neuroectoderm, Sox1 is induced earlier than Pax6 
(Li et al., 2005, Pankratz et al., 2007, Pevny et al., 1998, Ying et al., 2003).  Indeed, after 
brain regionalization, the expression pattern of Pax6 in nervous system is largely comparable 
across species, including human, mouse, frog, chick, and fish (Amirthalingam et al., 1995, 
Goulding et al., 1993, Moreno et al., 2014, Schlosser and Ahrens, 2004, Walther and Gruss, 
1991). Furthermore, it has been shown that overexpression of Pax6 is necessary and 
sufficient to induce neural differentiation in hESCs, but not in mESCs (Zhang et al., 2010). 
All these findings suggest that Pax6 may have different functions in human and mice during 
their neural differentiation and that Pax6 may play a critical role in early neural specification 
of hESCs.  
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3.3.2 Sox2 is indispensable for the pluripotency of hESCs  
In this study, I have shown that depletion of Sox2 in hESCs resulted in cell differentiation 
into non-neural lineages, possibly extraembryonic endoderm and mesoderm, as GATA6, 
GSC, and Brachyury were significantly upregulated, while Pax6 and Sox1 were 
downregulated. These results are consistent with previous findings performed in hESCs 
(Adachi et al., 2010, Fong et al., 2008) and mESCs (Avilion et al., 2003, Ivanova et al., 2006, 
Masui et al., 2007), confirming that Sox2 is essential for maintaining hESC pluripotency. 
Interestingly, the effects of Sox2 knockdown in hESCs is similar to those found in Oct4 
knockdown (Hay et al., 2004, Matin et al., 2004) and Nanog knockdown (Hyslop et al., 2005, 
Zaehres et al., 2005) in hESCs, suggesting that under hESC culture conditions, deficiency in 
any of these three core transcription factors will result in a differentiation to extraembryonic 
lineage. These indicate that Sox2 plays a similar role as Oct4 and Nanog in retaining hESCs 
phenotype. 
 
My results also demonstrated that one of the Sox2 functions in hESCs is perhaps to maintain 
Oct4 and Nanog expression at a high level as proposed by others (Boyer et al., 2005). After 
reducing Sox2 expression by shRNA, Oct4 level was decreased to 28%, whereas the level of 
Nanog was reduced to 9%. The regulation of Oct4 by Sox2 is also found in mESCs (Masui et 
al., 2007). In mESCs, Sox2 deficiency also led to a dramatically downregulation of Oct4, but 
not Nanog, Which differs from the results found in my Sox2 knockdown in hESCs. This 
discrepancy is perhaps attributed to differences in the function of Sox2 between human and 
mouse system.    
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3.3.3 Sox2 is required to maintain NPC identity 
Sox2 deficiency in hESC-derived NPCs were shown in this study to lead to a significant loss 
in the expression of neural markers, such as Pax6, Brn2 and Nestin and a failure in generating 
Tuj1-positive neurons. In addition, depletion of Sox2 in the NPCs resulted in an increase of 
apoptosis in these cells. These data indicate that Sox2 is required to maintain NPCs identity. 
This is consistent with the previous studies performed in vivo that downregulation of Sox2 in 
brain resulted in a significant reduction of Nestin expressing NPCs and impairment in 
neurogenesis (Cavallaro et al., 2008, Favaro et al., 2009, Pevny and Nicolis, 2010). These 
results also suggest that Sox2 may function to regulate the expression of Pax6 and Brn2 in 
these cells. However, the exact mechanisms remain to be elusive. Although the SoxB1 family 
members Sox1 and Sox3 are considered to be functionally equivalent to Sox2 (Kamachi et 
al., 1998, Nishiguchi et al., 1998, Pevny and Placzek, 2005, Wegner and Stolt, 2005), they did 
not display an upregulation upon Sox2-knockdown in the NPCs. 
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Chapter Four 
 
Sox2 plays an intricate role in the 
regulation of hESC differentiation 
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4.1 Introduction 
I have demonstrated in Chapter 3 that Sox2 is highly expressed in both hESCs and NPCs and 
that Sox2 is necessarily required for the maintenance of both hESCs and NPCs properties, 
including self-renewal and differentiation. Such dual functions of Sox2 in undifferentiated 
hESCs and their neural differentiation raise a possibility that Sox2 may specify ESC 
differentiation to neural lineage (Loh and Lim 2011). Two previous studies have attempted to 
address this hypothesis in mESCs but the outcomes differ from each other. One study 
demonstrated that even a small increase (about 2 fold) in Sox2 protein was able to induce 
mESCs differentiation and the resulting cells expressed a wide range of lineage makers, 
including neuroectoderm, mesoderm and trophectoderm (Kopp et al., 2008). Another study 
claimed that overexpression of Sox2 did not alter the mESCs pluripotency properties when 
cells were cultured under the mESC self-renewal condition and that only when these cells 
were grown in serum-free medium which is not optimal for mESC pluripotency, they became 
differentiated, primarily biased to neuroectoderm (Zhao et al., 2004). Therefore, it remains 
unclear the effect that Sox2 overexpression would impact on mESCs. In addition, it remains 
to be determined the implications of Sox2 overexpression in hESCs. Given that mESCs and 
hESCs are different in several aspects, from morphology, gene expression profile to 
signalling pathways, it would be interesting to investigate the function of Sox2 in regulation 
of hESCs self-renewal and differentiation.  
 
To further interrogate the function of Sox2 in ESC pluripotency and lineage specification, I 
have generated hESC lines in which Sox2 was overexpressed using a lentivirus-medicated 
Sox2 transduction. The resulting Sox2-overexpressing hESCs were characterised under 
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various culture conditions to investigate the role of Sox2 in regulation of hESC pluripotency 
and differentiation.  
 
4.2 Results 
4.2.1 Generation of Sox2 overexpressing hESC lines 
To further investigate the roles Sox2 plays in regulating hESC pluripotency and 
differentiation, Sox2 was overexpressed in H1 hESCs using lentiviral transduction, which has 
been shown to be more efficient than plasmid transfection to introduce DNA into hESCs (Cao 
et al., 2010). Firstly, a lentiviral expression vector was constructed in which Sox2 protein-
coding DNA sequence was tagged by 3×HA epitopes at its 5’-prime end and the HA-Sox2 
DNA fragment was subcloned into modified pLVTHM lentivector (Szulc et al., 2006) (see 
Chapter 2 for details), so that the expression of HA-Sox2 protein was under the control of a 
constitutive expressing promoter, the human elongation factor 1α (EF1α) promoter. 
Furthermore, in order to ensure that all surviving cells would definitely express HA-Sox2 
after puromycin selection, the cDNA encoding puromycin resistance (PuroR) protein was 
inserted downstream to the HA-Sox2 cDNA and linked in-frame with HA-Sox2 by the DNA 
sequence encoding a self-cleaving small 2A peptide (Figure 4.1 A). This 2A-mediated 
cleavage occurs in all eukaryotic cells (Donnelly et al., 2001, Szymczak et al., 2004), thus 
allowing efficient production of HA-Sox2 and PuroR proteins under the same transcriptional 
and translational controls. 
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To eliminate any effects on cells caused by the transduction procedure or toxicity of viral 
particles, a lentiviral vector expressing only the PuroR cDNA was used as a control (Figure 
4.1 A). Lentiviral particles were packaged in 293T cells, then collected and concentrated prior 
to transduction (see Chapter 2 for details). HESCs were infected with lentiviral particles 
overnight and the cells were selected 48 hours post-transduction in bFGF supplemented 
MEF-CM containing puromycin at 2μg/ml for 14 days. The surviving cells were pooled and 
expanded as normal hESCs. The lentiviral packaging and transduction experiments were 
repeated three times and all resulting cells displayed similar morphology and characteristics 
(see below). 
 
The resulting HA-Sox2 cells were able to form hESC-like colonies and exhibited similar 
morphology as controls under the MEF-CM culture condition (Figure 4.1 B). To validate the 
expression levels of Sox2, the total levels of Sox2 in Sox2-overexpressing (Sox2-OE) hESCs 
was first examined by qRT-PCR and the results showed that Sox2 mRNA levels in SOx2-OE 
hESCs were approximately two fold of that in the control cells (Figure 4.1 C). This was 
further confirmed by immunoblot and immunocytochemistry. In the immunoblot, Sox2 
protein levels in Sox2-OE hESCs also appeared about two fold of that in the controls (Figure 
4.1 D). Since the HA-Sox2 fusion protein is bigger than endogenous Sox2, it migrates at a 
slower rate than endogenous Sox2 and can be distinguished from the endogenous Sox2 in 
immunoblot using an anti-Sox2 antibody. In the immunocytochemistry, a co-localisation of 
HA and Sox2 was shown in all Sox2 overexpressing cells but not in the controls, indicating a 
successful introduction of HA-Sox2 into all the puromycin surviving cells (Figure 4.1 E). 
Therefore, these hESCs are indeed Sox2-overexpressing hESCs. 
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Figure 4.1 Generation of Sox2-overexpressing hESC lines 
The overexpression of Sox2 in hESCs was achieved by transducing hESCs with a lentivirus 
containing HA tagged Sox2 and puromycin expressing construct. The construct containing 
only puromycin gene was used as control. (A) Schematic representation of the Sox2 and 
control constructs. (B) Bright-field microscopy images of Sox2-overexpressing (Sox2-OE) 
and control hESCs under the hESC culture condition. Scale bar=100μm. (C) mRNA 
expression of Sox2 was analysed by qRT-PCR. Error bar indicates SD from three 
independent experiments. *p<0.05 and **p<0.01 by student t test. (D) Protein level of Sox2 
was examined by immunoblot. Arrow head and arrow indicate transgenic HA-Sox2 and 
endogenous Sox2, respectively. (E) Immunostaining of HA (red) and Sox2 (green) reveal Sox2 
overexpression in all Sox2-OE hESCs. Cell nuclei were stained with DAPI (Blue). 
Representative images taken from three independent experiments are depicted. 
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4.2.2 Sox2 overexpression enhances hESC self-renewal under the hESC culture 
conditions 
Given that there was no obvious morphological change observed in both Sox2-OE and 
control cells under hESC culture condition, it seemed that high levels of Sox2 did not affect 
hESC pluripotency in this culture system. In fact, I noticed that, in Sox2-OE cultures, there 
were less spontaneous differentiating cells in compare with the controls. To further validate 
this observation, I carried out more characterisation in these cells. The pluripotent markers, 
Oct4 and Nanog, exhibited a slightly increase in their expression in the Sox2-OE hESCs 
analysed by qRT-PCR and immunoblot (Figure 4.2 A & B). In addition, genes that are 
associated with three germ layers, such as neuroectoderm (Pax6), mesoderm (Brachyury) and 
endoderm (Sox17 and GATA6), revealed a significant reduction in their transcripts (Figure 
4.2 A). The decrease in Pax6 and Sox17 expression in the Sox2-OE hESCs was also 
confirmed at protein levels by immunoblot (Figure 4.2 B) and immunostaining (Figure 4.2 
C). Finally, an increase in proportion of TRA-1-81 positive hESCs in the Sox2-OE cell 
population was detected (Figure 4.2 D). These results together strongly suggest that Sox2 
overexpression suppresses spontaneous differentiation of hESCs and enhances their 
undifferentiated state under the hESC culture conditions.  
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Figure 4.2 Sox2 overexpression enhances pluripotency of hESCs under the hESC 
culture conditions 
(A) mRNA expression of indicated pluripotency and lineage-specific marker genes were 
analysed by qRT-PCR. Graphs indicate relative fold change when normalised to the level of 
control cells. Data was collected from three independent transduction experiments. Error bar 
indicates SD. *p<0.05 and **p<0.01 by student t test. (B) Protein expression of indicated 
pluripotency and lineage-specific markers were analysed by immunoblot. (C) Expression of 
Oct4 and Pax6 were analysed by immunostaining in the Sox2-OE and control hESCs 20 days 
post transduction. Representative confocal images obtained from two independent 
experiments. Scale bar = 50μm. (D) Flow cytometry analysis of TRA-1-81 and SSEA1 in both 
Sox2-OE and control hESCs cultured in the hESC condition. 
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4.2.3 Versatile effects of Sox2 overexpression on hESCs in suboptimal cultures 
The above results showed that when culture environment is optimal for hESCs, Sox2 
overexpression appears to enhance self-renewal of hESCs. I asked what effect Sox2 might 
have on hESCs when extrinsic culture conditions were suboptimal.  To address this question, 
the Sox2-OE and control hESCs were cultured in the medium, termed unconditional medium 
(UM) because this medium is similar to MEF-CM, consisting base medium of KNOCKOUT-
DMEM supplemented with 20% KNOCKOUT serum replacement but without conditioning 
for 24 hours with MEF and no addition of bFGF. It has been shown that this medium is 
unable to support hESCs to maintain pluripotency and that hESCs cultured in UM have 
greater BMP signalling activity than those cultured in the MEF-CM (Xu et al., 2005), thus 
triggering differentiation. Indeed, during 30 days culture in the UM, the control hESCs 
revealed gradual differentiation as shown in their morphological changes, in which many 
cells became flattened and lost the appearance of compact colonies. Although Sox2-OE cells 
exhibited similar morphological changes, they appeared to change in a slower rate than that 
of controls. By 30 days in this culture condition, there were still around 40% of ESC-like 
clusters observed in Sox2-OE cells whereas majority of the control cells lost ESC 
morphology and became flat (Figure 4.3A). This observation was supported by the evidence 
that Oct4 expression was significantly higher in the Sox2-OE cells than in the controls at both 
mRNA and protein levels (Figure 4.3 B & C). These indicate that Sox2 overexpression 
suppresses the differentiation of hESCs under this suboptimal culture condition for 
pluripotency, resulting in their delayed differentiation.  
 
In consistent with the morphological changes and Oct4 expression in these cells, when 
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analysing expression of lineage specific genes, it revealed that genes associated with 
mesoderm (Brachyury) and endoderm (Sox17, GATA6 and FoxA2) were expressed at much 
lower levels in the Sox2-OE cells than in the controls (Figure 4.3 B & C). In addition, more 
Sox17 positive cells were detected in the control cells by immunostaining (Figure 4.3 D). 
Since cells clusters were very compact in both groups, particularly the Sox2-OE cells, it was 
very difficult to perform quantitative analysis in these cells. By contrast, a significant 
upregulation in the mRNA expression of neural transcription factor Sox1 was revealed by 
qRT-PCR (Figure 4.3 B) and Pax6 was expressed at similar levels between the Sox2-OE and 
control cells (Figure 4.3 B & C). These results suggest that under suboptimal culture 
conditions for hESCs, Sox2 overexpression delays the downregulation of Oct4, promotes 
neural differentiation and inhibits mesoderm and endoderm differentiation. 
 
Taken together, these results suggest that Sox2 may exhibit versatile functions in this culture 
condition. On one hand, Sox2 overexpression suppresses the differentiation of hESCs by 
sustaining a high level expression of Oct4. On the other hand, upon exit of pluripotency, Sox2 
overexpression may repress mesoderm and endoderm differentiation, so that the Sox2-OE 
cells tend to differentiate into neural lineages.  
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Figure 4.3 Sox2 Overexpression impedes spontaneous differentiation of hESCs 
Sox2-OE and control hESCs were cultured in non-conditioned KSR medium without bFGF (UM) to 
induce spontaneous differentiation for 30 days. (A) Bright-field microscopy images of Sox2-OE and 
control hESCs under UM condition. (B) mRNA expression of pluripotency and germ layer markers 
were measured by qRT-PCR and is shown as relative fold change normalised to the control in CM 
condition. Dash line represents the level of indicated gene in control cells in CM condition. Average 
value and standard error were calculated from three independent experiments. *p<0.05 and **p<0.01 
by student t test. (C) Protein expression of indicated markers by immunoblot. Arrow head and arrow 
indicate HA-Sox2 and endogenous Sox2, respectively. (D) The presence of HA-Sox2 was confirmed by 
immunostaining. Endoderm differentiation was inhibited by Sox2-OE as shown by reduced 
immunostaining of endoderm marker, Sox17 (green) in Sox2-OE in compare with controls. 
Representative confocal images obtained from two independent experiments. 
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4.2.4 Sox2 Overexpression enhances neural differentiation in serum-free 
medium 
As demonstrated above, Sox2 is shown to play an intricate role in regulating pluripotency and 
differentiation of hESCs, which seems to be influenced by the culture 
environment/conditions. To further elucidate the function of Sox2 in hESC differentiation and 
minimise uncertain effect from serum replacement, the Sox2-OE and control hESCs were 
cultured in a serum-free, chemically defined N2B27 medium (Ying et al., 2003). It has 
previously been shown that hESCs can be efficiently differentiated into neural progenitors in 
the N2B27 medium supplemented with Noggin to inhibit BMP signalling (Gerrard et al., 
2005). Since Sox2 appeared to enhance neural differentiation of hESCs under the suboptimal 
hESC culture condition, in the current experiment, Noggin was not applied into the culture to 
further test its role in hESC differentiation, especially in the neural differentiation. After 
culturing in N2B27 medium for 30 days, both the Sox2-OE and control cells exhibited a 
heterogeneous population and ESC-like colonies were hardly observed (Figure 4.4 A) and 
much less in number than when they were cultured in the suboptimal hESC culture condition 
(see the above section), indicating that hESCs became differentiated quicker in the N2B27 
medium than in the UM culture. This observation was supported by the considerable 
downregulation of Oct4 and Nanog in these cells (Figure 4.4 B&C), which are different from 
that in the UM cultures.  
 
However, there were noticeable differences in morphology between the Sox2-OE and the 
control cells. In the control cells, there was a considerable population of cells exhibiting flat, 
primitive endoderm-like morphology, whereas a majority of Sox2-OE cells revealed neural 
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rosette or neural progenitor morphology (Figure 4.4 A), indicating that SOX2 promotes 
neural differentiation in this culture condition. Indeed, gene expression analysis showed that 
mRNA expression of neural progenitor marker Sox1 was significantly higher in the Sox2-OE 
cells than in the controls after they were cultured for 30 days in the N2B27 medium, while 
transcripts of endoderm markers GAGA6 and Sox17 were considerably lower in the Sox2-
OE cells (Figure 4.4 B). In consistent with this, protein levels of endoderm markers GAGA6, 
Sox17 and FoxA2 were also expressed at much lower levels in the Sox2-OE cells than the 
controls (Figure 4.4 C). Furthermore, immunostaining revealed that more Pax6 and Nestin 
positive cells in Sox2-OE group, whereas much more Sox17 positive cells were in the control 
group (Figure 4.4 D). These results provide further evidence that functions of Sox2 in hESCs 
are intricate and affected by culture environment. Under pluripotent culture conditions when 
extrinsic signals are optimal for hESC self-renewal, Sox2 overexpression enhances hESC 
self-renewal and pluripotency; whereas when culture condition no longer supports self-
renewal of hESCs, Sox2 overexpression promotes neural differentiation and inhibits 
endoderm generation.  
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Figure 4.4 Sox2 promotes neural differentiation under the N2B27 culture condition 
Sox2-OE and control hESCs were seeded at same density into matrigel-coated plates and 
cultured in N2B27 medium alone for 30 days. (A) Bright-field microscopy images of Sox2-
overexpressing (Sox2-OE) and control hESCs under N2B27 condition. (B) qRT-PCR analysis 
of the expression of pluripotency and germ layer markers is shown as fold change relative to 
the control in CM condition. Dash line represents the level of indicated gene in control cells 
in CM condition. Average value and standard error were calculated from three independent 
experiments. *p<0.05 and **p<0.01 by student t test. (C-D) Expression of the transgene and 
lineage markers, Sox17, Pax6 and Nestin analysed by immunoblot (C) and immunostaining 
(D). Representative confocal images obtained from two independent experiments. 
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4.3 Discussion 
In this chapter, I continued the studies from the previous chapter to investigate the roles that 
Sox2 plays in hESCs and during their differentiation using gain- and loss- of function 
approaches. Following the knockdown studies, here I focused on the studies to investigate the 
effect of ectopic expression of Sox2 on hESCs and revealed that overexpression of Sox2 has 
an intricate effect on hESCs depending on their culture conditions. When culture conditions 
are optimal or suboptimal for hESC self-renewal, Sox2 functions to suppress differentiation 
and enhance pluripotency. However, when culture condition does not support hESCs, upon 
exit of pluripotency, Sox2 appears to promote neural differentiation and inhibit hESC 
differentiation to mesoderm and endoderm, particularly extraembryonic endoderm.  
 
4.3.1 Manipulation of Sox2 level in hESCs 
The current study requires introduction of exogenous Sox2 into hESCs. Since it is much more 
difficult to introduce foreign DNA into hESCs than other tumour cell lines by standard 
transfection approaches, lentiviral transduction was utilised in these experiments. In order to 
further improve transgenic efficiency, a viral 2A sequence was introduced into the lentiviral 
expression vector, which allows expression of Sox2 and puro resistant gene at similar levels 
and under the same regulatory controls. It is argued that in terms of high efficiency and 
reliability, this 2A sequence represents an attractive advancement to the traditional internal 
ribosomal entry site (IRES) for co-expression of multiple genes as they are not only under the 
same transcriptional control but also being governed by the same translational machinery 
(Lewis et al., 2015, Ryan and Drew, 1994, Ryan et al., 1991, Trichas et al., 2008). The IRES 
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system has been the most common approach to simultaneously express two genes in target 
cells and the IRES functions as a ribosomes binding site to initiate translation on the second 
protein (Jang et al., 1988). However, there are two main limitations found in this system. 
Firstly, as the size of IRES is over 500bp, it limits the capacity of a vector to incorporate 
another foreign DNA, particularly in lentiviral vectors which can only accommodate up to 8 
kb insert between two LTR fragments. Secondly, it fails to produce equal amount of proteins 
for the two desired genes, as the downstream gene is often reduced. These limitations can be 
overcome by application of the 2A sequence. The 2A peptide is only 20 amino acids in size, 
encoded by 60 bp DNA fragment, much shorter than that of IRES, which seems to increase 
the expression of reporter genes when compared to the IRES sequence (Chan et al., 2011). 
Also 2A sequence leads to a failure in peptide bond formation between penultimate glycine 
residue and the terminal proline residue within the 2A sequence, thus allowing efficient 
production of multiple independent proteins at equal levels (Donnelly et al., 2001, Szymczak 
et al., 2004).  
 
Notably, in this study the successful transduced cells that survived after the puromycin 
selection were pooled and expanded, rather than being clonally picked and separated into 
different wells. This approach has its advantages as it shortens the time consumed for cell 
expansion and overcome the discrepancies of clonal differences and position effect. Although 
a heterogeneous morphology may be observed within pooled cells along treatments due to 
various levels of transgene expressed in cells, repeating experiments for three times makes 
the results more reliable. Overall, my experiments demonstrate that transgenic hESCs could 
be efficiently generated using this approach and that the presence of HA-Sox2 was confirmed 
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by both immunoblot and immunostaining (Figure 4.1). 
 
4.3.2 Sox2 enhances self-renewal of hESCs under optimal and suboptimal hESC 
culture conditions 
Using Sox2 transgenic hESCs, the effect of Sox2 on self-renewal and lineage differentiation 
was first examined when they were cultured in MEF-CM supplemented with bFGF, a culture 
condition proved to be optimal for maintenance of hESCs and routinely utilised in our 
laboratory. The pluripotent genes, Oct4 and Nanog were found to be expressed at slightly 
higher levels in the Sox2-OE cells than the controls. Also a downregulation in expression was 
detected in lineage-specific genes associated with neural ectoderm (Pax6), mesoderm 
(Brachyury) and endoderm (Sox17, GATA6) (Figure 4.2). This gene expression profile is 
consistent with the morphological appearance of less spontaneous differentiation, indicating 
Sox2 enhances hESC self-renewal under the hESC culture condition. This, to certain extent, 
is in agreement with the previous studies which showed that overexpression of Sox2 does not 
alter the undifferentiated state of ESCs (Wang et al., 2012, Zhao et al., 2004).  
 
Under suboptimal hESC culture condition, this notion of enhancement of pluripotency was 
more apparent. when these cells were cultured in the UM, a suboptimal hESC culture 
condition for 30 days, around 40% of Sox2-OE clusters still exhibited an ESC-like 
morphology and maintained a relative high level of Oct4 and Nanog, whereas majority of 
control cells became differentiated, indicating that Sox2 overexpression delays hESC 
differentiation under this suboptimal condition. All these results suggest that overexpression 
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of Sox2 enhances the self-renewal of hESCs in both optimal and suboptimal conditions.  
 
This enhancement of pluripotency by Sox2 under hESC culture conditions could be due to 
the enhancement of Oct4 expression in these cells. Sox2 has been reported in mESCs to 
promote Oct4 expression and therefore, the phenotypes caused by Sox2-null ESCs can be 
rescued by a forced expression of Oct4 expression (Masui et al., 2007). Furthermore, Sox2 
has been identified as a co-factor of Oct4 in maintaining pluripotency (Boyer et al., 2005, 
Chambers, 2004, Loh et al., 2006, Rodda et al., 2005). Cooperation between these two factors 
was first found in the activation of Fgf4 enhancer (Yuan et al., 1995), and then on large 
number of ESC-specific enhancers (Kuroda et al., 2005, Nakatake et al., 2006, Nishimoto et 
al., 1999, Tomioka et al., 2002, Tokuzawa et al., 2003). Genome-wide ChIP-on-ChIP analysis 
revealed that Oct4 and Sox2 co-occupy many putative regulatory elements to control 
pluripotency (Boyer et al., 2005). As such, an elevated level of Sox2 may enhance Oct4 
expression and they together subsequently activate pluripotent gene expression and repress 
lineage specific gene expression as well as activate an autoregulatory loop to further enhance 
their own expression (Chambers and Smith, 2004, Masui et al., 2007).  
 
Apart from this direct regulation, Sox2 may also regulate Oct4 expression in an indirect way. 
It has been shown that many transcription factors are involved in the regulation of Oct4 
expression in addition to Sox2 and Oct4. For example, the member of the nuclear receptor 
family, Nr5a2 has been shown to promote Oct4 expression (Ben-Shushan et al., 1995, Gu et 
al., 2005), whilst Nr2f1 inhibits Oct4 expression (Ben-Shushan et al., 1995, Gu et al., 2005, 
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Schoorlemmer et al., 1994). As the depletion of Sox2 in mouse ESCs simultaneously led to 
an upregulation of Nr2f1 and downregulation of Nr5a2, indicating that their expression may 
be regulated by Sox2. On the contrary, elevated Sox2 sustains Oct4 expression level perhaps 
via maintaining a certain level of Nr5a2 and meanwhile repressing the Nr2f2. 
 
Notably, lineage-specific markers associated with neural ectoderm (Pax6), mesoderm 
(Brachyury) and endoderm (Sox17, GATA6) were clearly downregulated in the Sox2-OE 
cells under the optimal hESC culture condition, suggesting that Sox2 inhibits their 
differentiation to enhance self-renewal of hESCs. It has been reported that Sox2 alone is 
sufficient to block definitive endoderm differentiation of hESCs (Teo et al., 2011). During 
mesoderm differentiation, the expression of Sox2 and Brachyury are mutually exclusive. 
ChIP-qPCR analysis revealed that Sox2 enrichment was increased at the promoter region of 
Brachyury (Thomson et al., 2011), suggesting a role of Sox2 on the regulation of Brachyury. 
Currently, little is known about the regulation of Pax6 by Sox2. A genome-wide ChIP-on-
ChIP analysis showed that Sox2 and Oct4 co-occupy the P1 promoter of Pax6, suggesting its 
regulation by the Oct4/Sox2 complex in hESCs (Boyer et al., 2005). Also the expression of 
Pax6 may be influenced by the extrinsic signals, such as BMPs (Pituello, 1997). The effect of 
extrinsic factors will be discussed later in this section. 
 
Taken together, it is likely that overexpression of Sox2 enhances self-renewal of hESCs via 
retaining a high level of Oct4 and meanwhile suppressing mesoderm and endoderm fate when 
cultured under hESC culture conditions. 
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4.3.3 Sox2 promotes neural differentiation upon losing pluripotency 
To determine whether elevated level of Sox2 influences the direction of hESCs differentiation 
to any specific lineages upon their exit of the pluripotency, a longer time culture (up to 30 
days) in the suboptimal UM was firstly applied. This culture medium is commonly used for 
embryoid body differentiation for cell aggregates and has lower activity of TGF-β and 
increased BMP signalling activity of cells (Gerrard et al., 2005, Xu et al., 2005). Sox2 
overexpression could not block the differentiation of hESCs, instead delayed their 
differentiation, which is correspondent to its role in enhancing pluripotency of hESCs. 
Interestingly, upon differentiation, Sox2 overexpression appeared to promote the 
differentiation more toward the neural lineage as shown by a significant increase of Sox1 
expression and reduced expression of endoderm and mesoderm genes. This is more 
pronounced when cells were cultured in N2B27 medium, a chemically defined, serum-free 
medium. Although this medium has been shown to enrich neural differentiation of mESCs 
(Ying et al., 2003), it does not exhibit clear enrichment of neural lineage in hESCs unless 
when coupled with BMP inhibitors (Gerrard et al., 2005; Chambers et al., 2009), indicating 
that this medium itself does not selectively promote neural differentiation. Consequently, a 
variable and heterogeneous differentiation was observed in the control hESC cultures. 
However, Sox2 overexpression exhibited an enriched differentiation to neural lineage as 
shown by a dramatically upregulated Sox1 expression and a significant decrease in 
expression of other lineage genes, in particular the endoderm genes. It has been found that 
constitutive expression of Sox2 biases the neuroectoderm fate choice in mouse ESCs (Kopp 
et al., 2008, Zhao et al., 2004). This result can be reproduced in vivo system, showing a 
heavily biased neural differentiation of Sox2-OE mESCs after grafting into mice (Zhao et al., 
2004). In addition, overexpression of Sox2 expands the neural plate at the expense of 
Chapter four 
___________________________________________________________________________  
 
133 
 
epidermal differentiation and neurogenesis (Rogers et al., 2009).  
 
Notably, in N2B27 medium, a more significant downregulation of Oct4 was observed in 
Sox2-OE cells than the controls, indicating that rather than maintaining a high level of Oct4 
in hESCs, Sox2 seems functioning to repress its expression during neural differentiation. This 
observation is consistent with my previous finding that Oct4 and Sox2 levels diverged during 
neural differentiation. The correlated pattern of Oct4 and Sox2 expression in hESCs was 
broken into a high level of Sox2 and gradual disappearance of Oct4. As Oct4 expression is 
sustained in mesoderm differentiation (Thomson et al., 2011), Sox2 here is likely to inhibit 
mesoderm differentiation via repressing the Oct4 expression. Similar in endoderm 
differentiation, I observed a dramatically downregulation of endoderm marker genes, 
including Sox17, FoxA2 and GATA6, indicating that they are repressed by Sox2 either in a 
direct or indirect way.  
 
In addition to repress other lineage differentiation, overexpression of Sox2 also results in a 
dramatically increase in Sox1 expression. This supports the previous study that elevated Sox2 
is sufficient to induce the expression of Sox1, but not Sox3, to promote neural differentiation 
(Archer et al., 2011). However, the expression of Pax6 did not reveal a significant difference 
between the Sox2-OE and the control cells and reasons for these remain to be elusive, given 
the fact that little is known about the relationship between Sox2 and Pax6. In addition to 
NPCs (Ericson et al., 1997, Goulding et al., 1993), Pax6 is also highly expressed in certain 
subtypes of ventral neurons (Hill et al., 1991) and plays a pivotal role in neuronal 
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differentiation (Lee et al., 2005, Mizuguchi et al., 2001, Novitch et al., 2001). Unlike Pax6, 
Sox2 is mainly expressed in NPCs and overexpression of Sox2 inhibits neurogenesis and 
maintains NPC identity (Rogers et al., 2009). As such, it is likely that the pax6 expression in 
Sox2 OE group is detected mainly in the NPCs, while in the control group Pax6 is expressed 
in both undifferentiated NPCs and neurons. The overall level of Pax6 compared between 
these two groups may not represent the number of cells from each group committed into 
neural differentiation. Moreover, Nestin, an important marker for NPCs, is highly expressed 
in the Sox2-OE cells after cultured for 30 days in N2B27 medium and has been reported as a 
target gene of Sox2 (Tanaka et al., 2004). Taken together, Sox2 overexpression promotes 
neural differentiation via inducing neural related genes, meanwhile repressing pluripotent 
marker Oct4 and other lineage genes. 
 
4.3.4 Effect of Sox2 in hESCs is influenced by extrinsic factors  
It has been shown in my experiments that overexpression of Sox2 in hESCs under optimal 
and sub-optimal hESC culture condition inhibits their differentiation, thus enhancing self-
renewal of hESCs. However, when cultured in non-hESC supporting conditions, Sox2 
overexpression is incapable of maintaining the pluripotency of hESCs. Instead, the cells 
gradually lose their pluripotency to become differentiated. Interestingly, upon exit of 
pluripotency, Sox2 overexpression appeared to bias the differentiation more toward the neural 
lineages as shown by a significant increase of Sox1 expression and downregulation of 
mesoderm and endoderm genes. Therefore, Sox2 exerts versatile functions in hESCs 
depending on the culture systems and the effect of Sox2 in hESCs is influenced by extrinsic 
factors or culture environment. The CM condition has active bFGF/TGF-β/Activin/Nodal 
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signalling pathways and other undefined molecules obtained from MEFs, which can 
cooperate to maintain self-renewal of hESCs and suppress their differentiation to any germ 
layers (James et al., 2005, Vallier et al., 2005, Wang et al., 2005, Xu et al., 2005). It is likely 
that this condition constrains the function of Sox2 on neural differentiation and enhances its 
ability of maintaining self-renewal in hESCs. By contrast, the UM and N2B27 conditions 
exhibit low activity of TGF-β and high activity of BMP signalling (Gerrard et al., 2005, Xu et 
al., 2005), which is unable to support self-renewal (Kaur et al., 2013) and favours 
differentiation to trophoblast (Xu et al., 2002) or extra-embryonic endoderm (Pera et al., 
2004). Under these conditions, high level of Sox2 alone is unable to sustain the pluripotency 
of hESCs. However, it appears to impede the hESC differentiation to extra-embryonic 
endoderm and promote the differentiation toward neural lineages.  
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Chapter Five 
 
Relationship of Sox2, Oct4 and Pax6 in 
hESCs and NPCs  
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5.1 Introduction 
Previous results have shown that Sox2 is highly expressed in both hESCs and NPCs and that 
Sox2 plays an essential role in both maintaining self-renewal of hESCs and promoting neural 
differentiation upon exit of pluripotency. These findings demonstrate dual functions of Sox2 
exerted in a cell-type specific manner, in which it targets different sets of genes and regulates 
their expression (Gifford et al., 2013, Lister et al., 2009, Lodato et al., 2013, Ng et al., 2013). 
However, the molecular mechanism regarding how Sox2 can regulate distinct set of genes 
remains not fully understood. Given the facts demonstrated by previous studies that most 
SOX family proteins require binding partners for the stable and substantial transcriptional 
regulation of its target genes (Lefebvre et al., 1997, Nishimoto et al., 1999, Yuan et al., 1995), 
it is plausible to anticipate that Sox2 may perform these two distinct functions in hESCs and 
NPCs by interacting with different partners, which leads to their targeting to distinct genes. 
Whilst Oct4 has been well characterised as a Sox2 binding partner in hESCs (Boyer et al., 
2005), the co-factor of Sox2 during neural differentiation of hESCs and in NPCs remains 
largely unknown. A recent study using neural differentiation from hESCs as an in vitro model 
system showed that Pax6 is the determinant for neuroectoderm development and neural 
differentiation, in which overexpression of Pax6 can induce neural differentiation in hESCs 
while deficiency of Pax6 hinders their neural differentiation (Zhang et al., 2010). Pax6 has 
been identified to interact with Sox2 protein in lens tissue and the resulting complex is able to 
initiate lens differentiation (Kamachi et al., 2001; Remenyi et al., 2003). Although I have 
demonstrated that expression of Pax6 is upregulated at a very early stage during neural 
differentiation (Figure 3.2 & 3.3), it was not clear whether Pax6 interacts with Sox2 during 
the early stage of neuronal differentiation and whether Sox2-Pax6 complex plays any role in 
promoting neural differentiation. Therefore, I aimed to address this issue in order to decipher 
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the molecular mechanisms underlying the role of Pax6 in neural differentiation. In this 
chapter, I described the experiments and results which were carried out to address this issue. 
 
5.2 Results 
5.2.1 Identification of Pax6 as a binding partner of Sox2 in early neural 
differentiation 
In order to address whether Pax6 interacts with Sox2 during neural induction of hESCs, I 
carried out Co-IP experiments in hESCs and during neural differentiation. Given that Oct4 is 
well-accepted as an important binding partner of Sox2, synergistically regulating 
pluripotency, this partnership existing between Sox2 and Oct4 was used as a positive control 
in Co-IPs when the cooperation between Sox2 and Pax6 was examined in early 
differentiating cells. Both Sox2 and Oct4 proteins can be detected by immunoblot in Sox2 
immunoprecipitants of undifferentiated hESCs (Figure 5.1 A, left panel). However, a similar 
size band to Oct4 (~55 kD) was also detected in the IgG immunoprecipitants with Oct4 
antibody. Given that this band was only detected in the reaction with Oct4 antibody (Figure 
5.1A) but absence in the reactions with Sox2 and Pax6 antibodies and that immunoblot with 
β-Actin antibody did not show any signal in the immunoprecipitants (Figure 5.1 A & B), it is 
likely that the IgG antibodies used as IP controls may cross-interact with Oct4 protein. 
Therefore, I carried out Oct4 Co-IP to validate that Sox2 indeed interacts with Oct4 in hESCs 
(Figure 5.1 A right panel). After setting up the Co-IP conditions, Sox2 Co-IP was performed 
with cell lysates isolated from NPCs and the immunoprecipitants were immunoblotted with 
Pax6 antibody. The results revealed clear signals that correspond to Pax6 protein size (Figure 
5.1B), which demonstrated that Sox2 does interact with Pax6 in the NPCs and suggested that 
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Pax6 could be a Sox2 binding partner to regulate gene expression in NPCs. 
 
 
 
Figure 5.1 Sox2 interacts with Oct4 and Pax6 in hESCs and NPCs, respectively 
Lysate from hESCs was immunoprecipetated with anti-Sox2 (left panel) and anti-Oct4 (right 
panel) antibodies and the immunoprecipitates were analysed by immunoblot with indicated 
antibodies. (B) Sox2-immnoprecipitants from NPCs were analysed by immunoblotting with 
indicated antibodies. Isotype-matched IgG was used as controls for immunoprecipitation. 1% 
cell lysate was used as input controls. Representative images were depicted from three 
experiments. Arrow head indicates light chain from immunoglobulin. Arrow indicates sox2 
protein. 
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5.2.2 Sox2 interacts with Oct4 and Pax6 via the same interface 
The study on Sox2 crystal structure suggests that Sox2 may interacts with Oct4 and Pax6 via 
the same interface, in which the HMG domain of Sox2, particularly the K57, R60 and R75 
residues are the major contributors to their interaction (Remenyi et al., 2003). To validate that 
these three residues are important in regulating the interaction between Sox2 and Oct4 as well 
as Sox2 and Pax6, I mutated the three residues in different combinations by site-directed 
mutagenesis and cloned them into expression vectors. The mutant construct are termed as 
mutant 1 (R75E), mutant 2 (K57E, R60E) and mutant 3 (K57E, R60E, R75E). These mutant 
constructs as well as the wild-type Sox2 were individually transfected into HEK-293T cells 
or co-transfected with a construct expressing wild-type Oct4 for Co-IP experiments. Since the 
HEK-293T cells express Pax6 protein, endogenous Pax6 was used in the Co-IP experiments. 
 
In cells co-transfected with various forms of Sox2 and Oct4, cell lysates were collected for 
immunoprecipitation. To avoid the interference by the heavy chain observed in the Sox2 Co-
IP (Figure 5.1 A left panel), Oct4 Co-IPs were performed to assess the binding affinity 
between Sox2 mutants and Oct4. Same amount of whole cell lysates from four transfections 
was subjected to Oct4 Co-IPs. The Sox2-Oct4 interaction was calculated as amount of Sox2 
pulled-down by per unit of Oct4 and then presented as relative fold change to that of wild-
type Sox2. As shown in Figure 5.2 A, both Sox2 mutant 1 and 2 proteins exhibited some 
reduction (43% and 12%, respectively) in their binding affinity with Oct4. However, more 
reduction (57%) was detected in mutant 3 which contains mutations in all three residues. 
Nonetheless, it should be noticed that slightly lower levels of Sox2 were observed in the input 
of mutants than that of the wild-type. This raised the question that the reductions in Oct4-
Sox2 mutant Co-IPs might be due to less Sox2 mutant proteins available for the Oct4-Sox2 
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interaction, i.e Oct4 pull-down. To validate this initial observation, the experiments were 
repeated two more times. As shown in Figure 5.2 B&C, experiment 2 and 3, all the Sox2 
mutants in the input western were detected at similar, if not higher levels, to the wild-type 
Sox2, particularly the mutant 3, indicating that all Sox2 mutants were expressed at the similar 
or higher levels as wild-type Sox2 in the cells. However, the amount of Sox2 pulled down by 
the Oct4 appeared still less in the mutant Sox2s than that of wild-type, particularly for the 
mutant 3 as before. On average, mutant 1 and 2 Sox2 proteins exhibited a decrease in binding 
affinity to Oct4 by 28% and 24%, respectively, while mutant 3 resulted in a 74% reduction 
(Figure 5.2 D). These results suggest that Sox2 indeed interacts with Oct4 through these 
residues as revealed by the crystal structural analysis (Remenyi et al., 2003). 
 
To ascertain whether these mutants have effect on Sox2 and Pax6 interaction, cell lysates 
were collected from 293T cells transfected with various Sox2 constructs only as Pax6 is 
endogenously expressed in these cells. Sox2 Co-IPs were then performed to detect Pax6 
interaction and the results showed that mutant 1 Sox2 exhibited a similar level of interaction 
with Pax6 as that of wild-type Sox2, whereas mutant 2 Sox2 showed a higher affinity to Pax6 
than the wild-type (>2 folds) (Figure 5 E,F,G&H). In these experiments, the transgenic Sox2 
genes (except mutant 3) were expressed at similar levels as shown in the input. Regarding the 
mutant 3 Sox2, I have difficulties to efficiently pull-down the Sox2 protein with HA antibody 
even that the Sox2 contains 3 HA epitopes at its N-terminus and that it was expressed at a 
higher level (Figure 5G). It is possible that mutations of all the three residues in Sox2 may 
change its structure that mask the HA epitopes. Thus, I am unable to address its interaction 
with Pax6 and probably, that is also why the mutant 3 disrupts the Sox2-Oct4 interaction 
more dramatically. 
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Notably, in both Sox2/Oct4 and Sox2/Pax6 interactions, mutant 1 of Sox2 protein exhibited 
negligible effect, whereas mutant 2 protein revealed significant changes, albeit contrarily 
between Sox2/Oct4 and Sox2/Pax6 interactions. These results suggest that these two residues 
(K57, R60) within Sox2 protein are responsible for both Sox2/Oct4 and Sox2/Pax6 
interactions.  
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Figure 5.2 Sox2 mutations affect its interaction with both Oct4 and Pax6 
Decrease of binding affinity between Sox2 mutants and Oct4. 293T cells were co-transfected with 
Oct4 and either wide type or indicated Sox2 mutants and then the whole cell lysate was subjected to 
co-immunoprecipitation analysis with anti-Oct4 antibody. The relative intensity value of each Sox2 
co-binding from three experiments (A,B,C) was shown in the bar chart (D). As the protein size of Oct4 
and β–actin are very similar, they are very close to each other if analysing them on a single western 
blot. Red arrows are used to point out these tow proteins. A blue arrow is used to point out that only 
lower bands represent Sox2 protein. The upper signals are from the previous probing with Oct4 
antibody. Three times of experiments were performed to examine the effect of Sox2 mutants on their 
interaction with Pax6 (E,F,G). 293T cells were transfected with either wide type or indicated Sox2 
mutants. The relative intensity value of each Pax6 co-binding from three experiments was shown in 
the bar chart (H). *p<0.05 and **<0.05 by student t test. 
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5.2.3 Binding of Sox2, Oct4 and Pax6 in Sox2 locus  
It has been shown that Sox2/Oc4 complex regulates both Sox2 and Oct4 expression in hESCs 
(Boyer et al., 2005) and now I have demonstrated that Sox2 interacts with Pax6 during neural 
differentiation and in NPCs, thus I wonder whether Sox2/Pax6 complex in NPCs also 
regulates Sox2 expression. Genome-wide chromatin immunoprecipitation-sequencing (ChIP-
seq) in hESCs has demonstrated that Sox2 and Oct4 co-ordinately bind to the loci of Sox2, 
Oct4 and Pax6, indicating a regulatory function of Sox2/Oct4 complex on these gene 
expressions (Boyer et al., 2005). Interestingly, by analysing a recent Pax6 Chip-seq database 
performed in early human neural ectodermal differentiation, I found that area in the Sox2 
locus, which is targeted by Sox2/Oct4 complex in hESCs, is also overlapped with Pax6 peaks 
(Bhinge et al., 2014). Therefore, it is likely that Sox2/Oct4 and Sox2/Pax6 complexes may 
target the same area to regulate Sox2 expression in hESCs and NPCs, respectively. 
 
To verify this hypothesis, ChIP-qPCR assays were performed to determine if Sox2, Pax6 and 
Oct4 are co-recruited to Sox2 regulatory elements. By analysing Sox2 ChIP-seq database 
performed in human NPCs (Ng et al., 2013) or in hESCs (Gifford et al. 2013), I found that 
some regions bound by Sox2 in hESCs may also bound by Sox2 in NPCs, indicating that 
Sox2 may regulate its expression through the same enhancer area in both NPCs and in 
hESCs. According to these findings, region-specific primers were designed to amplify the 
possible binding sites found in the vicinity of Sox2 gene (Figure 5.3A). ChIP experiments 
performed on chromatin prepared from hESCs with anti-Sox2 antibody exhibited a 6 fold, 15 
fold and 20 fold higher enrichment at N2, -1.0kb and +4.1kb regions respectively, in compare 
to the enrichment from a negative control region (referred to 2nd intron of GAPDH), 
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indicating that Sox2 was recruited to these areas. Particularly, a significant increment was 
found at +4.1kb region (Figure 5.3 B left panel). In the experiment of Oct4 ChIP in hESCs, 
the PCR exhibited a 4-fold, 2-fold and 10-fold enrichment at N2, -1.0kb and +4.1kb region 
respectively, indicating that Oct4 possibly binds to the N2 and +4.1kb, but not to the -1.0kb 
region. It is noticeable that, like the Sox2 ChIP, the highest enrichment is at +4.1kb region 
(Figure 5.3 B right panel), suggesting that this region is a binding site of Sox2/Oct4 complex. 
In order to investigate whether Sox2 /Oct4 complex and Sox2/Pax6 complex target the same 
region(s) of the Sox2 locus, Sox2 and Pax6 ChIP were performed in hESCs that had 
underwent neural differentiation for 8 days in SB431542 and dorsomorphin supplemented 
culture conditions (Bhinge et al., 2014). The Sox2 ChIP in these neural differentiating cells 
showed significant higher levels of enrichment in all three regions rather than predominantly 
on +4.1 kb region in hESCs, indicating that Sox2 was recruited to all these elements during 
differentiation (Figure 5.3 C, left panel). Similar to the Sox2 ChIP, the Pax6 ChIP also 
showed a 3~4 fold higher levels of enrichment at all three regions, but only the increases at -
1.0kb and +4.1kb were found to be statistically significant (Figure 5.3 C, right panel). These 
results demonstrate that both Sox2/Oct4 and Sox2/Pax6 complexes target +4.1 kb area of 
Sox2 locus to regulate its expression in hESCs and the neural differentiating cells, 
respectively, even though they may exhibit subtle difference in their binding in other regions. 
These findings suggest that in hESCs, Sox2 and Oct4 were co-recruited to the +4.1kb areas, 
while in early differentiating cells, Pax6 can replace Oct4 to bind to this regions, cooperating 
with Sox2 to possibly exert regulatory function on Sox2 expression. Sox2/Pax6 complex 
appears to also bind to other regions of Sox2 locus, which seems not being bound by 
Sox2/Oct4 complex. This may account for higher expression of Sox2 upon neural 
differentiation. 
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Figure 5.3 Binding of Sox2, Oct4 and Pax6 on the Sox2 locus in hESCs or neural 
differentiating cells 
(A) Schematic illustration of the Sox2 gene locus. The Sox2 enhancers (SRR1 and SRR2) and 
transcriptional starting site (+1) are indicated. The PCR primers are indicated by filled triangles, N2, 
-1.0 kb and +4.1 kb. (B) ChIP-qPCR analysis of Sox2 and Oct4 binding to the Sox2 promoter and 
enhancer area in hESCs. Primers to the second intron of GAPDH were used as control. (C) ChIP-
qPCR for Sox2 and Pax6 binding to the Sox2 promoter and enhancer region with samples collected 
from hESCs that were cultured for 8 days in neural differentiation conditions. Results are shown as 
fold enrichment when compared to the enrichment from a negative control region (referred to 2nd 
intron of GAPDH). Both qPCR data from the IgG and IP were taken into account. Data from three 
independent experiments are shown as means ± SD. *P < 0.05 and **P < 0.01 by student t test. 
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5.2.4 Binding of Sox2, Oct4 and Pax6 Oct4 locus 
The transcription of Oct4 gene has been reported to be mainly governed by two enhancers 
upstream of the Oct4 transcription starting site (TSS), which are named the proximal 
enhancer (PE) and distal enhancer (DE) according to their distance from the TSS (Yeom et 
al., 1996). To address the regulation of Sox2, Oct4 and Pax6 on Oct4 expression, the bindings 
of Sox2, Oct4 and Pax6 were next examined on Oct4 enhancers in both hESCs and neural 
differentiating cells (Figure 5.4 A). Sox2 ChIP-qPCR performed in hESCs exhibited 
significantly higher enrichments at the PE and DE regions than the control area, indicating 
that Sox2 binds to both enhancers (Figure 5.4 B left panel). Similar binding patterns on Oct4 
enhancers were also detected in the Oct4 ChIP in hESCs (Figure 5.4 B right panel). Notably, 
the enrichment at PE site was the highest among the two enhancers bound for both Sox2 and 
Oct4, suggesting that more Sox2 and Oct4 proteins were recruited at PE than that at DE in 
hESCs (Figure 5.4 B).  
In neural differentiating cells, Sox2 ChIP revealed that 3.6- and 7- fold higher enrichments 
were observed at DE and PE respectively (Figure 5.4 C left panel). Furthermore, in the Pax6 
ChIP, a 3.4- fold and 14- fold higher enrichments were detected at DE and PE, respectively, 
indicating that more Pax6 was more recruited to PE than that to the DE (Figure 5.4 C right 
panel). The enrichments of binding by Sox2/Pax6 in the neural differentiating cells are 
similar to that of Sox2/Oct4 in hESCs, exhibiting the highest enrichments at the PE region. 
Taken together, these results suggest that Sox2 and Oct4 as well as Sox2 and Pax6 may co-
occupy both PE and DE despite more at the PE region, to regulate the expression of Oct4 
gene in hESCs and the neural differentiating cells, respectively and that Sox2/Oct4 and 
Sox2/Pax6 may regulate Oct4 expression in different cell context, resulting different 
outcomes but through similar regions.  
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Figure 5.4 Binding of Sox2, Oct4 and Pax6 on the Oct4 locus in hESCs or neural 
differentiating cells 
(A) Schematic map of the Oct4 gene locus. The Oct4 proximal enhancer (PE) and distal enhancer 
(DE) are indicated. 1A, 1B and 2A sites contain nearly identical sequence homologous to the GC box 
and are important for the activity of PE and DE. The black triangles represent position of ChIP-PCR 
primers. (B) ChIP-qPCR analysis of Sox2 and Oct4 binding to the PE and DE in hESCs. Primers to 
the second intron of GAPDH were used as controls. (C) Sox2 and Pax6 binding to the Oct4 enhancers 
in the early neural differentiating cells as in Figure 5.4. Results are shown as fold enrichment when 
compared to the enrichment from a negative control region (referred to 2nd intron of GAPDH). Both 
qPCR data from the IgG and IP were taken into account. Data from three independent experiments 
are shown as means ± SD. *P < 0.05 and **P < 0.01 by student t test. 
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5.2.5 Binding of Sox2, Oct4 and Pax6 on Pax6 locus 
Genome-wide ChIP data showed that Sox2/Oct4 complex binds to the Pax6 promoter, which 
may repress Pax6 expression in ESCs (Boyer et al., 2005). However, no further experimental 
data was available for the validation of this observation. In addition, a Pax6 ChIP-seq 
performed in early neural differentiating cells has identified that Pax6 binds the Pax6 gene at 
areas near its TSS and inside its gene body (Figure 5.5 A) (Bhinge et al., 2014). These sites 
also overlap with distinct histone H3 at Lysine 27 Acetylation (H3K27Ac) peaks, indicating 
that these elements are responsible for the regulation of Pax6 expression. Therefore, to find 
out whether these sites are also occupied by Oct4 and Sox2 in hESCs or neural differentiating 
cells, various ChIP-qPCR assays were performed utilising corresponding region-specific 
primers (Figure 5.5A).  
 
In hESCs, the Sox2 ChIP-qPCR showed 3~4 fold enrichments at -2.3kb, -1.2kb and +3.2kb, 
but no increase was observed at +22kb. These indicate that Sox2 binds the Pax6 gene at -
2.3kb, -1.2kb and +3.2kb regions (Figure 5.5 B left panel). In Oct4 ChIP, it is shown that a 6 
fold, 7 fold and 2.6 fold higher enrichment was observed at -1.2kb, +3.2kb and +22kb 
respectively, indicating Oct4 binding events on these sites (Figure 5.5 B right panel). To 
determine the occupancy of Sox2 in neural differentiation, a Sox2 ChIP was carried out. The 
results showed that a 2~5 fold higher enrichment was observed at all sites with the highest 
enrichments at +3.2kb. These suggest that Sox2 binds to all these regions (Figure 5.5 C left 
panel). In Pax6 ChIP, significantly higher enrichments of binding were observed at -2.3kb, -
1.2kb and +3.2kb regions, but not at +22kb site.  These results are consistent with the 
published ChIP-seq data, confirming the Pax6 binding sites in the Pax6 gene (Figure 5.5 C 
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right panel). Taken together, these data show that Sox2/Oct4 co-occupy -1.2kb and +3.2kb 
sites of the Pax6 gene in hESCs and these sites are also co-bound by Sox2 and Pax6 in neural 
differentiating cells. This indicates that Sox2/Oct4 and Sox2/Pax6 may regulate Pax6 
expression in different cell context, resulting different outcomes but through similar regions.  
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Figure 5.5 Binding of Sox2, Oct4 and Pax6 on the Pax6 locus in hESCs or neural 
differentiating cells 
(A) Schematic map the Pax6 gene locus. The Pax6 p0, p1 promoters are indicated. The position of 
ChIP-PCR primers are named according to their position relative to p1 promoter transcription 
starting site as -2.3kb, -1.2kb, +3.2kb and +22kb and are indicated by filled triangles. (B) ChIP-
qPCR analysis of Sox2 and Oct4 binding to the potential binding sites in hESCs. (C) Sox2 and Pax6 
binding to the Pax6 promoter region in the early neural differentiating cells. Results are shown as fold 
enrichment when compared to the enrichment from a negative control region (referred to 2nd intron of 
GAPDH). Both qPCR data from the IgG and IP were taken into account. Data from three independent 
experiments are shown as means ± SD. *P < 0.05 and **P < 0.01 by student t test. 
Chapter five 
___________________________________________________________________________  
 
152 
 
5.2.6 OCT4 and SOX2 are unable to induce Oct4-luciferase activity in HT1080 
cells 
I have shown in my previously results that Sox2/Oct4 in hESCs and Sox2/Pax6 in NPCs can 
co-bind to the same regulatory regions in the Sox2, Oct4 and Pax6 genes, which suggests that 
these protein complexes may play a role in regulation of Sox2, Oct4 and Pax6 expression in 
hESCs and NPCs. In hESCs, Sox2 and Oct4 complex may activate the expression of Sox2 
and Oct4 genes and meanwhile repress the expression of Pax6 gene, whereas in neural 
differentiating cells, Sox2 and Pax6 complex functions to activate Sox2 and Pax6 expression 
and inhibit Oct4 expression. If this is true, I anticipate that Pax6 may have a critical function 
in inducing neural differentiation of hESCs to compete with Oct4 for the interaction with 
Sox2. The formation of Sox2/Pax6 complex subsequently enhances the expression of Pax6 
and Sox2 and supresses the expression of Oct4. However, binding of transcription factors to 
specific regions of a gene does not indicate that the transcription factors definitely exert a 
transcription activity on this gene. Therefore, it is not clear that whether the binding of Sox2, 
Pax6 and Oct4 have any role in the regulation of these genes. To investigate the 
transcriptional effect of these binding events, my attention was drawn to the Oct4 gene since 
Sox2/Oct4 complex has been shown to promote the expression of Oct4 through binding to 
their enhancers (Chew et al. 2005).  
 
In order to address these questions, I planned to utilise combination of transgenic and 
luciferase reporter assay technologies in HT1080 cells. Firstly, I constructed luciferase 
reporter constructs in which luciferase expression is under the control of various Oct4 
regulatory elements (Oct4-luciferase) as illustrated in Figure 5.6A. A ~4 kb human DNA 
fragment including and upstream the Oct4 TSS site is considered as full length Oct4 
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promoter, which includes both regions equivalent to the proximal and distal enhancers 
identified in mouse Oct4 gene and has been shown to faithfully reflect the regulation of 
endogenous Oct4 expression (Gerrard et al., 2005); whereas the most proximal 300bp region 
is considered here as minimal Oct4 promoter (Oct4 mini). Secondly, two transgenic HT1080 
cell populations were generated: one with stable expression of both Oct4 and Sox2 proteins 
by lentiviral transduction and the other being transduced with an empty lentivector as control. 
The presence of Oct4 and Sox2 in the transgenic HT1080 cells were validated by immunoblot 
and were clearly evident despite the levels appear much lower than that in the hESCs (Figure 
5.6B). Notably, in compare with the controls, the expression level of endogenous Pax6 was 
considerably downregulated in the cells with ectopic expression of Oct4 and Sox2, indicating 
an inhibition of Oct4/Sox2 on Pax6 expression. Finally, various Oct4-luciferase reporter 
constructs were transfected individually with Renillia-expressing vector into both Sox2/Oct4 
transgenic and control HT1080 cells, which were followed by the measurement of luciferase 
activities.  
 
Unexpectedly, in compare to luciferase activity in the control cells, Oct4 and Sox2 in 
transgenic cells showed no increased but decreased, though not significantly, luciferase 
activities in all Oct4-luciferase reporters (Figure 5.6C). Also, there was no obvious difference 
observed in luciferase activities when different Oct4 regulatory elements were applied to 
drive luciferase expression. These results indicate that Oct4 and Sox2 proteins are unable to 
activate Oct4 enhancers for promoting luciferase expression in HT1080 cells. This could be 
due to the lower levels of Oct4 and Sox2 in transgenic HT1080 cells. However, more likely, it 
could be resulted from lacking of other transcriptional co-factors that are required for 
Sox2/Oct4 complex to functionally activate the Oct4 regulatory elements.  
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Figure 5.6 Sox2 and Oct4 fail to activate Oct4 enhancers in HT1080 cells 
(A) Schematic illustration of the luciferase reporter constructs used to transfect into HT1080 
cells. (B) HT1080 cells co-transduced with Sox2- and Oct4- expressing lentiviral particles. 
The Sox2 and Oct4 expression levels were assessed by immunoblot. (C) Comparing luciferase 
activities in transgenic and control HT1080 cells. Both cell lines were transfected with 
luciferase-expressing constructs, in which luciferase expression is under the control of Oct4 
mini promoter, or Oct4 promoter containing both PE and DE enhancers or DE and mini 
promoter as indicated. Results from two independent experiments were shown as means ± 
SD. 
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5.2.7 Regulation of Oct4 transcriptional activity in hESCs is through PE and DE 
enhancers 
Given that Oct4-luciferase reporters did not show any response in the Sox2/Oct4 transgenic 
HT1080 cells and that this is thought to be related to cell properties, luciferase assays were 
next performed in hESCs as Oct4 regulatory elements are responsive to Sox2/Oct4 factors in 
these cells. Firstly, I optimised a lipofectamine-mediated transfection protocol (Ma et al., 
2012) using a GFP-expressing vector of similar size for easy observation and achieved the 
transfection efficiency consistently around 50% in hESCs (Figure 5.7A). This efficiency 
enables me to apply luciferase assays in these cells. As the experiments in HT1080 cells, I 
transfected various Oct4-luciferase reporter constructs into hESCs (Figure 5.7B) and assayed 
their luciferase activities (Figure 5.7C). As expected, mini-promoter of Oct4 gave rise to the 
lowest level of luciferase activity, whereas luciferase driven by the full length 4kb Oct4 
regulatory fragment resulted in the highest luciferase activity, almost 50 fold increase when 
compared to that of the mini promoter. The hESCs expressing the PE-luciferase reporter also 
exhibited very high levels of luciferase activities, an average of 42 fold increase in comparing 
to the mini-promoter, whereas the hESCs with the DE-luciferase reporter showed a less 
increase of luciferase activity (< 20 fold) (Figure 5.7C). These results indicated that both PE 
and DE are responsible for potentiating Oct4 transcriptional activity but PE seems more 
crucial in regulation of Oct4 expression in hESCs. 
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Figure 5.7 Oct4 expressions is regulated by both PE and DE enhancers in hESCs 
(A) Transfection efficiency of hESCs as shown by images of hESCs transfected with EGFP-
expressing constructs. (B) Schematic representation of Luciferase reporter constructs 
transfected into hESCs. (C) hESCs were transfected with indicated luciferase reporter 
constructs as well as control Renilla reporter construct and the luciferase activities were 
measured. All values were normalised to Renilla levels and then calculated as relative to 
mini-promoter-driven luciferase activity. Results from three independent experiments were 
shown as means ± SD.  **P < 0.01 by student t test. 
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5.2.8 Pax6 negatively regulates Oct4 transcriptional activity 
Having demonstrated that Sox2, Pax6 and Oct4 can all bind to the PE and DE DNAs, it is 
reasonable to think that these factors may play a role in regulation of Oct4 expression. Since 
Oct4 and Sox2 have been well studied to positively activate Oct4 expression via binding to 
its enhancer area, efforts here were more focused on Pax6 using the Oct4-luciferase reporters 
indicated above. Oct4-luciferase reporter constructs were co-transfected with either Pax6 
expression vector or a DsRed expression vector of the similar size into hESCs by the 
lipofectamine protocol indicated in the previous section and luciferase activities were 
measured 48 hours post transfection. In order to assess the effect of Pax6 in regulation of 
Oct4 expression, I also applied Sox2 knockdown by siRNA as another control. Successful 
overexpression of Pax6 and knockdown of Sox2 in hESCs were confirmed by immunoblot 
(Figure 5.8A). Luciferase assays showed that neither Pax6 overexpression nor Sox2 
knockdown have significant effects on the luciferase activity driven by Oct4 mini-promoter. 
In contrast, overexpression of Pax6 and deficiency of Sox2 on Oct4 (PE)-luciferase reporter 
resulted in a significant 31% and 48% reduction in luciferase activity, respectively (Figure 
5.8B). Similarly, in Oct4 (DE)-luciferase reporter, increase of Pax6 and decrease of Sox2 
produced a significantly reduction in luciferase activities by 42% and 38%, respectively. 
These results demonstrated that Pax6, like Sox2, does function to regulate Oct4 transcription 
through binding to the Oct4 enhancers.  However, contrasting to the role of Sox2 to enhance 
Oct4 transcription in hESCs, ectopic expression of Pax6 inhibits Oct4 expression. These 
results also support our hypothesis that increasing Pax6 may inhibit Oct4 expression by 
binding to Sox2 and targeting the Oct4 enhancers as repressor, which leads to the neural 
induction of hESCs. 
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Figure 5.8 Ectopic expression of Pax6 inhibits Oct4 expression in hESCs. 
Luciferase activity was measured in hESCs co-transfected with one of the luciferase-reporter 
constructs and either a plasmid expressing DsRed or Sox siRNA or a Pax6-expressing 
plasmid. (A) The expression level of Sox2 and Pax6 in transfected hESCs was analysed by 
immunoblot with indicated antibodies. (B) All values were normalised to the luciferase value 
of hESCs co-transfected with mini promoter reporter construct and the DsRed-expressing 
plasmid. Results from three independent experiments were shown as means ± SD. *P < 0.05 
and **P < 0.01 by student t test.  
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5.3 Discussion 
In this Chapter, I have provided evidence to show that Pax6 is a binding partner of Sox2 in 
neural induction of hESCs. In addition, alteration of the same residues in Sox2 HMG domain, 
which deteriorates its partnership with Oct4, also affect the interaction between Sox2 and 
Pax6, suggesting that Sox2 binds to oct4 and Pax6 via a same interface. In hESCs, Sox2 and 
Oct4 are found to occupy the same regions in the Sox2, Oct4 and Pax6 loci. Interestingly, the 
same areas were also co-occupied by Pax6 and Sox2 during hESC-neural differentiation. 
Moreover, ectopic expression of Pax6 in hESCs exerts an inhibitory function in Oct4 
transcriptional activity via its binding to Oct4 enhancers. These findings shed a new light on 
the molecular mechanism underlying early neural differentiation involving Sox2 and Pax6. 
 
5.3.1 Partnership of SOX2 and Pax6 in neural differentiation 
It is demonstrated here that binding partnership of Sox2 and Pax6 existing in early neural 
differentiation of hESCs and their co-occupancy at the same enhancer regions of Oct4, Sox2 
and Pax6 are confirmed by ChIP-qPCR. This paradigm supports a previous concept that all 
the Sox family proteins require cooperative partners to exert their transcriptional regulation 
(reviewed by Kamachi et al., 2000). This requirement of partners for Sox proteins accounts 
for the observation that Sox protein alone is not sufficient to form a stable DNA-protein 
complex. They need to recruit another partner to form a stable complex, which allows Sox 
proteins to perform their regulatory functions. A well-known analogous example is the co-
binding of Sox2 and Oct4 in synergistically activation of FGF4 and UTF1 enhancers during 
murine embryogenesis (Ambrosetti et al., 1997, Nishimoto et al., 1999, Ambrosetti et al., 
2000).  
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Similarly, Pax proteins do not act on their owns but are dependent on cooperation with other 
factors to specifically regulate target genes, since these proteins alone on consensus binding 
sequences exhibit a considerably low binding affinity. It has previously reported that Sox2 
and Pax6 form a regulatory complex to regulate DC5 expression for the lens development 
(Kamachi et al., 2001). Here I have extended this finding to show the collaboration of Sox2 
and Pax6 to form a stable DNA-protein complex, which could exert regulatory functions on 
many genes required for early neural differentiation of hESCs. Notwithstanding, Sox2 may 
also interact with other neural transcription factors. For example, Sox2 has been found to 
cooperate with Brn2 in the regulation of nestin gene (Tanaka et al., 2004). Therefore, further 
studies are required to identify a sox2-centred interaction network by co-immunoprecipitation 
and Mass spectrum analysis. 
 
5.3.2 Cooperation of Sox2 and Pax6 in neural induction  
In Oct4 locus, I found that PE and DE enhancers which are responsible for the regulation of 
Oct4 expression (Yeom et al., 1996) were co-bound by Sox2 and Oct4 in hESCs. These 
putative binding by Sox2 and Oct4 on PE and DE are also found in previous work carried out 
in hESCs (Boyer et al., 2005) as well as in mEpiSCs but in mESCs Sox2 and Oct4 are only 
found to bind on DE area (Tesar et al., 2007). However, when cells were differentiated into 
neural lineages, Pax6 was found to be recruited to this region, again with Sox2. Given that 
Pax6 binds to Oct4 and Sox2 regulatory elements at same regions as Sox2, it is reasonable to 
propose that it may function to regulate the expression of these two genes. However, little is 
known about the Pax6 function on the regulation of Sox2 and Oct4. Functionally examining 
these binding, I found that overexpression of Pax6 in hESCs led to a significant decrease on 
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Oct4 PE or DE transcriptional activity, suggesting that Pax6 can bind to PE and DE as a 
transcriptional repressor, possibly together with Sox2. This is in agreement with my previous 
results showing that Oct4 expression inversely correlates with Pax6 expression during neural 
differentiation. Since I found that Sox2 interacts with Oct4 and Pax6 by using a same 
interface, it is possible that there is a competition between Oct4 and Pax6 to interact with 
Sox2. When one of them becomes predominant in expression, it will dictate function of Sox2 
to either maintaining pluripotency or inducing neural differentiation. This is also supported 
by a previous report that ectopic expression of Oct4 alone in NPCs is able to reprogram NPCs 
back to pluripotent stem cells, presumably by collaborating with the endogenous Sox2 (Kim 
et al., 2009). Correspondingly, ectopic expression of Pax6 in hESCs induces neural 
differentiation (Zhang et al., 2010), which provided further evidence to support this notion. 
Thus I propose a model that by changing its partner from Oct4 to Pax6, Sox2 switches its 
function from maintaining pluripotency genes to induce genes associated with neural 
differentiation, meanwhile repressing those pluripotency genes. This model provides a 
paradigm example to support the notion that the function of SOX proteins is highly 
dependent on the molecular and cellular context. They interact with other co-factors to 
distinguish their target genes and act in a cell type-specific fashion. 
 
So far, except the crystallin gene been found as downstream of Sox2/Pax6 complex, their 
global downstream binding sites have not yet been identified. Interestingly, it is shown in this 
study that Sox2 and Pax6 can co-bind to their own locus, indicating that their expression 
might be under the control of Sox2/Pax6 complex. On Sox2 locus, A Sox2 and Pax6 co-
binding event is found in SRR2 (Figure 5.3 C left panel) which has been demonstrated to be 
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one of the main regulatory region responsible for Sox2 expression in both ESCs and NPCs as 
well as its repression upon further differentiation to postmitotic cells, such as postmitotic 
neurons (Miyagi et al., 2004). In NPCs, SRR2 even exhibits stronger activity than SRR1. 
This indicates that Sox2/Pax6 complex might involve in the Sox2 regulation in NPCs. In 
addition, I found that Sox2/Pax6 co-occupy -1.2kb and +3.2kb sites of the Pax6 gene and 
these sites are originally identified from a Pax6 ChIP-Seq database performed in NPCs by 
showing enriched Pax6 signals on them. Also these sites are overlapped with H3K27Ac peaks 
(Bhinge et al., 2014), suggesting that these elements are responsible for actively regulation of 
Pax6 expression. These together suggest that a positive auto-regulatory loop of sox2 and pax6 
protein may be involved in the early neural differentiation and the expression of Sox2 and 
Pax6 is interdependent. 
 
5.3.3 Regulatory elements of Oct4 in hESCs 
Oct4 is a key transcription factor for pluripotency and has been shown to play a pivotal role 
in the formation of inner cell mass during embryogenesis (Nichols et al., 1998) and the 
maintenance of ESCs in culture (Niwa et al., 2000). Two elements in its 5’ flanking region 
has been identified as Oct4 enhancers and named PE and DE, which regulate Oct4 expression 
in a cell-type specific manner (Yeom et al., 1996). In this study, transfection of various Oct4-
luciferase reporter constructs into hESCs showed that both PE and DE exhibited activity in 
hESCs. However, PE-driven reporter had a much higher activity than the DE reporter and the 
PE activity is similar to the entire Oct4 enhancer activity. However, either silencing of Sox2 
or ectopic expression of Pax6 caused similar levels of decrease on both PE and DE activity, 
indicating that these two elements are responsible for the regulation of Oct4 expression in 
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hESCs. This is consistent with the finding conducted in human embryonic carcinoma cells 
that each of these CRs takes part in controlling the expression of human Oct4 gene (Yang et 
al., 2005). However, this regulation mechanism differs in mESCs which exhibit only the DE 
activity (Tesar et al., 2007). Recently, an additional type of pluripotent cells derived from the 
post-implantation epiblast of murine embryos, termed mEpiSCs, have shown similar features 
with hESCs, including that the regulation of mouse Oct4 gene is mainly by PE rather than DE 
(Tesar et al., 2007). These findings suggest that even the use of mouse ES cells aids in 
understanding the molecular mechanisms of pluripotency and development, it still need to be 
carefully interpreted when applied in human system.   
 
5.3.4 Requirement for Oct4 and Sox2 to activate Oct4 expression is more 
complicated 
It has been well documented that the expression of Oct4 is under the control of Sox2/Oct4 
complex and putative Oct4 and Sox2 binding sites have been identified in Oct4 enhancer area 
(Chew et al., 2005). These co-bindings of Sox2/Oct4 on Oct4 locus have also been confirmed 
in this study. Therefore, I expected that Oct4/Sox2 overexpressing transgenic HT1080 cells 
would be a good cell model to determine the function of Sox2 and Oct4 on the regulation of 
Oct4 expression using Ocyt4-luciferase reporters. However, transfection of various Oct4 
promoter-driven reporters into these transgenic HT1080 cells did not reveal a clear difference 
in luciferase activity in comparison to control HT1080 cells, and neither did enhancer-
containing reporters compared to the mini-promoter reporter. These suggest that the Oct4 and 
Sox2 in HT1080 cells did not induce the Oct4-promoter-driven luciferase.  
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In contrast, transfection of Oct4 enhancer-containing luciferase reporters into hESCs 
exhibited a 15~49 fold increase in luciferase activity than that from the mini-promoter 
reporter. Lower levels in Sox2 and Oct4 protein expression may possibly be the reason for 
this difference observed in gene regulation between cell lines. Immunoblot confirmed the 
presence of Oct4 and Sox2 in transgenic HT1080 cells, but their expression levels appear 
much lower than that in the hESCs. Perhaps activation of Oct4 require certain levels of Sox2 
and Oct4 and these lower levels of Sox2 and Oct4 are not sufficient to reach the required 
threshold, they thus failed to activate Oct4 promoter in HT1080 cells. However, this 
explanation cannot rule out another possibility that apart from Sox2/Oct4, other factors which 
are expressed in hESCs but not in the transgenic HT1080 cells, may be necessarily required 
to activate the Oct4 expression. 
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Chapter Six 
 
General Discussion 
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6.1 Dual role of Sox2 in hESCs 
Due to the lack of sufficient embryonic materials, the molecular mechanisms of neural cell 
fate determination during embryogenesis are largely unknown, especially in human. Efficient 
differentiation of hESCs to NPCs utilising our defined differentiation protocol provides a 
valuable model system to investigate the mechanisms that drive pluripotent stem cells to exit 
the undifferentiated state and becoming neural cells. Sox2, cooperating with Oct4 and Nanog 
in hESCs, have been well-known for its function in the maintenance of pluripotency.  
Interestingly, elevated Sox2 in mESCs does not enhance pluripotency, but increase the 
differentiation potency to neural lineages (Kopp et al., 2008), leading to the hypothesis that 
Sox2 may play a dual role in hESCs: retaining pluripotency of hESCs and inducing their 
neural differentiation upon exit of pluripotency. In exploring the role of Sox2 in hESCs, I 
initially found that upon Sox2 depletion, hESCs differentiate into non-neural lineages, 
possibly extraembryonic endoderm and mesoderm, as GATA6, GSC, and Brachyury were 
significantly upregulated, while pluripotency genes (Oct4 and Nanog) and neural marker 
genes (Pax6 and Sox1) were downregulated, suggesting an essential role of Sox2 in hESCs. 
When overexpression of Sox2 in hESCs in CM, the level of Oct4 and Nanog were slightly 
upregulated in the Sox2-OE cells, in parallel with an decrease in neural marker genes (Pax6), 
mesoderm marker gene (Brachyury) and endoderm marker gene (Sox17, GATA6). This gene 
expression profile is also consistent with the morphological appearance of less spontaneous 
differentiation in Sox2-OE cells, suggesting that Sox2-OE enhances self-renewal of hESCs. 
This, to certain extent, is in agreement with the previous studies which showed that 
overexpression of Sox2 does not alter the undifferentiated state of ESCs (Wang et al., 2012, 
Zhao et al., 2004). Through these gain-and loss- function approaches, I demonstrated an 
important role of Sox2 in the maintenance of pluripotency in hESCs. This role is 
Chapter six 
___________________________________________________________________________  
 
167 
 
accomplished in part through maintaining Oct4 expression at a high level, as the Oct4 
expression significantly dropped down upon sox2 depletion, but increased in Sox2-OE cells. 
This regulation of Oct4 by Sox2 has been reported in mESCs (Masui et al., 2007). Thus, the 
phenotypes caused by Sox2-null ESCs can be rescued by forced expression of Oct4 
expression. Also, Sox2 has been identified as a co-factor of Oct4 in maintaining pluripotency 
(Boyer et al., 2005, Chambers, 2004, Loh et al., 2006, Rodda et al., 2005). Cooperation 
between these two factors was found in the activation of large number of ESC-specific 
enhancers, such as Fgf4 enhancer (Yuan et al., 1995; Kuroda et al., 2005, Nakatake et al., 
2006, Nishimoto et al., 1999, Tomioka et al., 2002, Tokuzawa et al., 2003). Genome-wide 
ChIP-on-ChIP analysis revealed that Oct4 and Sox2 co-occupy many putative regulatory 
elements to control pluripotency (Boyer et al., 2005). As such, Sox2 functions to maintain 
Oct4 expression at a high level and then they together activate pluripotent gene expression 
and repress lineage specific gene expression as well as activate the autoregulatory loop to 
further enhance their own expression (Chambers and Smith, 2004, Masui et al., 2007). The 
regulation of Oct4 by Sox2 was further proved by a luciferase assay showing that Sox2 
knockdown by siRNA causes a significantly reduction on Oct4 PE or DE activity, verifying 
that Sox2 is essential to maintain Oct4 expression by binding to PE and DE. Notably, lineage-
specific markers associated with neural ectoderm (Pax6), mesoderm (Brachyury) and 
endoderm (Sox17, GATA6) were clearly downregulated in the Sox2-OE cells under CM 
condition, suggesting that Sox2 inhibits their differentiation to enhance self-renewal of 
hESCs. This is correlated well with previous study that Sox2 alone is sufficient to block 
definitive endoderm differentiation of hESCs (Teo et al., 2011). During mesoderm 
differentiation, the expression of Sox2 and Brachyury are mutually exclusive. ChIP-qPCR 
analysis revealed that Sox2 enrichment was increased at the promoter region of Brachyury 
(Thomson et al., 2011), suggesting a role of Sox2 on the regulation of Brachyury. Currently, 
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little is known about the regulation of Pax6 by Sox2. A genome-wide ChIP-on-ChIP analysis 
showed that Sox2 and Oct4 co-occupy the P1 promoter of Pax6, suggesting its regulation by 
the Oct4/Sox2 complex in hESCs (Boyer et al., 2005). Taken together, I found that Sox2 is 
indispensable for the maintenance of pluripotency and it sustains pluripotency by maintaining 
a high level of Oct4 as well as repressing lineage differentiation, including neuroectoderm. 
 
Next, to determine whether Sox2 can influence lineage decision, the Sox2-OE hESCs were 
pushed to differentiate by culturing them in sub-optimal UM and chemical defined N2B27 
medium. In the UM condition, Sox2 OE could not block the differentiation of hESCs, instead 
delayed their differentiation, which is correspondent to its role in enhancing pluripotency of 
hESCs. However, once differentiation occurs, Sox2 OE appeared to promote the 
differentiation more toward the neural lineage as shown by a significant increase of Sox1 
expression and reduced expression of endoderm and mesoderm genes. This is more 
pronounced when cells were cultured in N2B27 medium. Given that the N2B27 medium 
itself does not selectively promote neural differentiation (Ying et al., 2003, Gerrard et al., 
2005), a variable and heterogeneous differentiation was observed in the control hESC 
cultures. However, Sox2 OE exhibited an enriched differentiation to neural lineage as shown 
by a dramatically upregulated Sox1 expression and a significant decrease in expression of 
other lineage genes, in particular the endoderm genes. These findings are consistent with the 
studies performed in mESCs showing that constitutive expression of Sox2 biases the 
neuroectoderm fate choice in mouse ESCs (Kopp et al., 2008, Zhao et al., 2004). Notably, in 
N2B27 medium, a more significant downregulation of Oct4 was observed in Sox2-OE cells 
than the controls, indicating that rather than maintaining a high level of Oct4 in hESCs, Sox2 
seems functioning to repress its expression during neural differentiation. This observation is 
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consistent with the finding that in my neural differentiation, Oct4 and Sox2 levels diverged 
during neural differentiation. Since Oct4 expression is sustained in mesoderm differentiation 
(Thomson et al., 2011), Sox2 is likely to inhibit mesoderm differentiation via repressing the 
Oct4 expression. The role of Sox2 in neural differentiation is further supported by the results 
of Sox2 knock-down in NPCs. Sox2 deficiency in hESC-derived NPCs lead to a significant 
loss in the expression of neural markers, such as Pax6, Brn2 and Nestin and a failure in 
generating Tuj1-positive neurons. In addition, depletion of Sox2 in the NPCs resulted in an 
increase of apoptosis in these cells. These data indicates that Sox2 is required to maintain 
NPCs identity and also suggests that Sox2 may function to regulate the expression of Pax6 
and Brn2 in NPCs. However, the exact mechanisms remain to be elusive.  
 
In this study, a dual role of Sox2 is uncovered in hESCs, as in CM condition, Sox2 OE 
enhances self-renewal of hESCs, but promoters neural differentiation upon losing 
pluripotency. It indicates that during the transition of hESCs from an undifferentiated state to 
NPCs, a shifting of the Sox2 function might occur along the transition. Then a question was 
raised as to what determines which function of Sox2 should exert in different cell context. 
 
6.2 Effect of Sox2 in hESCs is influenced by extrinsic factors 
I have found that when cultured in optimal and sub-optimal hESC culture conditions, Sox2-
OE inhibits their differentiation, thus enhancing self-renewal of hESCs. However, when 
cultured in non-hESC supporting conditions, Sox2-OE is incapable of maintaining the 
pluripotency of hESCs. Instead, the cells gradually lose their pluripotency to become 
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differentiated. Notably, upon losing pluripotency, Sox2-OE appeared to bias the 
differentiation more toward the neural lineages. Therefore, Sox2 exerts versatile functions in 
hESCs depending on the culture systems and the effect of Sox2 in hESCs is influenced by 
extrinsic factors or culture environment. The CM condition has active bFGF/TGF-
β/Activin/Nodal signalling pathways and other undefined molecules obtained from MEFs, 
which co-operate to maintain self-renewal of hESCs and suppress their differentiation to any 
germ layers (James et al., 2005, Vallier et al., 2005, Wang et al., 2005, Xu et al., 2005). It is 
likely that this condition constrains the function of Sox2 on neural differentiation and 
enhances its ability of maintaining self-renewal in hESCs. By contrast, the UM and N2B27 
conditions exhibit low activity of TGF-β and high activity of BMP signalling (Gerrard et al., 
2005, Xu et al., 2005), which is unable to support self-renewal (Kaur et al., 2013) and favours 
differentiation to trophoblast (Xu et al., 2002) or extra-embryonic endoderm (Pera et al., 
2004). Under these conditions, high level of Sox2 alone is unable to sustain the pluripotency 
of hESCs. However, it appears to impede the hESC differentiation to extra-embryonic 
endoderm and promote the differentiation toward neural lineages.  
 
6.3 Identification of Pax6 as a binding partner of Sox2 in 
NPCs 
Given that Sox2 can exert dual functions in hESCs: retaining pluripotency of hESCs and 
inducing their neural differentiation upon exit of pluripotency, the molecular mechanism 
regarding how Sox2 can regulate distinct set of genes remains not fully understood. In this 
study, I found that that Pax6 is a binding partner of Sox2 in neural induction of hESCs. This 
paradigm supports a previous concept that all the Sox family proteins require cooperative 
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partners to exert their transcriptional regulation, as Sox2 alone is not sufficient to form a 
stable DNA-protein complex (Kamachi et al., 2000). A well-known analogous example is the 
co-binding of Sox2 and Oct4 in synergistically activation of FGF4 and UTF1 enhancers 
during murine embryogenesis (Ambrosetti et al., 1997, Nishimoto et al., 1999, Ambrosetti et 
al., 2000).  
 
Currently, what are the downstream targets of this complex is largely unknown, but, at least it 
targets Sox2, Pax6 themselves as well as Oct4. Analysing their bindings by performing ChIP-
qPCR in chromatin prepared from NPCs, I found that Sox2 and Pax6 can co-bind to the 
enhancer SRR2 of Sox2 which has been demonstrated to be one of the main regulatory region 
responsible for Sox2 expression in both ESCs and NPCs as well as its repression upon further 
differentiation to postmitotic cells, such as postmitotic neurons (Miyagi et al., 2004), 
indicating that Sox2/Pax6 complex might involve in the Sox2 regulation in NPCs. Also co-
recruiting Sox2 and Pax6 were found within Pax6 gene body. This binding area of Pax6 is 
also found in a genome-wide Pax6 ChIP-Seq date performing in NPCs, overlapping with a 
H3K27Ac peak (Figure 1.7) (Bhinge et al., 2014), suggesting that Sox2/Pax6 complex here 
might act to activate Pax6 expression. Despite a number of data have been shown the 
conserved regulatory elements across many species (Zheng et al., 2001, Griffin et al., 2002, 
Aota et al., 2003, Kleinjan et al., 2004, Sansom et al., 2009), little is known about the 
transcriptional regulation of Pax6 during neural initiation. Apart from these in vivo 
experiments, I have shown a dramatically downregulation of Pax6 upon Sox2 knockdown in 
NPCs. These together suggest that a positive auto-regulatory loop of sox2 and pax6 protein 
may be involved in the early neural differentiation and the expression of Sox2 and Pax6 is 
interdependent. In Oct4 locus, Pax6 was found to be recruited to the PE and DE area, again 
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with Sox2. Given that PE and DE are responsible for the regulation of Oct4 expression 
(Yeom et al., 1996) and Oct4 expression inversely correlated with Pax6 expression during my 
neural differentiation, it is plausible that Sox2/Pax6 complex here act as a repressor on Oct4 
expression. Functionally examining these bindings, I found that overexpression of Pax6 in 
hESCs led to a significant decrease on Oct4 PE or DE transcriptional activity, suggesting that 
Pax6 can bind to PE and DE as a transcriptional repressor, possibly together with Sox2.  
 
Since I found that Sox2 interacts with Oct4 and Pax6 by using a same interface, it is possible 
that there is a competition between Oct4 and Pax6 to interact with Sox2. When one of them 
becomes predominant in expression, it will dictate function of Sox2 to either maintaining 
pluripotency or inducing neural differentiation. This is also supported by a previous report 
that ectopic expression of Oct4 alone in NPCs is able to reprogram NPCs back to pluripotent 
stem cells, presumably by collaborating with the endogenous Sox2 (Kim et al., 2009). 
Correspondingly, ectopic expression of Pax6 in hESCs induces neural differentiation (Zhang 
et al., 2010), which provided further evidence to support this notion. Thus I propose a model 
that by changing its partner from Oct4 to Pax6, Sox2 switches its function from maintaining 
pluripotency genes to induce genes associated with neural differentiation, meanwhile 
repressing those pluripotency genes. This model provides a paradigm example to support the 
notion that the function of SOX proteins is highly dependent on the molecular and cellular 
context. They interact with other co-factors to distinguish their target genes and act in a cell 
type-specific fashion. 
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6.4 Future work 
6.4.1 Does Pax6 compete with Oct4 to bind to Sox2 during neural differentiation?   
I have shown that Sox2 uses same interface to interact with Pax6 and Oct4. It would be 
interesting to test this competitive relationship between Pax6 and Oct4, the experiments will 
be carried out in two ways: 1) increasing the amount of Oct4 in transgenic 293T cells which 
express endogenous Pax6 and has been stably transfected to express HA-Sox2 and then 
performing HA co-immunoprecipitation; 2) increasing the amount of Pax6 in transgenic 
HT1080 cells which are stably transfected to express Sox2 and Oct4 and then performing HA 
co-immunoprecipitation. I already stably transfected 293T cells with a HA-Sox2 expression 
vector and generated a Sox2 expressing cell line. Next, I will transfect this 293T-Sox2 cell 
line with an Oct4 expression vector which I already generated to examine whether Oct4 
interferes Pax6-Sox2 binding. In complement, I will express Pax6 in a Sox2 and Oct4 dual 
stably transfected HT1080 cell line which I already generated and then verify the Pax6 and 
Oct4 competition. 
 
6.4.2 Characterize the effect of Sox2/Oct4 and Sox2/Pax6 complexes on their 
target genes 
i. Identify target genes of the complexes 
Possible target candidates of Sox2, Oct4 and Pax6 will be selected based on published data. 
Several published datasets (Chip-microarray, or Chip-seq) are available for Sox2 and Oct4 in 
hESCs and Sox2 and Pax6 in hESC-derived neuroectoderm. The selection will be mainly 
focused on transcription factors that are important for pluripotency or neural differentiation. 
However, binding along does not indicate whether the TFs act to activate or repress the target 
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genes. Given that H3K27Ac is a reliable indicator of active enhancers and promoters and 
H3K27Me3 is associated with repressed regions (Creyghton et al., 2010, Rada-Iglesias et al., 
2011, Gifford et al., 2013), these genomic loci will be overlapped with H3K27Ac and 
H3K27Me3 peaks. Also the genome-wide RNA expression during neural differentiation from 
hESCs that our laboratory has generated previously (Wu et al., 2010) will also facilitate the 
selection. 
 
ii. Validate the binding and expression of candidate genes by the complexes 
2-3 of these candidate genes will be validated for the dynamic binding of Sox2, Oct4 and 
Pax6 by performing Chip-qPCR in undifferentiated ES cells, initial stage and committed 
neural progenitors. The transcriptional regulation by these factors will be verified by 
luciferase-reporter assays. 
 
6.4.3 Identify Sox2-centered interaction network during neural differentiation 
I propose that neural differentiation of hESCs is initiated by altering the interacting partner of 
Sox2 from Oct4 to other neural TFs. I have verified that Pax6 is one of the binding partners 
of Sox2 in neural differentiation. However, it cannot exclude that Sox2 may have other 
partners. For example, it has been shown that Sox2 also interacts with Brn2 during 
neurogenesis of mouse embryos (Tanaka et al., 2004, Lodato et al., 2013). Therefore, 
identifying the interaction partners of Sox2 important for neural initiation could add novel 
factors to the intrinsic regulation network and help to elucidate the mechanism of neural 
initiation. To identify other neural partners of Sox2, I plan to compare Sox2 nuclear 
immunoprecipitation at different stage of differentiation: hESCs, early neural induction 
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(around day 8) and early neural progenitor stage. The immunoprecipitation utilising isotype-
matched IgG will be used as control. Firstly, I will run immunoprecipitation in SDS-PAGE 
gel and stain the gel with instant coomassie blue solution to determine the quality of the 
immunoprecipitation. The bands come from the control group will be considered as 
contaminants. Then these SDS-PAGE gels will be analysed by Mass spectrometry. The 
binding partners of Sox2 from each stage of differentiation will be compared, thus helping us 
to comprehensively understand how the function of Sox2 shifts during differentiation. 
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